UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

  

Commission file number 000-55648

  

INNOVATIVE PAYMENT SOLUTIONS, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   33-1230229
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

56B 5th AvenueLot 1 #ATCarmel By The SeaCA   93921
(Address of Principal Executive Office)   (Zip Code)

 

(866) 477-4729
(Registrant’s telephone number, including area code)

 

n/a
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files.) Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐  Accelerated filer ☐ 
  Non-accelerated filer ☒  Smaller reporting company  
    Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

 

As of November 12, 2024, there were 18,731,446 shares of the Company’s Common Stock issued and outstanding.

 

 

 

 

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

 

Form 10-Q

For the Quarter Ended September 30, 2024

 

Index

 

    Page No.
     
Cautionary Note Regarding Forward-Looking Statements ii
     
Part I. Financial Information 1
     
Item 1. Financial Statements (Unaudited) 1
     
  Condensed Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 1
     
  Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2024 and 2023 (Unaudited) 2
     
  Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2024 and 2023 (Unaudited) 3
     
  Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (Unaudited) 5
     
  Notes to the Condensed Consolidated Financial Statements (Unaudited) 6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 42
     
Item 4. Controls and Procedures 42
     
Part II. Other Information 43
     
Item 1. Legal Proceedings 43
     
Item 1A. Risk Factors 44
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 45
     
Item 3. Defaults Upon Senior Securities 45
     
Item 4. Mine Safety Disclosures 45
     
Item 5. Other Information 45
     
Item 6. Exhibits 46
     
Signatures 47

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains “forward-looking statements” (as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the section of this Report entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Readers are cautioned that significant known and unknown risks, uncertainties and other important factors (including those over which we may have no control and others listed in this Report and in the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”)) may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. You can identify some of these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “potential,” “continue” or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:

  

  our ability to implement our business plan, including our ability to launch and generate revenue from our IPSIPay Express joint venture or other digital payment solutions we may seek to develop or commercialize in the future;

 

  acceptance by the marketplace of our products and services, notably IPSIPay Express;

 

  our proposed merger with Business Warrior Corporation;

 

  our ability to formulate, implement and modify as necessary effective sales, marketing, and strategic initiatives to drive revenue growth;

 

  the viability of our current intellectual property and intellectual property created in the future;

 

  our ability to comply with currently applicable laws and government regulations and those that may be applicable in the future;

 

  our ability to retain key employees and third-party service providers;

 

  adverse changes in general market conditions for payment solutions such as IPSIPay Express and other products and services we offer;

 

  our ability to generate cash flow and profitability and continue as a going concern;

 

  our future financing plans and ability to repay outstanding indebtedness; and

 

  our ability to adapt to changes in market conditions which could impair our operations and financial performance.

 

These forward-looking statements involve numerous and significant risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results of operations or the results of other matters that we anticipate herein could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in the “Management’s Discussion and Analysis of Financial Condition and Results of Operation,” section contain in this Report and in the “Business,” “Risk Factors” and other sections of the 2023 Form 10-K. You should thoroughly read this Report and the documents that we refer to with the understanding that our actual future results may be materially different from, and worse than, what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

The forward-looking statements made in this Report relate only to events or information as of the date of this Report. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this Report completely and with the understanding that our actual future results may be materially different from what we expect.

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Balance Sheets

 

   September 30,   December 31, 
   2024   2023 
   (Unaudited)     
Assets        
Current Assets        
Cash  $1,033   $50,433 
Receivable from equity method investment   800    
-
 
Notes receivable - current   131,405    
-
 
Other current assets   12,389    38,818 
Total Current Assets   145,627    89,251 
           
Non-current assets          
Plant and equipment   5,400    7,027 
Notes receivable, net of unamortized discount of $48,243   177,947    
-
 
Security deposit   5,000    5,000 
Equity method investment   703,778    703,938 
Total Non-Current Assets   892,125    715,965 
Total Assets  $1,037,752   $805,216 
           
Liabilities and Stockholders’ Equity (Deficit)          
           
Current Liabilities          
Accounts payable  $2,595,191   $2,023,375 
Federal relief loans – current portion   7,670    9,369 
Notes payable, net of unamortized discount of $60,870 and $0, respectively   1,390,229    1,062,007 
Convertible debt, net of unamortized discount of $184,626 and $687,503, respectively   4,916,822    3,704,280 
Derivative liability   1,569,103    1,434,196 
Total Current Liabilities   10,479,015    8,233,227 
           
Non-Current Liabilities          
Federal relief loans   150,000    150,000 
Total Non-Current Liabilities   150,000    150,000 
           
Total Liabilities   10,629,015    8,383,227 
           
Stockholders’ Equity (Deficit)          
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023.   
-
    
-
 
Common stock, $0.0001 par value; 750,000,000 shares authorized, 16,185,552 and13,819,889 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.   1,619    1,382 
Additional paid-in-capital   51,926,805    50,656,225 
Accumulated deficit   (61,519,687)   (58,235,618)
Total Stockholders’ Equity (Deficit)   (9,591,263)   (7,578,011)
Total Liabilities and Stockholders’ Equity (Deficit)  $1,037,752   $805,216 

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

1

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Operations

(Unaudited)

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
                 
Net Revenue  $
-
   $(28)  $
-
   $410 
                     
Cost of Goods Sold   
-
    387    
-
    2,756 
                     
Gross loss   
-
    (415)   
-
    (2,346)
                     
General and administrative   296,438    745,688    1,330,367    2,753,266 
Depreciation and amortization   543    100,387    1,627    380,092 
Total Expense   296,981   846,075    1,331,994    3,133,358 
                     
Loss from Operations   (296,981)   (846,490)   (1,331,994)   (3,135,704)
                     
Loss on convertible notes   (4,534,491)   (58,769)   (4,636,843)   (77,247)
Fair value adjustment to price protected warrants   (2,051,405)   -    (2,051,405)   
-
 
Penalty on convertible notes   (6,611)   (9,306)   (6,611)   (9,306)
Loss on novation   
-
    (1,066,165)   
-
    (1,066,165)
Fair value of warrants issued   
-
    (14,176)   
-
    (14,176)
Loss on disposal of assets   
-
    
-
    (2,600)   
-
 
Interest expense   (152,376)   (110,328)   (435,471)   (290,628)
Interest income   9,740    
-
    21,019    
-
 
Amortization of debt discount   (233,948)   (303,042)   (874,193)   (414,696)
Derivative liability movements   5,538,008    1,795,642    6,461,496    1,483,710 
Loss before Income Taxes   (1,728,064)   (612,634)   (2,856,602)   (3,524,212)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Net Loss after income taxes   (1,728,064)   (612,634)   (2,856,602)   (3,524,212)
                     
Net loss from equity method investments   (88)   (402,509)   (660)   (403,890)
Net loss from continuing operations   (1,728,152)   (1,015,143)   (2,857,262)   (3,928,102)
                     
Discontinued operations                    
Operating loss from discontinued operations   
-
    
-
    
-
    (40,821)
Loss on disposal of subsidiary and investment   
-
    
-
    
-
    (495,424)
    
-
    
-
    
-
    (536,245)
Net loss   (1,728,152)   
(1,015143
)   (2,857,262)   (4,464,347)
Net loss attributable to non-controlling interest   
-
    
-
    
-
    1,597 
Deemed dividend   (426,807)   
-
    (426,807)     
Net loss attributable to Innovative Payment Solutions, Inc., stockholders  $(2,154,959)  $(1,015,143)  $(3,284,069)  $(4,462,750)
                     
Basic and diluted loss per share*                    
Continuing operations*  $(0.15)  $(0.08)  $(0.23)  $(0.31)
Discontinued operations*   
-
    
-
    
-
    (0.04)
   $(0.15)  $(0.08)  $(0.23)  $(0.35)
Weighted Average Number of Shares Outstanding – Basic and diluted   14,546,060    12,789,493    14,063,713    12,650,758 

  

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to the unaudited condensed consolidated financial statements.

 

2

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)

(Unaudited)

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-
controlling
shareholders
interest
   Total
Stockholders’
Equity
(Deficit)
 
Balance at December 31, 2023   
-
   $
-
    13,819,889   $1,382   $50,656,225   $(58,235,618)  $
-
   $(7,578,011)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    44,813    
-
    
-
    44,813 
Fair value of warrants issued on debt extinguishment   -    
-
    -    
-
    66,047    
-
    
-
    66,047 
Fair value of warrants issued for services   -    
-
    -    
-
    36,207    
-
    
-
    36,207 
Stock based compensation   -    
-
    -    
-
    94,464    
-
    
-
    94,464 
Net loss   -    
-
    -    
-
    
-
    (331,465)   
-
    (331,465)
Balance at March 31, 2024   
-
   $
-
    13,819,889   $1,382   $50,897,756   $(58,567,083)  $
-
   $(7,667,945)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    42,863    
-
    
-
    42,863 
Fair value of warrants issued on debt extinguishment   -    
-
    -    
-
    36,305    
-
    
-
    36,305 
Fair value of warrants issued for services   -    
-
    -    
-
    36,207    
-
    
-
    36,207 
Stock based compensation   -    
-
    -    
-
    94,464    
-
    
-
    94,464 
Net loss   -    
-
    -    
-
    
-
    (797,645)   
-
    (797,645)
Balance at June 30, 2024   
-
   $
-
    13,819,889   $1,382   $51,107,595   $(59,364,728)  $
-
   $(8,255,751)
Conversion of convertible debt   -    
-
    2,365,663    237    357,972    
-
    
-
    358,209 
Deemed dividend on warrant anti-dilution   -    
-
    -    
-
    426,807    (426,807)   
-
    
-
 
Fair value of warrants issued for services   -    
-
    -    
-
    2,943    
-
    
-
    2,943 
Stock based compensation   -    
-
    -    
-
    31,488    
-
    
-
    31,488 
Net loss   -    
-
    -    
-
    
-
    (1,728,152)   
-
    (1,728,152)
Balance at September 30, 2024   -   $
-
    16,185,552   $1,619   $51,926,805   $(61,519,687)  $
-
   $(9,591,263)

 

3

 

 

   Preferred
Stock
Shares
   Amount   Common
Stock
Shares*
   Amount*   Additional
Paid-in
Capital*
   Accumulated
Deficit
   Non-
controlling
shareholders
interest
   Total
Stockholders’
Equity (Deficit)
 
Balance at December 31, 2022   
-
   $
-
    12,563,426   $1,256   $48,442,355   $(52,399,858)  $1,597   $(3,954,650)
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    251,856    
-
    
-
    251,856 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
    -    
-
    
-
    (273,390)   (1,597)   (274,987)
Balance at March 31, 2023   
-
   $
-
    12,563,426   $1,256   $48,824,882   $(52,673,248)  $
-
   $(3,847,110)
Conversion of convertible debt   
-
    
-
    72,464    7    43,471    
-
    
-
    43,478 
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    130,025    
-
    
-
    130,025 
Fair value of warrants issued for equity method investments   -    
-
    -    
-
    108,220    
-
    
-
    108,220 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
                   (3,174,217)   
-
    (3,174,217)
Balance as of June 30, 2023   
-
   $
-
    12,635,890   $1,263   $49,237,269   $(55,847,465)  $
-
   $(6,608,933)
Conversion of convertible debt   -    
-
    391,306    40    193,729    
-
    
-
    193,769 
Additional shares issued on reverse stock split   -    
-
    2,838    
-
    
-
    
-
    
-
    
-
 
Fair value of warrants issued for services   -    
-
    -    
-
    14,176    
-
    
-
    14,176 
Fair value of warrants issued to convertible debt holders   -    
-
    -    
-
    437,953    
-
    
-
    437,953 
Stock based compensation   -    
-
    -    
-
    130,671    
-
    
-
    130,671 
Net loss   -    
-
    -    
-
    
-
    (1,015,143)   
-
    (1,015,143)
Balance at September 30, 2023   -   $
-
    13,030,034   $1,303   $50,013,798   $(56,862,608)  $
-
   $(6,847,507)

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

4

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

   Nine months
ended
   Nine months
ended
 
   September 30,   September 30, 
   2024   2023 
CASH FLOWS FROM OPERATING ACTIVITIES:        
Net loss  $(2,857,262)  $(4,464,347)
Net loss from discontinued operations   
-
    536,245 
Net loss from continuing operations   (2,857,262)   (3,928,102)
Adjustments to reconcile net loss to net cash used in operating activities:          
Derivative liability movements   (6,461,496)   (1,483,710)
Depreciation   1,627    380,092 
Amortization of debt discount   874,193    414,696 
Loss on convertible debt   4,636,843    77,247 
Fair value adjustment to price protected warrants   2,051,405    
-
 
Loss on novation   
-
    1,066,165 
Penalty on convertible debt   6,611    9,306 
Deemed interest income   (19,614)   
-
 
Unrealized loss on equity method investments   660    403,890 
Warrants issued for services   75,357    122,797 
Stock based compensation   220,416    283,392 
Changes in Assets and Liabilities          
Receivable from equity method investments   (800)   
-
 
Other current assets   25,024    47,628 
Accounts payable and accrued expenses   571,816    1,150,919 
Related party payables   
-
    50,000 
Interest accruals   394,374    281,383 
Cash used in operating activities – continuing operations   (480,846)   (1,124,297)
Cash provided by operating activities – discontinued operations   
-
    35,286 
CASH USED IN OPERATING ACTIVITIES   (480,846)   (1,089,011)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Investment in notes receivable   (288,333)   
-
 
Investment in intangibles   
-
    (44,405)
Deposits refunded   
-
    4,800 
Investment in equity method investment   (500)   (1,000,000)
Net cash used in investing activities – continuing operations   (288,833)   (1,039,605)
Net cash used in investing activities – discontinued operations   
-
    (36,230)
CASH USED IN INVESTING ACTIVITIES   (288,833)   (1,075,835)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from notes payable   233,333    
-
 
Proceeds from convertible notes   785,502    2,001,666 
Repayment of convertible notes   (298,556)   (189,326)
Repayment of federal relief loans   
-
    (2,864)
Net cash provided by financing activities – continuing operations   720,279    1,809,476 
Net cash provided by financing activities – discontinued operations   
-
    
-
 
NET CASH PROVIDED BY FINANCING ACTIVITIES   720,279    1,809,476 
           
NET DECREASE IN CASH   (49,400)   (355,370)
Cash and cash included in assets held for sale at the beginning of the period   50,433    374,765 
CASH AT END OF PERIOD  $1,033   $19,395 
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $50,433   $373,822 
Cash included in assets held for sale   
-
    943 
CASH AT THE BEGINNING OF THE PERIOD  $50,433   $374,765 
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS          
Cash  $1,033   $19,395 
Cash included in assets held for sale   
-
    
-
 
CASH AT THE END OF THE PERIOD  $1,033   $19,395 
CASH PAID FOR INTEREST AND TAXES:          
Cash paid for income taxes  $
-
   $
-
 
Cash paid for interest  $41,096   $9,245 
NON-CASH INVESTING AND FINANCING ACTIVITIES          
Fair value of warrants issued with convertible notes  $87,676   $819,384 
Conversion of convertible debt to equity  $198,716   $160,000 
Fair value of warrants issued for equity method investments  $
-
   $108,220 

 

See notes to the unaudited condensed financial statements.

 

5

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Qpagos Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Qpagos Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the Qpagos “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Qpagos Merger Agreement, upon consummation of the Qpagos Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Qpagos Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Qpagos Merger. Prior to and as a condition to the closing of the Qpagos Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Qpagos Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Qpagos Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

  

On June 21, 2021, the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless delivered to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enabled payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

6

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

  

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  a) Organizational History (continued)

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below, the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 was impaired.

 

On August 30, 2023, the Company implemented a 1 for 30 reverse stock split of its Common Stock. Unless the context expressly requires otherwise, as used in this Report, all share and per share numbers reflect such reverse stock split.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express LLC (“IPSIPay Express”) joint venture. See note 1(b) for further information.

 

  b) Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Direct Payments as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express. This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company was required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023. In late 2023, the Company agreed with its joint venture partners that such investment was not required as IPEX is not operational. The need for any additional advances will be addressed with the joint venture partners once IPEX becomes operational and begins generating revenue, the Company’s current equity holding in IPSIPay Express remains at 22%.

 

7

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  b) Description of current business (continued)

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year Common Stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

  c) Merger Agreement with Business Warrior

 

On July 28, 2024, the Company entered into an Agreement and Plan of Merger (the “BW Merger Agreement”), by and among the Company, IPSI Merger Sub, Inc., a Delaware corporation and a newly formed, wholly owned subsidiary of the Company (“Merger Sub”) and Business Warrior.

 

Pursuant to the BW Merger Agreement, subject to the terms and conditions set forth therein, at the closing of the transactions contemplated by the BW Merger Agreement (the “Closing”), Merger Sub will merge with and into Business Warrior (the “BW Merger” and, together with the other transactions contemplated by the BW Merger Agreement, the “BW Transactions”), with Business Warrior continuing as the surviving Wyoming corporation in the BW Merger and a wholly owned subsidiary of the Company.

 

Subject to the terms and conditions set forth in the BW Merger Agreement, at the effective time of the BW Merger (the “Effective Time”): (i) each outstanding share of common stock, par value $0.0001 per share, of Business Warrior (“Business Warrior Common Stock”), other than treasury shares and shares as to which appraisal rights have been exercised, will be automatically converted into the right to receive a number of shares of Common Stock equal to the Applicable Per Share Portion (as defined in the BW Merger Agreement) of the BW Merger Consideration (as defined below), (ii) each outstanding share of preferred stock of Business Warrior (“Business Warrior Preferred Stock”), other than treasury shares and shares as to which appraisal rights have been exercised, will be automatically converted into the right to receive a number of shares of Common Stock equal to the Applicable Per Share Portion (as defined in the BW Merger Agreement) of the BW Merger Consideration (as defined below) had such share of Business Warrior Preferred Stock been converted into shares of Business Warrior Common Stock immediately prior to the Effective Time and (iii) any other options, warrants or rights to subscribe for or purchase any capital stock of Business Warrior or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital stock of Business Warrior, if not exercised or converted prior to the Effective Time, shall be cancelled, retired and terminated.

 

Merger Consideration 

 

Pursuant to the terms of the BW Merger Agreement, the consideration to be delivered to the holders of Business Warrior Common Stock and Business Warrior Preferred Stock in connection with the BW Merger Consideration (the “BW Merger Consideration”) will be a number of newly issued shares of Common Stock representing forty-five percent (45%) of the Common Stock outstanding immediately following the Closing, and after giving effect to the conversion, exercise or cancellation of the Business Warrior Preferred Stock and other Business Warrior securities referred to above.

 

8

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

  

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  c) Merger Agreement with Business Warrior (continued)

 

Representations and Warranties

 

The BW Merger Agreement contains representations and warranties of each of the Company, Merger Sub and Business Warrior that are customary for similar transactions and that include certain qualifications and customary exceptions, as applicable.

  

Covenants of the Parties

 

The BW Merger Agreement includes customary covenants of the parties with respect to, among others things, (i) operation of their respective businesses prior to consummation of the BW Merger and efforts to satisfy conditions to consummation of the BW Merger, (ii) access to information, (iii) cooperation in the preparation of the registration statement on Form S-4 (as may be amended or supplemented from time to time, the “Registration Statement”) which the Company is expected to file with the U.S. Securities and Exchange Commission (“SEC”) in connection with the BW Merger and the Transactions, (iv) use of reasonable best efforts to obtain regulatory approvals, (v) notification of the other party of certain breaches, (vi) Section 16 matters, (vii)  indemnification of directors and officers and tail insurance and (viii) obtaining all requisite approvals of each party’s respective stockholders. Additionally, Business Warrior has agreed not to solicit or enter into a competing alternative transaction (an “Alternative Transactions”), subject to the fiduciary duties of the board of directors Business Warrior, in accordance with customary terms and provisions set forth in the BW Merger Agreement.

 

The parties agreed to take all necessary actions to cause the Company’s board of directors immediately after Closing to consist of five directors, including: (i) two persons who are designated by the Company prior to Closing, (ii) two persons who are designated by Business Warrior prior to Closing and (iii) one person mutually agreed upon by the Company and Business Warrior.

 

Conditions to Consummation of the Merger; Convertible Note Exchange

 

Each party’s obligation to consummate the BW Merger is conditioned upon, among other things: (i) approval by the Company stockholders of the amendment to its certificate of incorporation (“the Company Stockholder Approval”), (ii) approval by Business Warrior stockholders of the BW Merger and related transactions and matters (“Business Warrior Stockholder Approval”), (iii) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and all other requisite regulatory approval, (iv) the absence of any applicable law or order that makes illegal, or prohibits or prevents, the Transactions and (v) the Registration Statement having become effective in accordance with the provisions of the Securities Act of 1933, as amended (“Securities Act”).

 

In addition, each party’s obligation to consummate the BW Merger is conditioned upon the following agreements being in full force and effect: (i) exchange agreements, to be entered into by and among the Company, Business Warrior and each holder of the outstanding convertible notes of the Company (the “Company Exchange Agreements”), pursuant to which each outstanding convertible note of the Company will be exchanged for shares of newly-issued shares of a newly designated Series A Convertible Preferred Stock of the Company (the “Company Series A Preferred”) and (ii) exchange agreements, to be entered into by and among the Company, Business Warrior and each holder of the outstanding convertible notes of Business Warrior (the “Business Warrior Exchange Agreements”), pursuant to which each outstanding convertible note of Business Warrior will be exchanged for shares of newly-issued shares of Company Series A Preferred. The designation of the Company Series A Preferred is subject to the Company Stockholder Approval. Further, as of the date of this Report, the terms of the Company Series A Preferred remain subject to negotiation between the Company, Business Warrior and the holders of such convertible notes. The Company and Business Warrior have certain convertible note holders in common.

 

In addition, the Company’s obligation to consummate the BW Merger is conditioned upon, among other things: (i) the representations and warranties of Business Warrior being true and correct on and as of the Closing Date (as defined in the Merger Agreement) as if made on the Closing Date (subject to certain exceptions and an overall “Material Adverse Effect” standard), (ii) Business Warrior having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the BW Merger Agreement to be performed or complied with by it on or prior to the Closing Date and (iii) receipt by the Company of each Lock-Up Agreement (as defined below) and Employment Agreement (as defined in the BW Merger Agreement).

 

9

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  c) Merger Agreement with Business Warrior (continued)

 

Business Warrior’s obligation to consummate the BW Merger is further conditioned upon, among other things: (i) the representations and warranties of the Company being true and correct on and as of the Closing Date as if made on the Closing Date (subject to certain exceptions and an overall “Material Adverse Effect” standard) and (ii) the Company and Merger Sub having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the BW Merger Agreement to be performed or complied with by it on or prior to the Closing Date.

 

Termination

 

The BW Merger Agreement may be terminated at any time prior to the Effective Time by either the Company or Business Warrior if the BW Merger and related transactions are not consummated on or before the seven-month anniversary of the date of the Merger Agreement (the “Termination Date”), provided that the Termination Date shall be automatically extended to the nine-month anniversary of the BW Merger Agreement if the conditions to closing, other than receipt of the Company Stockholder Approval and Business Warrior Stockholder Approval, effectiveness of the Registration Statement and that the Company Exchange Agreements and Business Warrior Exchange Agreements are in full force and effect, have been satisfied.

   

The BW Merger Agreement may also be terminated under certain other customary and limited circumstances at any time prior the Closing, including, among other reasons (i) by mutual written consent of the Company and Business Warrior, (ii) by written notice by either the Company or Business Warrior if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the BW Merger, and such order or other action has become final and non-appealable, (iii) by written notice by Business Warrior of the Company’s or Merger Sub’s uncured breach of a representation, warranty, or covenant contained in the BW Merger Agreement that would cause the related condition to closing to not be satisfied, (iv) by written notice by the Company of Business Warrior’s uncured breach of a representation, warranty, or covenant contained in the BW Merger Agreement that would cause the related Closing condition to not be satisfied or a material breach of a Business Warrior Voting and Support Agreement (as defined below), (v) by either the Company or Business Warrior if Business Warrior holds its stockholder meeting to approve the BW Merger Agreement and the BW Merger, and Business Warrior Stockholder Approval is not obtained, (vi) by the Company if Business Warrior’s board of directors has failed to recommend or shall have withdrawn, amended or modified in any respect materially adverse to the Company its recommendation of the BW Merger Agreement or shall have recommended another proposal for an Alternative Transaction or accepted a Superior Proposal (as defined in the BW Merger Agreement) and (vii) by Business Warrior if, prior to receipt of Business Warrior Stockholder Approval, Business Warrior accepts a Superior Proposal, subject to the terms and conditions of the BW Merger Agreement.

 

Governing Law

 

The Merger Agreement is governed by the laws of the State of New York and the parties are subject to the jurisdiction of any New York state court or any federal court sitting in the State of New York in any action arising out of or relating to the Merger Agreement.

 

Certain Agreements Related to the Merger Agreement

 

Business Warrior Voting and Support Agreements

 

In connection with the execution of the Merger Agreement, on July 29, 2024, certain stockholders of Business Warrior, including Rhett Doolittle and Jonathan Brooks, the Chief Executive Officer and President, respectively, of Business Warrior (the “Business Warrior Holders”) entered into support agreements with the Company (the “Business Warrior Voting and Support Agreements”), pursuant to which such Business Warrior Holders agreed, among other things, to vote all shares of capital stock of Business Warrior beneficially owned by the Business Warrior Holders (the “Business Warrior Shares”) in favor of the BW Merger and related transactions. Such Business Warrior Holders also agreed to take certain other actions in support of the BW Merger Agreement and related transactions (and any actions required in furtherance thereof) and refrain from taking actions that would adversely affect such Business Warrior Holders’ ability to perform their obligations under the Business Warrior Voting and Support Agreement. Pursuant to the Business Warrior Voting and Support Agreements, the Business Warrior Holders also agreed not to transfer the Business Warrior Shares during the period from and including the date of the Business Warrior Voting and Support Agreement and the first to occur of the Effective Time or the date on which the Business Warrior Support Agreement is terminated, except for certain permitted transfers where the recipient also agrees to comply with the Business Warrior Voting and Support Agreement.

 

10

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

1 ORGANIZATION AND DESCRIPTION OF BUSINESS (continued)

 

  c) Merger Agreement with Business Warrior (continued)

 

Certain Agreements Related to the Merger Agreement (continued)

 

Lock-Up Agreements

 

Concurrently with and effective upon the Closing, officers, directors and certain stockholders of Business Warrior (each, a “Significant Stockholder”) shall each enter into a Lock-Up Agreement with the Company (each, a “Lock-Up Agreement”). Pursuant to the Lock-Up Agreements, with respect to the shares received as BW Merger Consideration, each Significant Stockholder may not, with limited exceptions, transfer shares, or publicly disclose the intention to transfer shares until the twelve-month anniversary of the Closing.

   

2 ACCOUNTING POLICIES AND ESTIMATES

 

  a) Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

  b) Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of September 30, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, the Company currently has no subsidiaries.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

  c) Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services, debt extinguishments or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

11

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, notes receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. In particular, there is a risk that that IPSIPay Express business (the commercial launch of which has taken longer than originally expected) may never generate revenue for the Company. There are also significant risks and uncertainties associated with the Company’s proposed merger with Business Warrior (see notes 1(c) and 6 for further information). Further, the ongoing wars in Ukraine and between Israel, Hamas and more recently, Hezbollah and uncertainties regarding the global economic environment which has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

12

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

 

  h) Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2024 and 2023.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on the balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

13

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description  Estimated
Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

  m) Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $0 and $410 for the nine months ended September 30, 2024 and 2023, respectively. 

 

14

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value include, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

15

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

2 ACCOUNTING POLICIES AND ESTIMATES (continued)

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

 

3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the nine months ended September 30, 2024, the Company had a net loss of $2.86 million. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2024, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended September 30, 2024 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and, ultimately, becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about its ability to continue as a going concern.

 

4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 1,000,000 (30,000,000 pre-split) shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18-month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

16

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH (continued)

 

The assets and liabilities disposed of were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 

 

5 DISCONTINUED OPERATIONS

 

In the prior year, effective May 12, 2023, the Company disposed of its investment in Beyond Fintech.

 

The statement of operations from discontinued operations is as follows:

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
                 
Net Revenue  $
               -
   $
               -
   $
               -
   $
               -
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    
-
    
-
    40,821 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    
-
    
-
    40,821 
                     
Loss from operations before income taxes   
-
    
-
    
-
    (40,821)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $
-
   $
-
   $(40,821)

 

17

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

6 LOANS RECEIVABLE

 

On February 22, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned funds to Business Warrior in the principal amount of $226,190, which includes an original issue discount equal to $67,857, for net proceeds to Business Warrior of $158,333. The loan is memorialized by a secured promissory note (the “Business Warrior Note”). The Business Warrior Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The Business Warrior Note matures on the earlier to occur of December 31, 2025 and the date that Business Warrior securities are listed on a national securities exchange. The Business Warrior Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. The Company has the right to exchange the Business Warrior Note for securities issued by Business Warrior in any subsequent private placement by Business Warrior. The principal and accrued interest under Business Warrior Note is convertible into common stock of Business Warrior at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. Business Warrior’s obligations under the Business Warrior Note are guaranteed by Business Warrior’s subsidiaries and secured by a lien on Business Warrior’s accounts receivable.

 

The debt discount on the Business Warrior’s note is amortized as income utilizing the effective interest rate method.

 

Between June 19, 2024 and September 10, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned additional funds to Business Warrior in the aggregate principal amount of $130,000 (the “2024 Business Warrior Note”). The 2024 Business Warrior Notes accrues interest at 8% per annum and matures between November 1, 2024 and February 1, 2025. The 2024 Business Warrior Notes plus any accrued interest may be prepaid at any time without penalty.

 

Loans receivable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
 
Business Warrior Corporation  0.0%  December 31, 2025  $226,190   $
-
   $(48,243)  $177,947 
   8.0%  November 1, 2024   30,000    677    
-
    30,677 
   8.0%  January 1, 2025   35,000    399         35,399 
   8.0%  February 1, 2025   50,000    263         50,263 
   8.0%  February 1, 2025   15,000    66         15,066 
Total convertible notes payable        $356,190   $1,405   $(48,243)  $309,352 
Disclosed as follows:                          
Current portion of notes receivable                       $131,405 
Long-term portion of notes receivable                        177,947 
                        $309,352 

  

Discount amortized to income as deemed interest during the three months and nine months ended September 30, 2024 was $8,407 and $19,614, respectively.

 

Interest earned for the three and nine months ended September 30, 2024 was $1,333 and $1,405, respectively.

 

7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. Prior to the disposal of Beyond Fintech to Frictionless the Company spent an additional 77,211 on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, prior to the novation of the rights and obligation to a third party, the Company spent an additional $1,171,805 to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party.

 

Amortization expense was $0 and $93,095 for the three months ended September 30, 2024 and 2023, respectively, and $0 and $347,298 for the nine months ended September 30, 2024 and 2023, respectively.

 

18

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay. As described in Note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of September 30, 2024, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended September 30, 2024 and December 31, 2023 is as follows:

 

   September 30,
2024
   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (660)   
-
 
   $703,778   $703,938 

  

9 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90-day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Operating lease expense  $
                -
   $40,704 

 

Other lease information:

 

   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
                -
   $(40,704)
           
Remaining lease term – operating lease   -    Monthly 

 

19

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

  

10 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $7,670 and $9,369 on this loan as of September 30, 2024 and December 31, 2023, respectively.

 

11 NOTES PAYABLE

 

Notes payable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.00%  October 31, 2024  $482,000   $85,689   $
-
   $567,689   $531,004 
Mercer Street Global Opportunity Fund, LLC  10.00%  October 31, 2024   482,000    85,689    
-
    567,689    531,003 
2024 notes  8.5%  February 28, 2025 to May 5, 2025   311,111    4,609    (60,869)   254,851    
-
 
Total notes payable        $1,275,111   $175,987   $(60,869)  $1,390,229   $1,062,007 

  

Interest expense totaled $28,489 and $24,635 for the three months ended September 30, 2024 and 2023, respectively, and $77,980 and $73,371 for the nine months ended September 30, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $14,248 and $0 for the three months ended September 30, 2024 and 2023, respectively, and $16,908 and $0 for the nine months ended September 30, 2024 and 2023, respectively.

 

Cavalry Fund I LP and Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in note 12 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024 with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

20

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

11 NOTES PAYABLE (continued)

 

2024 Notes

 

Between May 29, 2024 and September 9, 2024, the Company entered into five Securities Purchase Agreements with three accredited investors, pursuant to which the Company issued five non-convertible promissory notes (the “2024 Notes”) with an aggregate principal amount of $311,111 for gross proceeds of $233,333, after taking into account an aggregate original issuance discount of $77,778.

 

The 2024 Notes mature between February 28, 2025 and June 6, 2025 and bear interest at 8.5% per annum.

 

The 2024 Notes have restrictions relating to fundamental transactions which require the approval of the note holder, in addition the note holder has an optional redemption right on subsequent transactions that may require the Company to redeem all or part of the Note, at a premium of 120% of the cash amount of the Note, at the note holder’s discretion.

 

12 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

  (1) The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 to $0.345 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 shares.

 

  (2) The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

  (3) Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

  (4) Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 per share; and

 

  (5) The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

21

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

12 CONVERTIBLE NOTES PAYABLE (continued)

 

December 2022 Note Amendment Transaction (continued)

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 to $0.345 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $43,608 and the value of the notes of $964,000 (see note 11 above) and the value of full ratchet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003, the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023, on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, other than the maturity date all other terms remained the same. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.0%  October 31, 2024  $868,951   $46,925   $
-
   $915,876   $909,218 
Mercer Street Global  Opportunity Fund, LLC  10.0%  October 31, 2024   901,334    222,687    
-
    1,124,021    1,139,764 
Red Road Holdings Corporation*  29.32%  -   
-
    
-
    
-
    
-
    41,771 
   27.77%  -   
-
    
-
    
-
    
-
    18,683 
   32.04%  September 30, 2024   7,900    181    
-
    8,081    3,109 
   24.98%  December 30, 2024   88,500    11,657    (29,608)   70,549    
-
 
   24.51%  March 30, 2025   125,080    8,481    (81,437)   52,124    
-
 
Quick Capital, LLC*  11.12%  -   
-
    
-
    
-
    
-
    
-
 
   11.03%  November 28, 2024   57,144    6,871    (2,406)   61,609    
-
 
2023 and 2024 convertible notes   8.0 to 12.0%  May 22, 2024 to May 9, 2025   2,523,890    231,847    (71,175)   2,684,562    1,591,735 
Total convertible notes payable        $4,572,799   $528,649   $(184,626)  $4,916,822   $3,704,280 

 

* The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $121,916 and $83,829 for the three months ended September 30, 2024 and 2023, respectively, and $351,764 and $212,886 for the nine months ended September 30, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $219,700 and $303,042 for the three months ended September 30, 2024 and 2023, respectively, and $857,284 and $414,696 for the nine months ended September 30, 2024 and 2023, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

22

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

12 CONVERTIBLE NOTES PAYABLE (continued)

 

Cavalry Fund LP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of principal into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

Between September 5, 2024 and September 10, 2024, Cavalry converted $30,029 of principal and $31,527 of interest into 732,815 shares of Common Stock at a conversion price of $0.084 per share realizing a loss on conversion of $32,253. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084 (see note 13).

 

The balance of the Cavalry Note plus accrued interest at September 30, 2024 was $915,876.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of Common Stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Mercer entered into a note amendment with the Company extending the maturity date of the convertible note to April 30, 2024. with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC 470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

Between August 20, 2024 and September 5, 2023, Mercer converted an aggregate principal amount of $90,420 into 1,076,433 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $84,291. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084 (see note 13).

 

The balance of the Mercer Note plus accrued interest at September 30, 2024 was $1,124,021.

 

23

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

12 CONVERTIBLE NOTES PAYABLE (continued)

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The RRH note 1 was repaid in full during the quarter ended June 30, 2024.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

On August 6, 2024, RRH converted an aggregate of $13,833, including a penalty of $4,611 into 164,679 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $28,984, thereby extinguishing the note.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at September 30, 2024 was $8,081.

     
 

On April 2, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $70,000, after an original issue discount and fees of $18,500 in exchange for the issuance of a $88,500 Convertible Note (“RRH Note 4”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 24.98%, and maturing on December 30, 2024. The RRH Note 4 has mandatory repayments of $61,065 on September 30, 2024 and $13,570 per month on October 30, 2024, November 30, 2024 and December 30, 2024. The RRH Note 4 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion.

 

The balance of the RRH Note 4 plus accrued interest at September 30, 2024 was $70,549, net of unamortized debt discount of $29,608.

     
 

On June 25, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $25,080 in exchange for the issuance of a $125,080 Convertible Note (“RRH Note 5”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 24.51%, and maturing on March 30, 2025. The RRH Note 5 has mandatory repayments of $93,498 on December 30, 2024 and $16,782 per month on January 30, 2025, February 28, 2025 and March 30, 2025. The RRH Note 5 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion.

 

The balance of the RRH Note 5 plus accrued interest at September 30, 2024 was $52,124, net of unamortized debt discount of $81,437.

 

Quick Capital, LLC

 

 

On March 4, 2024, the Company closed a transaction with Quick Capital, LLC (“Quick Capital”) pursuant to which the Company received net proceeds of $94,000, after an original issue discount and fees of $20,286 in exchange for the issuance of a $114,286 Convertible Note (“Quick Cap Note 1”) , bearing interest at an effective interest rate of 11.12% per annum, which interest is earned on issuance of the note, and maturing on September 4, 2024. The Quick Cap Note 1 has monthly 30,875 commencing on May 4, 2024. The Note was convertible into shares of Common Stock at an adjusted conversion price of $0.084 per share, in addition, the Company issued a warrant exercisable for 357,764 shares of Common Stock at an initial exercise price of $0.345 per share. The warrant has full ratchet price protection which has resulted in the number of shares exercisable under the warrant increasing to 1,469,388 and the exercise price being amended to $0.084 per share.

 

The Company had repaid an aggregate of $92,523 of the principal and interest outstanding and between September 6, 2024 and September 17, 2024, Quick Capital converted an aggregate of $32,906, including a penalty of $2,000 into 391,736 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $13,965, thereby extinguishing the note.

 

24

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

12 CONVERTIBLE NOTES PAYABLE (continued)

 

Quick Capital, LLC (continued)

 

 

On May 28, 2024, the Company closed a transaction with Quick Capital pursuant to which the Company received net proceeds of $46,500, after an original issue discount and fees of $10,644 in exchange for the issuance of a $57,144 Convertible Note (“Quick Cap Note 2”), bearing interest at an effective interest rate of 11.03% per annum, which interest is earned on issuance of the note, and maturing on November 28, 2024. The Quick Cap Note 2 has monthly 15,429 commencing on July 28, 2024. The Note is convertible into shares of Common Stock at an adjusted conversion price of $0.084 per share, in addition, the Company issued a warrant exercisable for 178,882 shares of Common Stock at an initial exercise price of $0.345 per share. The warrant has full ratchet price protection which has resulted in the number of shares exercisable under the warrant increasing to 734,694 and the exercise price being amended to $0.084 per share.

 

No repayments have been made on the Quick Capital Note 2 which provides for a no notice default, whereupon the note accrues penalty interest at a rate of 24% per annum on the total balance outstanding. Penalty interest amounting to $2,597 has been accrued on the Quick Capital 2 note as at September 30, 2024.

 

The balance of the Quick Capital note plus accrued interest at September 30, 2024 was $61,610, net of unamortized debt discount of $2,406.

 

2023 and 2024 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors to purchase convertible notes (the “2023 Convertible Notes”). Between February 6, 2024 and August 9, 2024, the Company entered into Securities Purchase Agreements with 8 accredited investors to purchase convertible notes (the “2024 Convertible Notes”). The Company received an aggregate of $2,026,666 from the 2023 Convertible Notes and $475,002 from the 2024 Convertible Notes, in gross proceeds in private placements through the issuance of:

 

  the 2023 Convertible Notes and the 2024 Convertible Notes; and

 

  five-year warrants to purchase an aggregate 5,696,586 shares of Common Stock associated with the 2023 Convertible Notes (the “2023 Warrants”) and an aggregate of 289,856 shares of Common Stock associated with the 2024 Convertible Notes (the “2024 Warrants”), at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Convertible Notes and the 2024 Convertible Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Convertible Notes and 2024 Convertible Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the 2023 Convertible Notes and the 2024 Convertible Notes or the 2023 Warrants and the 2024 Warrants, for public resale.

 

The 2023 Convertible Notes, the 2024 Convertible Notes and the 2023 Warrants and the 2024 Warrants contain conversion limitations providing that a holder thereof may not convert or exercise such securities to the extent that, if after giving effect to such conversion or exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 ($200,000 and $25,000, respectively) which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the extension, the Company issued the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as consideration for the extension, the note holders were issued additional warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share. The modification was assessed in terms of ASC 470 and determined to be a debt extinguishment, resulting in the warrant value of $66,047 being expensed as a loss on convertible notes.

 

At September 30, 2024, notes with a principal amount of $1,676,666 and accrued interest thereon on $186,789 have matured. No further extensions on notes that have matured or are expected to mature prior to and subsequent to the date of this Report have been requested or granted. Pursuant to the Merger Agreement entered into with Business Warrior on July 28, 2024 and as a condition precedent to the consummation of the merger contemplated thereunder, the Company is negotiating with all of its convertible note holders to exchange such convertible notes for shares to be designated and issued as Series A Convertible Preferred Stock of the Company. The terms of the exchange and such Series A Convertible Preferred Stock are still to be determined and are subject to Company stockholder approval.

 

The balance of the 2023 Convertible Notes and the 2024 Convertible Notes plus accrued interest at September 30, 2024 was $2,684,562, net of unamortized debt discount of $71,175.

 

25

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

13DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described in Note 12 have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

Between September 12, 2023 and December 20, 2023, and between April 2, 2024 and June 25, 2024, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 and $268,873, respectively, but limited to the cash value of the convertible notes of $235,000 and $170,000, respectively, using a Black-Scholes valuation model.

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12) pursuant to which $13,833 of the remaining principal, interest and late payment penalty under the RRH 2 Note was converted into 164,679 shares of Common Stock at a conversion price of $0.084 per share. As a result of the conversion of the RRH Note 2, all other outstanding promissory notes and warrants of the Company that contain price-based anti-dilution protection had the conversion prices of such notes and the exercise price of such warrants adjusted to $0.084 per share and certain warrants of the Company that contain “full ratchet” anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.084 per share (the “Triggering Event”).

 

Convertible notes with an aggregate principal and interest balance outstanding on August 6, 2024 of $2,165,578 have such price-based anti-dilution protection. Based on the conversion by the RRH Note 2 as described above, the conversion price of these notes will reset to $0.084. In addition, certain warrants exercisable for 3,145,342 shares of common stock at an exercise price of $0.345 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 9,773,028 to a total number of shares of Common Stock exercisable for such warrants of 12,918,370. In addition to this, certain warrants exercisable for 457,897 shares of common stock have exercise price protection which will reduce the exercise price of these warrants to $0.084 per share from $0.345 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $119,511.

 

The value of the derivative liability related to the anti-dilution price protected convertible notes and warrants was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability of $4,318,669 on the convertible notes and $2,051,405 on the warrants. In addition, a payment was not made on a convertible note with a no notice default clause, resulting in the triggering of a variable priced conversion feature, which gave rise to a derivative liability on the payment due date, this gave rise to an additional derivative liability of $56,329, both determined using a Black-Scholes valuation model.

 

The net mark-to-market movement of the derivative liability for the three months ended September 30, 2024 was a net mark-to-market credit of $5,538,008 and for the nine months ended September 30, 2024 was a net mark-to-market credit of $6,461,496, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   nine months
ended
September 30,
2024
   Year ended
December 31,
2023
 
Conversion price  $ 0.0491 to $0.345    $ 0.104 to $0.345 
Risk free interest rate   3.58 to 5.50 %    3.60 to 5.55% 
Expected life of derivative liability   1 to 35 months      3.5 to 47 months 
Expected volatility of underlying stock   24.3 to 262.09%      158.72 to 217.01% 
Expected dividend rate   0%    0% 

 

The movement in derivative liability is as follows:

 

   September 30,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   226,329    385,000 
Derivative liability arising on anti-dilutive convertible notes and warrants   6,370,074    
-
 
Fair value adjustment to derivative liability   (6,461,496)   (1,501,446)
   $1,569,103   $1,434,196 

 

26

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 16,185,552 and13,819,889 shares of Common Stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt.

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12) pursuant to which $13,833 of the remaining principal, interest and late payment penalty under the RRH 2 Note was converted into 164,679 shares of Common Stock at a conversion price of $0.084 per share. As a result of the conversion of the RRH Note 2, a warrant, with full ratchet anti-dilution price protection, exercise price was reduced from $0.345 per share to $0.084 per share and the number of shares exercisable was increased from 3,145,342 shares to 12,918,370 shares, resulting in a deemed dividend charge and a credit to additional paid in capital of $426,807.

 

Between August 6, 2024 and September 17, 2024, in terms of conversion notices received from 4 convertible note holders, including the RRH Note 2 described above, the Company issued 2,365,663 shares of common stock for the conversion of $198,716 of convertible debt at a conversion price of $0.084 per share, realizing an aggregate loss on conversion of $159,493.

 

27

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14STOCKHOLDERS’ EQUITY (continued)

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding September 30, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at September 30, 2024 is as follows:

 

    Restricted Stock
Granted and Vested
 
Grant date Price   Number Granted*   Weighted Average
Fair Value per Share*
 
$1.47              683,167   $     1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 for the three and nine months ended September 30, 2024 and 2023. 

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2024 and December 31, 2023.

 

  d. Warrants

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

On August 11, 2023, the Company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of Common Stock at an exercise price of $1.50 per share.

 

28

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above. As of the date of this Report, it is not expected that the full IPSI Capital Contribution will be required to be funded.

 

On December 14, 2023, the maturity date of two notes totaling $225,000 ($200,000 and $25,000, respectively) which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the maturity date extension, the Company issued the note holders five-year warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

  

During 2023, warrants exercisable for 33,334 shares expired as unexercised and an additional warrant exercisable for 1,000,000 shares of Common Stock was forfeited on the disposal of Frictionless and Beyond Fintech.

 

On March 4, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, as disclosed in note 12 above. In terms of the Securities Purchase Agreement, the Company issued a five-year warrant to purchase an aggregate of 357,764 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share.

 

Between May 3, 2024 and May 28, 2024, the Company entered into a Securities Purchase Agreements with four accredited investors, as disclosed in note 12 above. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 468,738 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

29

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12). As a result of the conversion of the RRH Note 2, all warrants of the Company that contain price-based anti-dilution protection had the exercise price of such warrants adjusted to $0.084 per share and certain warrants of the Company that contain “full ratchet” anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.084 per share. Certain warrants exercisable for 3,145,342 shares of common stock at an exercise price of $0.345 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 9,773,028 to a total number of shares of Common Stock exercisable for such warrants of 12,918,370 and a reduction in the exercise price to $0.084 per share from $0.345 per share, In addition to this, certain warrants exercisable for 457,897 shares of common stock have exercise price protection which reduced the exercise price of these warrants to $0.084 per share from $0.345 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $119,511. This resulted in a fair value adjustment charge of $2,478,211 of which $2,051,405 was recorded as a charge to the statement of comprehensive loss as it related to warrants subject to derivative liability treatment and $426,807 was recorded as a deemed dividend expense, as it related to a down round adjustment to the price of a warrant issued during the current year, which is not subject to derivative liability treatment.

 

The 2023 and 2024 Warrants contain exercise limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

  

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months ended
September 30,
2024
 
Exercise price  $0.084 to 0.345 
Risk free interest rate   3.73 to 4.56% 
Expected life   1 to 5 years 
Expected volatility of underlying stock   

177.78 to 191.17%

 
Expected dividend rate   0% 

 

A summary of warrant activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   1,506,638    0.345    0.345 
Increase in warrants issued due to anti-dilution price protection   9,773,028    0.084    0.084 
Forfeited   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   21,721,759   $0.084 – 5.625   $0.3196 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

30

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14STOCKHOLDERS’ EQUITY (continued)

 

  d. Warrants (continued)

 

The warrants outstanding and exercisable at September 30, 2024 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$             0.084    13,376,267    3.12                  13,376,267                     3.12 
$0.345    6,959,041    3.89         6,959,041         3.89 
$0.450    266,668    3.73         266,668         3.73 
$1.035    500,000    0.77         500,000         0.77 
$1.500    33,334    3.87         33,334         3.87 
$4.50    505,560    1.46         505,560         1.46 
$5.625    80,889    1.46         80,889         1.46 
      21,721,759    3.28   $0.3196    21,721,759   $0.3196    3.28 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $13,376 and $0 as of September 30, 2024 and 2023.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

During 2023, the Company cancelled options exercisable for 23,891 shares of Common Stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

31

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

14 STOCKHOLDERS’ EQUITY (continued)

 

  e. Stock options (continued)

 

During 2024, the Company options exercisable for 6,667 shares of Common Stock expired due to the resignation of a director whose options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

A summary of option activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   1,543,891   $1.20 to 12.00   $       4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (6,667)   1.20    1.20 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   1,513,335   $1.20 to 12.00   $4.47 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at September 30, 2024 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    13,334       7.96                13,334         7.96 
$4.50    1,500,001    7.19         1,500,001         7.19 
      1,513,335    7.20   $     4.47    1,513,335   $       4.47          7.20 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2024 and 2023.

 

The option expense was $31,488 and $94,464 for the three months ended September 30, 2024 and 2023, respectively, and $220,416 and $283,392 for the nine months ended September 30, 2024 and 2023, respectively.

 

32

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

  

15 LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
Expense on extension of maturity date of convertible notes   -    
-
    102,352    
-
 
Loss on conversion of convertible notes   159,493    58,769    159,493    77,247 
Loss on anti-dilution price protection adjustment   4,318,669    
-
    4,318,669    
-
 
Loss on no notice default convertible note   56,329    
-
    56,329    
-
 
    4,534,491    58,769    4,636,843    77,247 

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes which matured between February 13, 2024 and February 23, 2024 by six months and issued the note holders additional warrants exercisable for 387,673 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

 

The debt extinguishments resulted in a charge of $0 and $102,352 for the three and nine months ended September 30, 2024, respectively.

 

Between August 6, 2024 and September 17, 2024, in terms of conversion notices received from 4 convertible note holders, the Company issued 2,365,663 shares of common stock for the conversion of $198,716 of convertible debt at a conversion price of $0.084 per share, realizing an aggregate loss on conversion of $159,493.

 

As a result of the conversion of the RRH Note 2 ( see note 12 above), included in the paragraph above, all other outstanding convertible notes of the Company that contain price-based anti-dilution protection had the conversion prices of such notes adjusted to $0.084 per share (the “Triggering Event”).

 

The value of the derivative liability related to the anti-dilution price protected convertible notes was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability and loss on convertible notes of $4,318,669. In addition, a payment was not made on a convertible note with a no notice default clause, resulting in the triggering of a variable priced conversion feature, which gave rise to a derivative liability on the payment due date, this gave rise to an additional loss on convertible notes of $56,329.

  

16 NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2024 and 2023 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2024 and 2023 are as follows:

 

  

Three and
nine months
ended
September 30,
2024

(Shares)

   Three and
nine months
ended
September 30, 
2023
(Shares)
 
Convertible debt   38,680,397    13,046,469 
Stock options   1,513,335    1,543,893 
Warrants to purchase shares of Common Stock   21,721,759    9,135,137 
    61,915,491    23,725,499 

 

33

 

 

INNOVATIVE PAYMENT SOLUTIONS, INC.

Notes to the unaudited Condensed Consolidated Financial Statements

 

17 RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties during the nine months ended September 30, 2024:

 

William Corbett

 

An option expense for options still vesting for Mr. Corbett was $22,196 and $66,587 for the three months ended September 30, 2024 and 2023, respectively and $155,369 and $199,760 for the nine months ended September 30, 2024 and 2023, respectively.

 

Richard Rosenblum

 

An option expense for options still vesting for Mr. Rosenblum was $9,292 and $27,879 for the three months ended September 30, 2024 and 2023, respectively and $65,047 and $83,636 for the nine months ended September 30, 2024 and 2023, respectively.

 

18 COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under Notes 11 and 12 above, which had and have maturity dates between May 22, 2024 and May 9, 2025. The Company may settle certain of the notes payable, at its option by the issue of shares of its Common Stock and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

 

19 SUBSEQUENT EVENTS

 

October 2024 Senior Promissory Notes

 

On October 10, 2024, the Company entered into two Securities Purchase Agreements with accredited investors, pursuant to which the Company issued two senior promissory notes each with a principal amount totaling $66,667 (totaling $133,334), for gross proceeds of $50,000 each (totaling $100,000), including an aggregate original issuance discount of $16,667 (totaling $33,334), for each note. The notes mature on October 10, 2025 and bear interest at 8.5% per annum.

 

October 2024 Convertible Promissory Notes

 

On October 22, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, pursuant to which the Company received an aggregate of $100,000 through the issuance of a convertible promissory note and a five-year warrant to purchase an aggregate of 289,855 shares of common stock, at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The note matures on October 22, 2025 and bears interest at 8% per annum and are convertible into shares of Common Stock at a conversion price of $0.084 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The note may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the notes or the warrants for public resale.

 

The note and warrant contain conversion limitations providing that a holder thereof may not convert the notes or exercise the warrants, to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. The holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

Note Conversions

 

On October 11, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $33,922 (totaling $67,844) of the interest outstanding on the notes, into an aggregate of 403,829 (totaling 807,658) shares of common stock, at a conversion price of $0.084 per share.

 

On October 25, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $35,614 (totaling $71,229) of the interest outstanding on the notes into an aggregate of 423,981 (totaling 847,962) shares of common stock, at a conversion price of $0.084 per share.

 

On November 11, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $37,392 (totaling $74,783) of interest and principal outstanding on the notes into an aggregate of 445,137 (totaling 890,274) shares of common stock, at a conversion price of $0.084 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

34

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

All references to “we,” “us,” “our” and the “Company” refer to Innovative Payment Solutions, Inc., a Delaware corporation and its consolidated subsidiaries unless the context requires otherwise.

 

Overview

 

We are a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Direct Payments (which we call IPEX) as well as traditional credit card processing services. We have in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

Known Trends, Demands, Commitments, Events or Uncertainties Impacting Our Business

 

Development of IPSIPay Express

 

Our principal business as of the date of this Report consists of our participation in the IPSIPay Express joint venture. Since May 2023, we have been working with our joint venture partners OpenPath and EfinityPay to establish the necessary elements to commercially launch IPEX. This remains our top business priority. We have been responsible for certain key aspects of establishing and launching IPEX. We have continued these efforts during 2024. No assurances can be given that we will be able to launch IPEX with our joint venture partners or that IPSIPay Express will generate revenues for us.

 

Merger Agreement with Business Warrior

 

On July 28, 2024, we entered into an Agreement and Plan of Merger pursuant to which we would acquire Business Warrior Corporation, a Wyoming corporation (“Business Warrior”). See Note 1(c) to the accompanying financial statements for information regarding the terms and conditions of this proposed merger.

 

Business Warrior offers a proprietary software solution for lenders called PayPlan, a next-generation SaaS platform that offers lenders unprecedented flexibility to customize their loan offerings and adjust underwriting rules in minutes, without the need for coding or significant financial outlay.

 

We believe this strategic merger brings together the strengths of both our Company and Business Warrior, creating an expanded fintech offering and promising immediate cost efficiencies and a stronger executive team capable of raising additional capital.  The integration of our Company with Business Warrior will enable optimization of talent and networks, allowing the teams from both companies to leverage their experience and connections to drive business growth. The merger also aligns the scalable technologies of our Company and Business Warrior, paving the way for increased revenue generation and, ultimately, profitability.

 

We expect to spend much of the fourth quarter of 2024 raising capital necessary to seek appropriate shareholder approvals, and seeking such approvals, for the merger and otherwise fulfilling the conditions to closing of the merger. Among such conditions is an exchange of our and Business Warrior’s outstanding convertible promissory notes for shares of a newly designated preferred stock of our Company (we have convertible note investors in common with Business Warrior). However, the terms of such exchange and such preferred stock remain subject to negotiation and approval of our shareholders. Moreover, there are several other key conditions to closing which will be challenging to fulfill. Therefore, our ability to consummate the merger is subject to significant risks and uncertainties, and the merger may never be consummated. The efforts needed to complete the merger and these risks and uncertainties will affect our results of operations in the coming periods.

 

35

 

 

Critical Accounting Estimates

 

Preparation of our consolidated financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues and expenses, as well as related disclosure of contingent assets and liabilities. Significant accounting policies are fundamental to understanding our financial condition and results as they require the use of estimates and assumptions which affect the financial statements and accompanying notes. See Note 2 - Summary of Significant Accounting Policies of the Notes to the condensed Consolidated Financial Statements included in Part I, Item I of this Form 10-Q for further information.

  

The critical accounting policies that involved significant estimation included the following:

 

Derivative liabilities

 

We have certain short-term convertible notes and certain warrants which have fundamental transaction clauses which might result in cash settlement. The conversion feature of these convertible notes and warrants are recorded as derivative liabilities which are valued at each reporting date.

 

The derivative liability is valued using the following inputs:

 

  Conversion prices;

 

  Current market prices of our equity

  

  Risk free interest rates;

 

  Expected remaining life of the derivative liability;

 

  Expected volatility of the underlying stock; and expected dividend rates

 

Any change in the above factors such as a change in risk free interest rates, a significant increase or decrease in our current stock prices and a change in the volatility of our Common Stock may result in a significant increase or decrease in the derivative liability.

  

Results of Operations

 

Results of Operations for the Three Months Ended September 30, 2024 and 2023

 

Net revenue

 

We recorded minimal revenues of $0 and $(28) during the three months ended September 30, 2024 and 2023, respectively. The revenue in the prior year was generated from our legacy IPSIPay platform which was novated to a third party in September 2023. We pivoted to focus our attention on the IPSIPay Express joint venture, where we expect to generate initial revenues during the 2024 fiscal year, dependent on product testing, which is currently underway, and market acceptance. In addition, if the merger with Business Warrior is consummated, we expect to generate revenues from Business Warrior’s business activities.

 

Cost of goods sold

 

We did not have any revenues or cost of goods sold for the three months ended September 30, 2024. Cost of goods sold was $387 for the three months ended September 30, 2023 and consisted primarily of bank and merchant related fees and chargebacks.

 

36

 

 

General and administrative expenses

 

General and administrative expenses were $296,438 and $745,688 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $449,250 or 60.2%. The decrease is primarily due to the following:

 

  (i) Legal fees were $89,334 and $236,832 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $147,498 or 62.3%. The decrease is primarily due to the prior year legal fees related to unfair dismissal matters which were claimed in the prior year by several individuals, offset by legal fees incurred on the proposed merger with Business Warrior.
     
  (ii) Professional fees were $11,607 and $131,867 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $120,260 or 91.2%. The decrease is primarily due to professional fees incurred in the prior year from Frictionless for management fees and customer support fees and a decrease in solicitation agent fees incurred in the prior year to support our prior year annual general meeting.
     
  (iii) Salaries and wages were $140,087 and $278,345 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $138,258 or 49.7%. the decrease is primarily due to the decrease in accrued compensation due to our CEO by $60,000 during the current period and a reduction in payroll taxes of $8,704 related to the reduction in payroll and the reduction in stock-based compensation of $62,976 due to the full amortization of option expense during the current year.
     
  (iv) Audit fees were $12,500 and $(23,000) for the three months ended September 30, 2024 and 2023, an increase of $35,500 or 154.3%, primarily due to a credit processed in the prior year for duplicated invoices recorded in the prior year.
     
  (v) Insurance expense was $317 and $11,771 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $11,454 or 97.3%. This is primarily due to the suspension of insurance coverage during the current period as no business is being conducted during this development phase.
     
  (vi) Selling and marketing expenses were $5,991 and $87,361 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $81,370 or 93.1%. the decrease is primarily due the decrease in social media marketing expenses and the decrease in endorsement fees due to Mario Lopez which were fully amortized during the current year.
     
  (vii) The balance of the general and administrative expenses was $36,601 and $22,512 for the three months ended September 30, 2024 and 2023, respectively, an increase of $14,089 or 62.6%. The increase is made up of several individually insignificant items.

  

Depreciation and amortization

 

Depreciation was $543 and $100,387 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $99,844, primarily due to the prior period depreciation of our legacy IPSIPay software platform and purchased software of $93,095 prior to the novation of such platform to a third party during the prior year.

 

Loss on convertible notes

 

Loss on convertible notes was $4,534,491 and $58,769 for the three months ended September 30, 2024 and 2023, respectively, an increase of $4,475,722. The loss on convertible notes during the current year related to; (i) a loss of $4,318,669 realized on an anti-dilution adjustment to the conversion feature of certain convertible notes; (ii) a loss of $56,329 realized on the conversion feature of a convertible note which through a no notice default clause, triggered a variable priced conversion liability; and (iii) a loss of $159,493 realized on conversion of certain convertible notes at prices lower than the current market price during the current year. In the prior year, the loss on convertible notes related to the conversion of $135,000 of convertible debt into 391,306 shares of common stock.

 

Fair value on price protected warrants

 

Fair value on price protected warrants was $2,051,405 and $0 for the three months ended September 30, 2024 and 2023, respectively. During the current year the exercise price of certain warrants were reset due to the anti-dilution price protection and in the case of certain warrants, full ratchet price protection, from an exercise price of $0.345 to $0.084. This resulted in a Black -Scholes derived valuation difference related to those certain warrants of $2,051,405.

 

Penalty on convertible notes

 

Penalty on convertible notes was $6,611 and $9,306 for the three months ended September 30, 2024 and 2023, a decrease of $2,695 or 29.0%. The current year penalty arose on certain warrants conversions which were triggered by delayed payments to the note holders, resulting in the charge of $6,611.

 

37

 

 

Loss on novation

 

Loss on novation was $0 and $1,066,165 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $1,066,165 or 100%. The prior year loss on novation arose due to the September 2023 transfer of our legacy IPSIPay platform and all rights and obligations associated with the service agreement with Frictionless to a third party.

 

Fair value of warrants issued

 

Fair value of warrants issued was $0 and $14,176 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $14,176 or 100.0%. We issued a replacement warrant exercisable for 33,334 shares to an investor during the prior period.

 

Interest expense, net

 

Interest expense was $152,376 and $110,328 for the three months ended September 30, 2024 and 2023, respectively, an increase of $42,048 or 38.1%. The increase is related to the additional $785,502 of new convertible note funding and $233,333 of promissory note funding during the current year for working capital purposes.

  

Amortization of debt discount

 

Amortization of debt discount was $233,948 and $303,042 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $69,094 or 22.8%. The decrease is primarily due to the full amortization of debt discount on convertible notes carried over from the prior year , the current year debt discount, and consequent amortization thereof, on new funding is significantly lower than the prior year.

 

Derivative liability movements

 

Derivative liability movements were $5,538,008 and $1,795,642 for the three months ended September 30, 2024 and 2023, respectively, a net movement of $3,742,366 or 72.7%. The derivative liability arose primarily due to the revaluation of certain repriced conversion features on convertible notes and the reset of the exercise price and full ratchet reset of certain warrants during the current year, and the subsequent mark-to-market of these derivatives due to a declining stock price on the exercise of certain convertible notes during the current year.

 

Net loss from equity method investment

 

Net loss from equity method investment was $88 and $402,509 for the three months ended September 30, 2024 and 2023, respectively, a decrease of $402,421 or 99.9%. The loss in the prior year related is due to the dilutive effect of withdrawals of cash out of the joint venture by the other joint venture parties, impacting on the overall value of the. IPSIPay Express Joint venture attributes to the Company.

 

Net loss

 

Net loss was $1,728,152 and $1,015,143 for the three months ended September 30, 2024 and 2023, respectively, an increase of $713,009 or 70.2%. The increase is primarily due to the increase in the loss on convertible notes and the increase in the fair value adjustment on price protected warrants, offset by the decrease in loss on novation, the decrease in operating loss and the movement in derivative liabilities, as discussed in detail above.

 

Results of Operations for the Nine Months Ended September 30, 2024 and 2023

 

Net revenue

 

We did not have any revenues during the nine months ended September 30, 2024 and minimal revenues of $410 for the nine months ended September 30, 2023. The revenue in the prior year was generated from the IPSIPay platform which was been novated to a third party in September 2023. We pivoted to focus our attention on the IPSIPay Express joint venture, where we expect to generate initial revenues during the 2024 fiscal year, dependent on product testing, which is currently underway, and market acceptance. In addition, if the merger with Business Warrior is consummated, we expect to generate revenues from Business Warrior’s business activities.

 

Cost of goods sold

 

We did not have any revenues or cost of goods sold for the nine months ended September 30, 2024. Cost of goods sold was $2,756 for the nine months ended September 30, 2023 and consisted primarily of bank and merchant related fees and chargebacks.

 

38

 

 

General and administrative expenses

 

General and administrative expenses were $1,330,367 and $2,753,266 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $1,422,899 or 51.7%. The decrease is primarily due to the following:

 

  (i) Legal fees were $307,997 and $611,178 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $303,181 or 49.6%. The decrease is primarily due to the legal matters relating to unfair dismissal matters which were claimed in the prior year by several individuals, offset by legal expenses related to the proposed acquisition of Business Warrior.
     
  (ii) Professional fees were $35,441 and $583,873 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $548,432 or 93.9%. The decrease is due to the reduction in professional fees related to services previously provided to us by Frictionless, amounting to $490,293 and a reduction in proxy solicitation agent fees of $47,069, which were required in the prior year to approve the reverse stock split at our 2023 annual meeting of stockholders.
     
  (iii) Salaries and wages were $614,081 and $836,887 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $222,806 or 26.6%. The decrease is primarily attributable to the reduction in stock-based compensation of $62,976 due to the current-year full amortization of option expense related to options issued to our management, the decrease in our previous CEO’s salary of $120,000 during the second and third quarter of 2024 and the related decrease in employer related payroll taxes and health insurance costs during the current year.
     
  (iv) Audit fees were $105,000 and $84,000 for the nine months ended September 30, 2024 and 2023, an increase of $21,000 or 25.0%, primarily due to a credit processed in the prior year for duplicated invoices recorded in the prior year.
     
  (v) Insurance expense was $943 and $105,067 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $104,124 or 99.1%. This is primarily due to the suspension of insurance coverage during the current period as no business is being conducted during this development phase.
     
  (vi) Selling and marketing expenses were $154,864 and $348,003 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $193,139 or 55.5%. The decrease is primarily due to the fair value of the prior period immediately vesting warrants granted to Mario Lopez (who performed spokesperson services for us), offset by the monthly amortization of vesting warrants during the current period, and a reduction in both social media marketing and marketing expenses related to the launch of our legacy IPSIPay platform and e-wallet in the prior year.
     
  (vii) The balance of the general and administrative expenses was $112,042 and $184,258 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $72,216 or 39.9%, which is made up of several individually insignificant items.

  

Depreciation

 

Depreciation was $1,627 and $380,092 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $378,465 or 99.6%, primarily due to the depreciation of the software platform and purchased software of $374,298, prior to the novation of the platform to a third party during the prior year.

  

Loss on convertible notes

 

Loss on convertible notes was $4,636,843 and $77,247 for the nine months ended September 30, 2024 and 2023, respectively, an increase of $4,559,596. The loss on convertible notes during the current year related to; (i) a loss of $4,318,669 realized on an anti-dilution adjustment to the conversion feature of certain convertible notes; (ii) a loss of $56,329 realized on the conversion feature of a convertible note which through a no notice default clause, triggered a variable priced conversion liability; (iii) a loss of $159,493 realized on conversion of certain convertible notes at prices lower than the current market price during the current year; and (iv) a loss on debt extinguishment of $102,352. In the prior year, the loss on debt conversion related to the conversion of $160,000 of convertible debt into 463,770 shares of common stock.

 

Fair value on price protected warrants

 

Fair value on price protected warrants was $2,051,405 and $0 for the nine months ended September 30, 2024 and 2023, respectively. During the current year the exercise price of certain warrants were reset due to the anti-dilution price protection and in the case of certain warrants, full ratchet price protection, from an exercise price of $0.345 to $0.084. This resulted in a Black -Scholes derived valuation difference related to those certain warrants of $2,051,405.

 

39

 

 

Penalty on convertible notes

 

Penalty on convertible notes was $6,611 and $9,306 for the nine months ended September 30, 2024 and 2023, a decrease of $2,695 or 29.0%. The current year penalty arose on certain warrants conversions which were triggered by delayed payments to the note holders, resulting in the charge of $6,611.

 

Loss on novation

 

Loss on novation was $0 and $1,066,165 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $1,066,165 or 100%. The prior year loss on novation arose due the novation of our legacy IPSIPay platform and all rights and obligations associated with the service agreement with Frictionless to a third party.

 

Fair value of warrants issued

 

Fair value of warrants issued was $0 and $14,176 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $14,176 or 100.0%. We issued a replacement warrant exercisable for 33,334 shares to an investor during the prior period.

 

Interest expense, net

 

Interest expense was $435,471 and $290,628 for the nine months ended September 30, 2024 and 2023, respectively, an increase of $144,843 or 49.8%. The increase is related to the additional $785,502 of new convertible note funding and $233,333 of promissory note funding during the current year for working capital purposes.

  

Amortization of debt discount

 

Amortization of debt discount was $874,193 and $414,696 for the nine months ended September 30, 2024 and 2023, respectively, an increase of $459,497 or 110.8%. The increase is primarily due to the amortization of debt discount on convertible notes carried over from the prior year and additional debt discount on new convertible notes issued during the current year to fund working capital.

 

Derivative liability movements

 

Derivative liability movements were $6,461,496 and $1,483,710 for the nine months ended September 30, 2024 and 2023, respectively, an increase of $4,977,7862,541,364 or 171.3%. The derivative liability arose primarily due to the revaluation of certain repriced conversion features on convertible notes and the reset of the exercise price and full ratchet reset of certain warrants during the current year, and the subsequent mark-to-market of these derivatives due to a declining stock price on the exercise of certain convertible notes during the current year.

 

Net loss from equity method investment

 

Net loss from equity method investment was $660 and $403,890 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $403,230 or 99.8%. The loss in the prior year related is due to the dilutive effect of withdrawals of cash out of the joint venture by the other joint venture parties, impacting on the overall value of the. IPSIPay Express Joint venture attributes to the Company.

 

Net loss from continuing operations

 

Net loss from continuing operations was $2,857,262 and $3,928,102 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $1,070,840 or 27.3%. The decrease is primarily due to the decrease in general and administrative expenses, a decrease in depreciation and amortization, a decrease in loss on novation and the movement in derivative liability, offset by an increase in loss on convertible notes and fair value oof price protected warrants, as discussed in detail above.

 

Operating loss from discontinued operations

 

Operating loss from discontinued operations was $0 and $40,821 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $40,821 or 100.0%. On May 12, 2023, we entered into an agreement with Frictionless to unwind the equity ownership stakes that we and Frictionless have in each other and in Beyond Fintech. We assigned to Frictionless all common stock of Frictionless owned by us and all shares of common stock of Beyond Fintech owned by us.

 

Loss on disposal of subsidiary

 

Loss on disposal of subsidiary was $0 and $495,424 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $495,424 or 100.0%. This relates to the unwinding of our relationship with Frictionless as described above. The consideration received by us for the assignment of our equity in Beyond Fintech to Frictionless was $250,000, resulting in a net loss on disposal of $495,424.

 

40

 

 

Net loss

 

Net loss was $2,857,262 and $4,464,347 for the nine months ended September 30, 2024 and 2023, respectively, a decrease of $1,607,085 or 36.0%. the decrease is primarily attributable to the decrease in net loss from continuing operations and the decrease in loss on disposal of subsidiary and investment, as described above.

 

Liquidity and Capital Resources

 

To date, our primary sources of cash have been funds raised primarily from the sale of our debt and equity securities.

 

We have an accumulated deficit of $61.5 million through September 30, 2024 and incurred negative cash flow from operations of $0.5 million for the nine months ended September 30, 2024. Our primary focus is on our IPSIPay Express LLC three-way joint venture to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors. To date, this joint venture has not generated revenue, but we believe much of the background work necessary for IPSIPay Express to commence revenue generating operations from payment processing has been completed. No assurances can be given, however, that such revenue generation will commence or be meaningful to us as an approximately 22% joint venture partner in IPSIPay Express.

 

We have also entered into a merger agreement with Business Warrior as described above and expect to generate revenue from Business Warrior’s product offerings following this merger if the transaction is consummated.

 

At September 30, 2024, we had cash of $1,033 and working capital deficit of $10.3 million, including a derivative liability of $1.6 million. After eliminating the derivative liability our working capital deficit is $8.7 million.

 

We used cash of $0.5 million and $1.1 million in operations for the nine months ended September 30, 2024 and 2023, respectively. Overall cash used in operations decreased by $0.6 million due to cost containment to preserve cash balances.

 

We invested $0.3 million in Business Warrior in the form of notes receivable for strategic purposes during the nine months ended September 30, 2024. In the prior year we had invested $0.1million in our payment platforms which we subsequently disposed of or novated to other parties and we invested $1.0 million in our equity method investment.

  

We generated cash of $0.8 million from promissory notes and convertible notes and repaid $0.3 million of convertible notes and generated a further $0.2 million in notes payable during the current period. In the prior year we generated $2.0 million from convertible notes and repaid $0.2 million.

 

At September 30, 2024, we had outstanding convertible notes, including interest thereon of $4.9 million, net of unamortized debt discount of $0.2 million and outstanding promissory notes, including interest thereon of $1.4 million, net of unamortized debt discount of $0.06 million. The notes contain certain covenants, such as restrictions on: (i) distributions on capital stock, (ii) stock repurchases, and (iii) sales and the transfer of assets. The notes bear interest at a rates of 8% to 32.0% per annum. and are convertible into our common stock at conversion prices ranging from fixed conversion prices of $0.084 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events), to variable conversion prices of 60% to 70% of lowest trading prices over a 10 to 20-trading day period. Should the investors choose not to convert these convertible notes, we may need to repay these notes together with interest thereon which will impact on our liquidity.

 

Given our losses and negative cash flows, we will be required to raise significant additional funds by issuing equity or equity-linked securities to progress our existing business, complete the Business Warrior merger and grow the combined company (should the merger be consummated) as planned. Should this occur, our stockholders would experience dilution, perhaps significantly. Additional debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. Any additional debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders and require significant debt service payments, which diverts resources from other activities. Moreover, there is a risk that financing may be unavailable to support our operations on favorable terms, or at all.

 

There is also a significant risk that none of our plans to raise financing will be implemented in a manner necessary to sustain us for an extended period of time. If adequate funds are not available to us when needed, we may be required to continue with reduced or discontinued operations or to obtain funds through arrangements that may require us to relinquish rights to technologies or potential markets, any of which could have a material adverse effect on our Company. In addition, our inability to secure additional funding when needed could cause our business to fail or become bankrupt or force us to wind down or discontinue operations.

 

We do not have any off-balance sheet financing arrangements as of the date of this report.

 

41

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risks

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

Pursuant to Rule 13a-15(b) under the Exchange Act, our management carried out an evaluation, with the participation of our Executive Chairman (“Executive Chairman”) and our President and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Report. Based upon that evaluation, our Executive Chairman and CFO concluded that our disclosure controls and procedures as of September 30, 2024 are not effective due to a lack of written policies and procedures to address all material transactions and developments impacting our financial statements.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during our fiscal quarter ended September 30, 2024.

 

Our management is committed to improving our controls and procedures by, among other matters, continuing to consider and adopt appropriate policies and procedures to address all material transactions and developments impacting our financial statements. However, our management does not expect that our disclosure controls and procedures and our internal control processes, even if improved, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of error or fraud, if any, within our Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that the breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

 

42

 

 

Part II. Other Information

 

Item 1. Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Below is a description of outstanding pending litigation matters. As also noted previously, litigation is subject to inherent uncertainties and an adverse result in the below described or other matters may arise from time to time that may harm our business. Other than as set forth below, we are not presently a party to any legal proceedings that, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Voloshin, et al., v. Innovative Payment Solutions, Inc., et al.

 

On October 20, 2021, a complaint was filed against our Company and certain of its officers and directors with the Occupational Safety and Health Administration of the United States Department of Labor (“OSHA”), captioned Naum Voloshin, Yulia Rey, Alexander Voloshin, Andrey Novikov, and Frank Perez v. Innovative Payment Solutions, Inc., William Corbett, Richard Rosenblum, Madisson Corbett, Jim Fuller, Cliff Henry and David Rios. The complaint generally alleged that complainants, four former employees (or independent consultants) of our Company and one employee who was on suspension, did not receive compensation to which they claim they were entitled and that they were wrongfully terminated for engaging in protected activities in violation of the Sarbanes-Oxley Act of 2002, 18 U.S.C. § 1514A. The complaint sought reinstatement of complainants’ employment, monetary damages including back pay, raises, bonuses, benefits, overtime, emotional distress and loss of reputation, orders of abatement and injunctive relief, and costs of litigation.

 

In early 2022, OSHA dismissed the claims of Ms. Rey and Mr. Perez, and they appealed that decision. Prior counsel moved to dismiss the remaining claims and as of this writing OSHA took no action with respect to that motion as ultimately the former employees elected to proceed in federal court. Pursuant to agreement and stipulation, dismissal of the OSHA claims was accomplished without prejudice on November 10, 2022.

 

On November 7, 2022, the same five employees filed a lawsuit, not in federal court, but in the California Superior Court for the County of Los Angeles, against our Company and the same individuals against whom they had asserted their OSHA claim. The complaint asserted claims for, among other things, breach of contract, failure to pay wages and failure to reimburse expenses under the California Labor Code and asserting retaliation claims under the California Labor Code. On December 16, 2022, the same five employees filed an amended complaint dropping all defendants from the case except Mr. Corbett and our Company. The amended complaint asserts claims for violations of California Labor Code Section 1102.5; wrongful termination in violation of public policy; breach of contract; breach of covenant of good faith and fair dealing; violation of California Labor Code Section 201; waiting time penalties (Cal. Lab. Code Sections 201 & 203) and violation of California Labor Code Section 2802.

 

We and Mr. Corbett, the sole remaining individual defendant, through prior counsel moved to compel arbitration on February 17, 2023. As a result of that motion and a stipulated order entered by the court, all proceedings in the Superior Court were stayed.

 

On June 8, 2023, while our motion to compel arbitration was pending in the Superior Court three of the employees (Naum Voloshin, Alexander Voloshin, and Novikov) filed a civil action in the U.S. District Court for the Central District of California. Naum Voloshin, et al., v. Innovative Payment Solutions, Inc., Case No. CV 23-4515-JFW (PVCx), which alleges a single cause of action for retaliation in violation of The Sarbanes-Oxley Act of 2002 (the “Federal Action”). The plaintiffs in the Federal Action made no attempt to serve their complaint or to give notice to any defendant in the Federal Action until August 2023.

 

On August 30, 2023, the Hon. William A. Crowfoot granted our and Mr. Corbett’s motion to compel arbitration, concluding that all of the claims alleged in the former employees’ first amended complaint were subject to arbitration. The California Court of Appeal subsequently denied the former employees’ petition for writ of mandate on November 1, 2023. On December 15, 2023, all five former employees filed a demand for arbitration. We withdrew our motion to compel appointment of an arbitrator.

 

Upon motion of our Company and Mr. Corbett, on January 10, 2024, the U.S. District Court for the Central District of California stayed all proceedings in the Federal Action until the arbitration is completed.

 

43

 

 

Plaintiffs Naum Voloshin, Andrey Novikov, and Alexander Voloshin asserted, in the Federal Action, that they are entitled to damages in the following amounts: Naum Voloshin: $950,000 plus an unstated amount of lost wages and emotional distress damages. The claim is premised upon Mr. Voloshin earning $15,000 per month and a claim that he was entitled to receive 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021 that he would have sold on July 1, 2021 for $2.85 per share on July 1, 2021 for $950,000. Andrey Novikov: $285,000 plus emotional distress and punitive damages. The claim is premised upon Mr. Novikov earning $15,000 per month and a claim that he was entitled to receive 100,000 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021, that he would have sold at $2.85 per share on July 1, 2021 for $285,000. Alexander Voloshin: $263,000 plus emotional distress and punitive damages. The claim is premised upon an alleged two-year contract signed in May 2021 that paid him $7,000 per month and that promised him 333,334 shares of Common Stock (after giving effect to our August 2023 reverse stock split) on or about June 29, 2021. We have not received meaningful information on the amount of the claims of the other two plaintiffs.

 

An arbitrator was appointed through the American Arbitration Association and the arbitrator issued a scheduling order and Notice of Hearing. The ten-day arbitration has been set for April 7-11, 2025, and April 14-18, 2025. Management continues its vigorous defense of the claims.

 

In mid-April 2024, the Company and Mr. Corbett changed attorneys. The Law Offices of Jeffrey B. Neustadt replaced prior counsel. Mr. Neustadt and Plaintiffs’ counsel conferred and timely submitted the required joint statement on April 25, 2024.

 

Initial discovery was served by both sides. Documents were exchanged, and depositions proceeded for 4 persons with three depositions still outstanding, the first scheduled to be heard on November 20, 2024.

 

Minkovich v. Corbett, et al.

 

On May 26, 2022, Mr. Jan Minkovich (“Minkovich”) filed a lawsuit in California Superior Court in Los Angeles County (Minkovich v. Corbett, et al., CASE NO. 22CHCV00377) against our Company and our Chairman and Chief Executive Officer William Corbett. The complaint asserts six causes of action for: (i) breach of contract; (ii) nonpayment of wages; (iii) waiting time penalties; (iv) failure to indemnify for alleged employee business expenses; (v) violation of Section 17200 of the California Business and Professional Code; and (vi) wrongful termination of employment in violation of public policy. Minkovich seeks $570,000 in damages, penalties, and attorneys’ fees plus shares equal to five percent (5%) ownership of our Company. He bases his claim in part on the unilateral expectation that he receives 2.7 million shares of the Company. Assuming he is owed any shares, a claim which we dispute, after the reverse 30-1 split he would receive only 90,000 shares.

 

Through prior counsel, we and Mr. Corbett filed a motion to compel arbitration. The motion was denied on October 4, 2022. We and Mr. Corbett then appealed that decision to the California Court of Appeal. As a result of the appeal, the court case was stayed until the appeal was decided. As a result of the stay, the demurrer (the equivalent of a motion to dismiss) we filed through prior counsel was not decided.

 

On February 27, 2024, the California Court of Appeal, Second District, reversed the Superior Court’s decision denying our motion to compel arbitration. The Court of Appeal remanded the case to the Superior Court with directions to issue a new order compelling to arbitration the parties’ dispute regarding the enforceability of the arbitration clause. As the prevailing parties, the Company and Mr. Corbett were awarded costs on appeal.

 

As expected, the plaintiff-initiated arbitration before the American Arbitration Association (“AAA”) based on the appellate ruling. While, as the court order states, the plaintiff may renew his challenge to the arbitration clause before the arbitrator, we believe such challenges are rare and rarely succeed. Accordingly, we expect the dispute likely will be resolved through AAA arbitration. Management is vigorously defending the claims and intends to continue to do so.

 

In mid-April 2024, the Company and Mr. Corbett changed attorneys. The Law Offices of Jeffrey B. Neustadt replaced prior counsel. Mr. Neustadt’s office submitted the cost bill and an attorneys’ fees motion that will be decided on September 10, 2024, by the trial court for the fees incurred on the successful appeal. As with the Voloshin matter, we are contractually bound to proceed through arbitration and to that end completed the process of selecting an arbitrator under the AAA rules. That appointment was made on August 7, 2024. Henceforth, the Minkovich matter will track along the same lines as the Voloshin matter but on a smaller scale as there is only one plaintiff in the Minkovich matter as opposed to five in the Voloshin matter. The arbitration hearing (“trial”) in the Minkovich matter was set for June 30, 2025 to July 3, 2025at the continued “preliminary conference” held on October 7, 2024. Before the arbitration hearing, the parties will engage in discovery and some motion work which may (1) either dispose of all or some of the case, and/or (2) result in the Minkovich matter being sent back to the Superior Court for final determination.

 

Item 1A. Risk Factors.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

44

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Unregistered Sales of Equity Securities 

 

Between February 6, 2024 and October 22, 2024, we entered into Securities Purchase Agreements with 9 accredited investors, pursuant to which we received an aggregate of $575,001 in gross proceeds from the Investors through the initial closing of a private placement issuance of:

 

  Convertible Promissory Notes (the “Notes” and each a “Note”); and

 

  five-year warrants (the “Warrants” and each a “Warrant”) to purchase an aggregate 579,711 shares of the Company’s Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes mature between 9 months and 12 months, and bear interest at 8% per annum and are convertible into shares of Common Stock at a conversion prices ranging from $0.084 to $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the Notes or the Warrants for public resale, pursuant to Section 4(a)(2) of the Securities Act.

 

Between April 2, 2024 and May 28, 2024, we entered into Securities Purchase Agreements with 2 accredited investors, whereby we received net proceeds of $310,000 after original issued discounts of $74,510 in exchange for:

 

  Variable Priced Convertible Promissory Notes (the “Variable Notes” and each a “Variable Note”); and

 

 

five-year warrants (the “Warrants” and each a “Warrant”) to purchase an initial aggregate 536,646 shares of the Company’s Common Stock at an initial exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

On August 6, 2024, in terms of a conversion notice received, the terms of the warrants were changed, in terms of a full ratchet provision by increasing the number of shares subject to exercise of the warrants by 9,773,028 shares of the Company’s common stock to a total of 12,918,370 shares of the Company’s common stock, and an adjustment to the exercise price to $0.084 per share.

 

The Variable Notes are convertible into common stock at a variable conversion price upon an event of default, the Variable conversion price was triggered in the last quarter. The Variable Notes are convertible into shares of common stock at conversion prices ranging from 65% to 70% of the lowest trading price five to ten day prior to conversion, bear interest at a one-time interest charge rate ranging from 8% to 15%, giving rise to an effective interest rates between 11.03% and 24.98%. The Variable Notes each have fixed instalment repayment terms.

 

Between August 6, 2024 and September 17, 2024, the Company received conversion notices from 4 convertible noteholders, converting $198,716 of principal and interest of convertible notes into 2,365,663 shares of Common Stock at a conversion price of $0.084 per share.

 

Between October 11, 2024 and November 11, 2024, the Company received conversion notices from 2 convertible noteholders, converting $213,855 of principal and interest of convertible notes into 2,545,894 shares of Common Stock at a conversion price of $0.084 per share.

 

On August 6, 2024, three notes with an aggregate principal balance of $1,859,174 as of September 30, 2024 ($868,951, 901,334 and $88,889, respectively), maturing between October 31, 2024, which maturity date gets automatically extended on a monthly basis, and May 9, 2025, had their conversion prices reset from between $0.10 and $0.345 to $0.084 per share of common stock.

 

Between March 12, 2024 and June 14, 2024, the Company issued five-year warrants exercisable for 680,136 shares of the Company’s common stock at an exercise price of $0.345 per share, in exchange for extending the maturity date of the underlying convertible notes.

 

Use of Proceeds from Public Offering of Common Stock

 

Not applicable.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

None

 

45

 

 

Item 6. Exhibits

 

Exhibit No.   Exhibit Description
3.1   Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Registration Statement on Form S-1 (File No. 333-192877) filed with the Securities and Exchange Commission on December 16, 2013)
3.2   Amended and Restated Bylaws of the Company (Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 6, 2021)
3.3   Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on June 2, 2016)
3.4   Certificate of Amendment to Articles of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on March 6, 2018)
3.5   Certificate of Amendment to the Articles of Incorporation of the Company (Name Change) (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on November 4, 2019)
3.6   Certificate of Correction to the Certificate of Amendment to the Articles of Incorporation of the Company, dated August 24, 2023, to effect a 1-for-30 reverse stock split (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 30, 2023)
31.1*   Certification of Richard Rosenblum, President and Chief Financial Officer, pursuant to Rule 13a-14(a) or Rule15d-14(a)
32.1*   Certification of Richard Rosenblum, President and Chief Financial Officer pursuant to Section 1350 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document.*
101.SCH   Inline XBRL Taxonomy Extension Schema Document.*
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

 

* Filed herewith

 

46

 

 

SIGNATURES

 

Pursuant to the requirements of the Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  INNOVATIVE PAYMENT SOLUTIONS, INC.
   
Date: November 12, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    Principal Officer, President & Chief Financial Officer
    (Principal Executive Officer, Principal Financial and Accounting Officer)

 

47

 

1015143 3111111 P5Y false --12-31 Q3 0001591913 0001591913 2024-01-01 2024-09-30 0001591913 2024-11-12 0001591913 2024-09-30 0001591913 2023-12-31 0001591913 2024-07-01 2024-09-30 0001591913 2023-07-01 2023-09-30 0001591913 2023-01-01 2023-09-30 0001591913 us-gaap:PreferredStockMember 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001591913 us-gaap:RetainedEarningsMember 2023-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-12-31 0001591913 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001591913 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0001591913 2024-01-01 2024-03-31 0001591913 us-gaap:PreferredStockMember 2024-03-31 0001591913 us-gaap:CommonStockMember 2024-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001591913 us-gaap:RetainedEarningsMember 2024-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2024-03-31 0001591913 2024-03-31 0001591913 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001591913 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001591913 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2024-04-01 2024-06-30 0001591913 2024-04-01 2024-06-30 0001591913 us-gaap:PreferredStockMember 2024-06-30 0001591913 us-gaap:CommonStockMember 2024-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001591913 us-gaap:RetainedEarningsMember 2024-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2024-06-30 0001591913 2024-06-30 0001591913 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001591913 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001591913 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2024-07-01 2024-09-30 0001591913 us-gaap:PreferredStockMember 2024-09-30 0001591913 us-gaap:CommonStockMember 2024-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001591913 us-gaap:RetainedEarningsMember 2024-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2024-09-30 0001591913 us-gaap:PreferredStockMember 2022-12-31 0001591913 us-gaap:CommonStockMember 2022-12-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001591913 us-gaap:RetainedEarningsMember 2022-12-31 0001591913 us-gaap:NoncontrollingInterestMember 2022-12-31 0001591913 2022-12-31 0001591913 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0001591913 2023-01-01 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-03-31 0001591913 us-gaap:CommonStockMember 2023-03-31 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001591913 us-gaap:RetainedEarningsMember 2023-03-31 0001591913 us-gaap:NoncontrollingInterestMember 2023-03-31 0001591913 2023-03-31 0001591913 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-04-01 2023-06-30 0001591913 2023-04-01 2023-06-30 0001591913 us-gaap:PreferredStockMember 2023-06-30 0001591913 us-gaap:CommonStockMember 2023-06-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001591913 us-gaap:RetainedEarningsMember 2023-06-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-06-30 0001591913 2023-06-30 0001591913 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001591913 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001591913 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0001591913 us-gaap:PreferredStockMember 2023-09-30 0001591913 us-gaap:CommonStockMember 2023-09-30 0001591913 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001591913 us-gaap:RetainedEarningsMember 2023-09-30 0001591913 us-gaap:NoncontrollingInterestMember 2023-09-30 0001591913 2023-09-30 0001591913 us-gaap:CommonStockMember 2024-09-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2024-09-30 0001591913 ipsi:QpagosCorporationsCapitalStockMember 2024-01-01 2024-09-30 0001591913 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001591913 ipsi:QPAGOSMember 2024-01-01 2024-09-30 0001591913 srt:MaximumMember 2019-11-01 0001591913 srt:MinimumMember 2019-11-01 0001591913 ipsi:ViviHoldingsIncMember 2019-12-31 2019-12-31 0001591913 ipsi:StockPurchaseAgreementMember 2019-12-31 2019-12-31 0001591913 2019-12-31 0001591913 ipsi:GastonPereiraMember 2019-12-31 0001591913 ipsi:AndreyNovikovMember 2019-12-31 0001591913 ipsi:JosephAbramsMember 2019-12-31 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 2021-06-21 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-06-21 0001591913 ipsi:FrictionlessMember 2021-06-21 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 2021-08-26 2021-08-26 0001591913 2023-05-12 0001591913 2023-05-12 2023-05-12 0001591913 ipsi:ThreeTranchesMember 2024-01-01 2024-09-30 0001591913 ipsi:TrancheMember 2023-06-21 2023-06-21 0001591913 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-08-04 2023-08-04 0001591913 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-09-30 2023-09-30 0001591913 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-11-30 2023-11-30 0001591913 ipsi:IPEXWarrantMember 2024-01-01 2024-09-30 0001591913 ipsi:TrancheMember 2024-01-01 2024-09-30 0001591913 ipsi:SecondTrancheMember 2024-01-01 2024-09-30 0001591913 ipsi:ThirdTrancheMember 2024-01-01 2024-09-30 0001591913 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2024-09-30 0001591913 ipsi:BeyondFintechIncMember 2024-09-30 0001591913 ipsi:LongTermInvestmentMember 2024-09-30 0001591913 us-gaap:ComputerEquipmentMember 2024-09-30 0001591913 us-gaap:OfficeEquipmentMember 2024-09-30 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-05-12 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-05-12 0001591913 ipsi:BeyondFintechIncMember 2023-05-12 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2023-05-12 2023-05-12 0001591913 us-gaap:DisposalGroupNotDiscontinuedOperationsMember 2024-09-30 0001591913 us-gaap:DisposalGroupNotDiscontinuedOperationsMember 2024-01-01 2024-09-30 0001591913 ipsi:BZWRNoteMember 2024-02-22 0001591913 2024-02-22 0001591913 2024-02-22 2024-02-22 0001591913 ipsi:BZWRNoteMember 2024-02-22 2024-02-22 0001591913 ipsi:BZWRNoteMember us-gaap:CommonStockMember 2024-02-22 0001591913 ipsi:BusinessWarriorCorporationMember 2024-01-01 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationMember 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationOneMember 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationOneMember 2024-01-01 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationTwoMember 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationTwoMember 2024-01-01 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationThreeMember 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationThreeMember 2024-01-01 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationFourMember 2024-09-30 0001591913 ipsi:BusinessWarriorCorporationFourMember 2024-01-01 2024-09-30 0001591913 ipsi:LoansReceivablesMember us-gaap:ConvertibleNotesPayableMember 2024-09-30 0001591913 ipsi:BeyondFintechIncMember 2021-08-26 0001591913 ipsi:FrictionlessFinancialTechnologiesIncMember 2021-08-26 0001591913 2021-01-01 2021-12-31 0001591913 2023-01-01 2023-01-01 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 0001591913 ipsi:SmallBusinessEconomicInjuryDisasterLoanMember 2020-07-07 2020-07-07 0001591913 ipsi:CavalryFundILPMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryAndMercerMember 2021-02-16 0001591913 us-gaap:WarrantMember 2021-02-16 2021-02-16 0001591913 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-02-16 0001591913 ipsi:AmendmentTransactionMember 2022-12-31 0001591913 ipsi:AmendmentTransactionMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001591913 us-gaap:ConvertibleDebtMember 2024-09-30 0001591913 ipsi:AmendmentTransactionMember 2024-01-01 2024-09-30 0001591913 ipsi:TwoThousandTwentyFourNotesMember 2024-01-01 2024-09-30 0001591913 ipsi:TwoThousandTwentyFourNotesMember ipsi:PurchaseAgreementsMember 2024-01-01 2024-09-30 0001591913 ipsi:TwoThousandTwentyFourNotesMember 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2024-01-01 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-01-01 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:NotePayableMember ipsi:TwoThousandTwentyThreeAndTwoThousandTwentyFourNotesMember 2024-01-01 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:TwoThousandTwentyThreeAndTwoThousandTwentyFourNotesMember 2024-09-30 0001591913 ipsi:NotePayableMember ipsi:TwoThousandTwentyThreeAndTwoThousandTwentyFourNotesMember 2023-12-31 0001591913 ipsi:NotePayableMember 2024-09-30 0001591913 ipsi:NotePayableMember 2024-01-01 2024-09-30 0001591913 ipsi:NotePayableMember 2023-12-31 0001591913 ipsi:CavalryAndMercerMember 2022-02-03 2022-02-03 0001591913 ipsi:CavalryAndMercerMember 2024-09-30 0001591913 srt:MaximumMember 2024-09-30 0001591913 srt:MinimumMember 2024-09-30 0001591913 2021-02-16 0001591913 ipsi:ExchangeNotesMember 2021-02-16 2021-02-16 0001591913 ipsi:ExchangeNotesMember 2021-02-16 0001591913 2022-12-30 2022-12-30 0001591913 2022-12-28 2022-12-28 0001591913 ipsi:CavalryAndMercerMember 2022-12-28 2022-12-28 0001591913 us-gaap:WarrantMember 2022-12-28 2022-12-28 0001591913 srt:MaximumMember ipsi:CavalryAndMercerMember 2024-09-30 0001591913 srt:MinimumMember ipsi:CavalryAndMercerMember 2024-09-30 0001591913 ipsi:CavalryMercerNoteMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationAndQuickCapitalLLCMember 2024-07-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationAndQuickCapitalLLCMember 2023-07-01 2023-09-30 0001591913 ipsi:RedRoadHoldingsCorporationAndQuickCapitalLLCMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationAndQuickCapitalLLCMember 2023-01-01 2023-09-30 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2021-02-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 srt:MinimumMember ipsi:CavalryFundLLPMember 2022-11-01 2022-11-16 0001591913 ipsi:CavalryFundLLPMember 2023-08-24 2023-08-24 0001591913 ipsi:CavalryFundLLPMember 2023-11-20 2023-11-20 0001591913 2023-08-24 2023-08-24 0001591913 2023-11-20 2023-11-20 0001591913 ipsi:CavalryFundLLPMember 2024-09-05 2024-09-05 0001591913 ipsi:CavalryFundLLPMember 2024-09-10 2024-09-10 0001591913 us-gaap:CommonStockMember 2024-09-05 2024-09-05 0001591913 us-gaap:CommonStockMember 2024-09-10 2024-09-10 0001591913 2024-09-05 2024-09-05 0001591913 2024-09-10 2024-09-10 0001591913 ipsi:CavalryFundLLPMember 2024-09-05 0001591913 ipsi:CavalryFundLLPMember 2024-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2021-02-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-16 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-11-01 2022-11-16 0001591913 srt:MaximumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 srt:MinimumMember ipsi:MercerStreetGlobalOpportunityFundLLCMember 2022-12-30 0001591913 ipsi:MercerConvertedMember 2023-05-19 2023-05-19 0001591913 ipsi:MercerConvertedMember 2023-08-30 2023-08-30 0001591913 ipsi:MercerConvertedMember 2024-08-20 2024-08-20 0001591913 ipsi:MercerConvertedMember 2023-09-05 2023-09-05 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-08-20 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-09-05 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-09-05 0001591913 2023-09-05 2023-09-05 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-09-30 0001591913 ipsi:ConvertibleNoteMember ipsi:DiagonalStreetLendingLLCMember 2023-09-09 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-09-09 2023-09-09 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-09-09 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-10-14 2023-10-14 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-10-19 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-10-19 2023-10-19 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-11-30 2023-11-30 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-11-30 0001591913 ipsi:ConvertedMember 2024-08-06 2024-08-06 0001591913 2024-08-06 0001591913 2024-08-06 2024-08-06 0001591913 ipsi:RRHMember 2024-08-06 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-20 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-01 2023-12-20 0001591913 ipsi:Note4PlusAccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2024-09-30 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-04-02 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-04-02 2024-04-02 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-09-30 2024-09-30 0001591913 srt:ScenarioForecastMember ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-10-30 2024-10-30 0001591913 srt:ScenarioForecastMember ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-11-30 2024-11-30 0001591913 srt:ScenarioForecastMember ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-12-30 2024-12-30 0001591913 ipsi:ConvertibleNoteMember ipsi:RedRoadHoldingsCorporationMember 2024-09-30 0001591913 ipsi:AccruedInterestMember ipsi:DiagonalStreetLendingLLCMember 2024-09-30 0001591913 ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2024-06-25 0001591913 ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2024-06-25 2024-06-25 0001591913 srt:ScenarioForecastMember ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2024-12-31 2024-12-31 0001591913 srt:ScenarioForecastMember ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2025-01-30 2025-01-30 0001591913 srt:ScenarioForecastMember ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2025-02-28 2025-02-28 0001591913 srt:ScenarioForecastMember ipsi:AccruedInterestMember ipsi:RedRoadHoldingsCorporationMember 2025-03-30 2025-03-30 0001591913 ipsi:QuickCapitalLLCMember 2024-03-04 2024-03-04 0001591913 ipsi:QuickCapitalLLCMember 2024-03-04 0001591913 ipsi:ConvertibleNoteMember ipsi:QuickCapitalLLCMember 2024-03-04 2024-03-04 0001591913 2024-03-04 2024-03-04 0001591913 ipsi:QuickCapitalLLCMember 2023-06-01 2023-06-20 0001591913 ipsi:ConvertibleNoteMember ipsi:QuickCapitalLLCMember 2024-03-04 0001591913 us-gaap:WarrantMember 2024-03-04 0001591913 ipsi:QuickCapitalLLCMember 2024-09-06 2024-09-06 0001591913 ipsi:QuickCapitalLLCMember 2024-09-17 2024-09-17 0001591913 2024-09-06 0001591913 us-gaap:CommonStockMember 2024-09-06 2024-09-06 0001591913 ipsi:QuickCapitalLLCMember 2024-09-06 0001591913 ipsi:QuickCapitalLLCMember 2024-05-28 0001591913 ipsi:QuickCapitalLLCMember 2024-05-28 2024-05-28 0001591913 2023-07-28 2023-07-28 0001591913 2024-05-28 0001591913 us-gaap:WarrantMember ipsi:QuickCapitalLLCMember 2024-09-30 0001591913 ipsi:QuickCapitalLLCMember 2024-09-30 0001591913 ipsi:TwoThousandTwentyThreeAndTwoThousandTwentyFourConvertibleNotesMember 2023-09-30 0001591913 ipsi:TwoThousandTwentyThreeAndTwoThousandTwentyFourConvertibleNotesMember 2024-01-01 2024-09-30 0001591913 ipsi:ConvertibleNoteMember 2024-01-01 2024-09-30 0001591913 ipsi:ConvertibleNoteMember 2024-09-30 0001591913 srt:MinimumMember ipsi:ConvertibleNoteMember 2024-09-30 0001591913 srt:MaximumMember ipsi:ConvertibleNoteMember 2024-09-30 0001591913 ipsi:ConvertibleNoteMember ipsi:NoteTwoMember 2023-12-14 0001591913 srt:MaximumMember 2023-12-14 0001591913 srt:MinimumMember 2023-12-14 0001591913 ipsi:ConvertibleNoteMember 2023-12-14 0001591913 ipsi:ConvertibleNoteMember ipsi:NoteTwoMember 2024-05-04 0001591913 ipsi:ConvertibleNoteMember 2024-05-04 0001591913 ipsi:ConvertibleNoteMember 2023-03-14 2023-03-14 0001591913 ipsi:ConvertibleNoteMember 2023-03-14 0001591913 ipsi:AccruedInterestMember 2024-09-30 0001591913 ipsi:CavalryFundILPMember 2024-09-30 0001591913 ipsi:CavalryFundILPMember 2024-01-01 2024-09-30 0001591913 ipsi:CavalryFundILPMember 2023-12-31 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2024-01-01 2024-09-30 0001591913 ipsi:MercerStreetGlobalOpportunityFundLLCMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationMember 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationOneMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationTwoMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationThreeMember 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationThreeMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationThreeMember 2023-12-31 0001591913 ipsi:RedRoadHoldingsCorporationFourMember 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationFourMember 2024-01-01 2024-09-30 0001591913 ipsi:RedRoadHoldingsCorporationFourMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCMember 2024-09-30 0001591913 ipsi:QuickCapitalLLCMember 2024-01-01 2024-09-30 0001591913 ipsi:QuickCapitalLLCMember 2023-12-31 0001591913 ipsi:QuickCapitalLLCOneMember 2024-09-30 0001591913 ipsi:QuickCapitalLLCOneMember 2024-01-01 2024-09-30 0001591913 ipsi:QuickCapitalLLCOneMember 2023-12-31 0001591913 srt:MinimumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-09-30 0001591913 srt:MaximumMember ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-01-01 2024-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2024-09-30 0001591913 ipsi:TwoThousandAndTweentyThreeConvertibleNotesMember 2023-12-31 0001591913 ipsi:TotalConvertibleNotesPayableMember 2024-09-30 0001591913 ipsi:TotalConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001591913 ipsi:TotalConvertibleNotesPayableMember 2023-12-31 0001591913 2023-09-12 0001591913 2023-12-20 0001591913 2024-04-02 0001591913 2024-06-25 0001591913 ipsi:RRHMember 2024-08-06 2024-08-06 0001591913 us-gaap:WarrantMember ipsi:ConvertibleNotesMember 2024-08-06 0001591913 ipsi:TriggeringEventMember 2024-08-06 0001591913 ipsi:ConvertibleNotesMember 2024-08-06 0001591913 us-gaap:CommonStockMember 2024-08-06 0001591913 us-gaap:WarrantMember us-gaap:CommonStockMember 2024-08-06 0001591913 us-gaap:WarrantMember 2024-08-06 0001591913 us-gaap:WarrantMember 2024-09-30 0001591913 ipsi:BlackScholesValuationModelMember 2024-09-30 0001591913 ipsi:BlackScholesValuationModelMember 2024-07-01 2024-09-30 0001591913 ipsi:BlackScholesValuationModelMember 2024-01-01 2024-09-30 0001591913 srt:MinimumMember us-gaap:MeasurementInputConversionPriceMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:MeasurementInputConversionPriceMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:MeasurementInputConversionPriceMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:MeasurementInputConversionPriceMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember 2023-12-31 0001591913 us-gaap:MeasurementInputExpectedDividendRateMember 2024-09-30 0001591913 us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001591913 2023-01-01 2023-12-31 0001591913 us-gaap:CommonStockMember 2023-12-31 0001591913 2023-05-19 2023-05-19 0001591913 2023-08-16 2023-08-16 0001591913 2023-08-30 2023-08-30 0001591913 2023-08-31 2023-08-31 0001591913 2023-11-08 2023-11-08 0001591913 srt:MaximumMember us-gaap:WarrantMember 2024-08-06 2024-08-06 0001591913 srt:MinimumMember us-gaap:WarrantMember 2024-08-06 2024-08-06 0001591913 srt:MinimumMember 2024-08-06 0001591913 srt:MaximumMember 2024-08-06 0001591913 2024-08-06 2024-09-17 0001591913 ipsi:RRHMember 2024-09-17 0001591913 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001591913 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001591913 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001591913 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001591913 2023-11-27 0001591913 us-gaap:WarrantMember 2023-08-11 2023-08-11 0001591913 us-gaap:CommonStockMember 2023-08-11 2023-08-11 0001591913 ipsi:OpenPathAndEfinityPayMember 2024-09-30 0001591913 ipsi:AdditionalWarrantsMember ipsi:OpenPathAndEfinityPayMember 2024-09-30 0001591913 ipsi:OpenPathAndEfinityPayMember 2023-09-30 0001591913 ipsi:AdditionalWarrantsMember ipsi:OpenPathAndEfinityPayMember 2023-09-30 0001591913 ipsi:IPSICommonStockMember 2023-09-30 0001591913 2023-12-14 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-12-14 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-12-14 0001591913 us-gaap:WarrantMember 2023-12-14 0001591913 2024-05-04 0001591913 us-gaap:CommonStockMember 2024-05-04 0001591913 2024-03-04 0001591913 2024-03-14 0001591913 2024-05-03 2024-05-28 0001591913 us-gaap:WarrantMember 2024-05-04 0001591913 2024-05-04 2024-05-04 0001591913 us-gaap:WarrantMember 2024-05-04 2024-05-04 0001591913 us-gaap:WarrantMember 2024-08-06 2024-08-06 0001591913 srt:MaximumMember 2024-01-01 2024-09-30 0001591913 ipsi:TwoThousandEighteenStockIncentivePlanMember 2024-01-01 2024-09-30 0001591913 srt:MaximumMember us-gaap:CommonStockMember 2024-09-30 0001591913 ipsi:TwoThousandTwentyOnePlanMember 2021-10-22 2021-10-22 0001591913 ipsi:TwoThousandTwentyOnePlanMember srt:MaximumMember 2024-09-30 0001591913 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2022-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2022-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2022-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-01-01 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-01-01 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2023-12-31 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalVestedRestrictedSharesMember 2023-12-31 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2023-12-31 0001591913 ipsi:TotalRestrictedSharesMember 2024-01-01 2024-09-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-09-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2024-01-01 2024-09-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-09-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2024-01-01 2024-09-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-01-01 2024-09-30 0001591913 ipsi:TotalRestrictedSharesMember 2024-09-30 0001591913 ipsi:WeightedAverageFairMarketValuePerShareMember 2024-09-30 0001591913 ipsi:TotalUnvestedRestrictedSharesMember 2024-09-30 0001591913 ipsi:UnvestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-09-30 0001591913 ipsi:TotalVestedRestrictedSharesMember 2024-09-30 0001591913 ipsi:VestedRestrictedWeightedAverageFairMarketValuePerShareMember 2024-09-30 0001591913 ipsi:GrantDatePriceOnePointFourSevanMember 2024-01-01 2024-09-30 0001591913 ipsi:GrantDatePriceOnePointFiveZeroMember 2024-01-01 2024-09-30 0001591913 ipsi:GrantDatePriceOnePointSixFiveMember 2024-01-01 2024-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:WarrantMember us-gaap:MeasurementInputOptionVolatilityMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember us-gaap:MeasurementInputOptionVolatilityMember 2024-09-30 0001591913 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedDividendRateMember 2024-09-30 0001591913 us-gaap:WarrantMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2022-12-31 0001591913 us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-01-01 2023-12-31 0001591913 us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:WarrantMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:WarrantMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:WarrantMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointZeroEightFourMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointZeroEightFourMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointThreeFourFiveMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceZeroPointFourFiveZeroMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointZeroThreeFiveMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceOnePointFiveZeroZeroMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2024-09-30 0001591913 us-gaap:WarrantMember ipsi:ExercisePriceFivePointSixTwoFiveMember 2024-01-01 2024-09-30 0001591913 us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2022-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2022-12-31 0001591913 us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-01-01 2023-12-31 0001591913 us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2023-12-31 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2023-12-31 0001591913 us-gaap:StockOptionMember 2024-01-01 2024-09-30 0001591913 us-gaap:StockOptionMember 2024-09-30 0001591913 srt:MinimumMember us-gaap:StockOptionMember 2024-09-30 0001591913 srt:MaximumMember us-gaap:StockOptionMember 2024-09-30 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2024-09-30 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceOnePointTwoZeroMember 2024-01-01 2024-09-30 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-09-30 0001591913 us-gaap:StockOptionMember ipsi:ExercisePriceFourPointFiveZeroMember 2024-01-01 2024-09-30 0001591913 2024-03-14 2024-03-14 0001591913 ipsi:TwoNotesMember 2024-05-04 2024-05-04 0001591913 ipsi:NoteOneMember 2024-05-04 0001591913 ipsi:NoteOneMember 2024-05-04 2024-05-04 0001591913 ipsi:NotesTwoMember 2024-05-04 0001591913 ipsi:NotesTwoMember 2024-05-04 2024-05-04 0001591913 us-gaap:WarrantMember 2024-06-14 0001591913 ipsi:ConvertibleNotesMember 2024-09-17 0001591913 ipsi:TriggeringEventMember 2024-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-09-30 0001591913 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-09-30 0001591913 ipsi:StockOptionsMember 2024-01-01 2024-09-30 0001591913 ipsi:StockOptionsMember 2023-01-01 2023-09-30 0001591913 us-gaap:WarrantMember 2024-01-01 2024-09-30 0001591913 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001591913 ipsi:WilliamCorbettMember 2024-07-01 2024-09-30 0001591913 ipsi:WilliamCorbettMember 2023-07-01 2023-09-30 0001591913 ipsi:WilliamCorbettMember 2024-01-01 2024-09-30 0001591913 ipsi:WilliamCorbettMember 2023-01-01 2023-09-30 0001591913 ipsi:RichardRosenblumMember 2024-07-01 2024-09-30 0001591913 ipsi:RichardRosenblumMember 2023-07-01 2023-09-30 0001591913 ipsi:RichardRosenblumMember 2024-01-01 2024-09-30 0001591913 ipsi:RichardRosenblumMember 2023-01-01 2023-09-30 0001591913 ipsi:NotePayableMember us-gaap:ConvertibleNotesPayableMember 2024-01-01 2024-09-30 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2024-10-10 0001591913 us-gaap:SubsequentEventMember 2024-10-10 2024-10-10 0001591913 ipsi:SecuritiesPurchaseAgreementMember us-gaap:SubsequentEventMember 2024-10-10 2024-10-10 0001591913 us-gaap:SubsequentEventMember 2024-10-10 0001591913 srt:ScenarioForecastMember ipsi:SecuritiesPurchaseAgreementMember 2025-10-25 0001591913 ipsi:ConvertibleNoteMember us-gaap:SubsequentEventMember 2024-10-22 2024-10-22 0001591913 us-gaap:SubsequentEventMember 2024-10-22 2024-10-22 0001591913 us-gaap:WarrantMember ipsi:ConvertibleNoteMember us-gaap:SubsequentEventMember 2024-10-22 0001591913 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-10-22 0001591913 ipsi:ConvertiblePromissoryNotesMember 2024-01-01 2024-09-30 0001591913 ipsi:ConvertibleNoteMember us-gaap:SubsequentEventMember 2024-10-22 0001591913 ipsi:SecuritiesPurchaseAgreementMember 2024-01-01 2024-09-30 0001591913 ipsi:ConvertiblePromissoryNotesMember 2024-01-01 2024-09-30 0001591913 srt:MinimumMember us-gaap:SubsequentEventMember 2024-10-11 2024-10-11 0001591913 srt:MaximumMember us-gaap:SubsequentEventMember 2024-10-11 2024-10-11 0001591913 us-gaap:SubsequentEventMember 2024-10-11 2024-10-11 0001591913 srt:MinimumMember us-gaap:SubsequentEventMember 2024-10-25 2024-10-25 0001591913 srt:MaximumMember us-gaap:SubsequentEventMember 2024-10-25 2024-10-25 0001591913 us-gaap:SubsequentEventMember 2024-10-25 2024-10-25 0001591913 srt:MinimumMember us-gaap:SubsequentEventMember 2024-11-11 2024-11-11 0001591913 srt:MaximumMember us-gaap:SubsequentEventMember 2024-11-11 2024-11-11 0001591913 us-gaap:SubsequentEventMember 2024-11-11 2024-11-11 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

 

CERTIFICATION PURSUANT TO RULE 13a-14 OR RULE

15d-14 OF THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Richard Rosenblum, certify that:

 

1.I have reviewed this Quarterly Report on Form 10-Q of Innovative Payment Solutions, Inc.:
  
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and.

 

5.I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 12, 2024 /s/ Richard Rosenblum
  Richard Rosenblum
  President and Chief Financial Officer
  (Principal Executive Officer and Principal Accounting Officer)

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Innovative Payment Solutions, Inc. (the “Registrant”) on Form 10-Q for the quarterly period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard Rosenblum, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2)To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: November 12, 2024 By: /s/ Richard Rosenblum
    Richard Rosenblum
    President and Chief Financial Officer
    (Principal Executive and Principal Accounting Officer)

 

 

 

 

v3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Nov. 12, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Amendment Flag false  
Document Period End Date Sep. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Entity Information [Line Items]    
Entity Registrant Name INNOVATIVE PAYMENT SOLUTIONS, INC.  
Entity Central Index Key 0001591913  
Entity File Number 000-55648  
Entity Tax Identification Number 33-1230229  
Entity Incorporation, State or Country Code NV  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Shell Company false  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Incorporation, Date of Incorporation May 12, 2016  
Entity Contact Personnel [Line Items]    
Entity Address, Address Line One 56B 5th Avenue  
Entity Address, Address Line Two Lot 1 #AT  
Entity Address, City or Town Carmel By The Sea  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 93921  
Entity Phone Fax Numbers [Line Items]    
City Area Code (866)  
Local Phone Number 477-4729  
Entity Listings [Line Items]    
Title of 12(b) Security None  
Entity Common Stock, Shares Outstanding   18,731,446
v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current Assets    
Cash $ 1,033 $ 50,433
Receivable from equity method investment 800
Notes receivable - current 131,405
Other current assets 12,389 38,818
Total Current Assets 145,627 89,251
Non-current assets    
Plant and equipment 5,400 7,027
Notes receivable, net of unamortized discount of $48,243 177,947
Security deposit 5,000 5,000
Equity method investment 703,778 703,938
Total Non-Current Assets 892,125 715,965
Total Assets 1,037,752 805,216
Current Liabilities    
Accounts payable 2,595,191 2,023,375
Federal relief loans – current portion 7,670 9,369
Notes payable, net of unamortized discount of $60,870 and $0, respectively 1,390,229 1,062,007
Convertible debt, net of unamortized discount of $184,626 and $687,503, respectively 4,916,822 3,704,280
Derivative liability 1,569,103 1,434,196
Total Current Liabilities 10,479,015 8,233,227
Non-Current Liabilities    
Federal relief loans 150,000 150,000
Total Non-Current Liabilities 150,000 150,000
Total Liabilities 10,629,015 8,383,227
Stockholders’ Equity (Deficit)    
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of September 30, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 16,185,552 and13,819,889 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. 1,619 1,382
Additional paid-in-capital 51,926,805 50,656,225
Accumulated deficit (61,519,687) (58,235,618)
Total Stockholders’ Equity (Deficit) (9,591,263) (7,578,011)
Total Liabilities and Stockholders’ Equity (Deficit) $ 1,037,752 $ 805,216
v3.24.3
Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Notes receivable, net of unamortized discount (in Dollars) $ 48,243 $ 48,243
Notes payable, net of unamortized discount (in Dollars) 60,870 0
Convertible debt, net of unamortized discount (in Dollars) $ 184,626 $ 687,503
Preferred stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized 25,000,000 25,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value (in Dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized 750,000,000 750,000,000
Common stock, shares issued 16,185,552 13,819,889
Common stock, shares outstanding 16,185,552 13,819,889
v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net Revenue $ (28) $ 410
Cost of Goods Sold 387 2,756
Gross loss (415) (2,346)
General and administrative 296,438 745,688 1,330,367 2,753,266
Depreciation and amortization 543 100,387 1,627 380,092
Total Expense 296,981 846,075 1,331,994 3,133,358
Loss from Operations (296,981) (846,490) (1,331,994) (3,135,704)
Loss on convertible notes (4,534,491) (58,769) (4,636,843) (77,247)
Fair value adjustment to price protected warrants (2,051,405)   (2,051,405)
Penalty on convertible notes (6,611) (9,306) (6,611) (9,306)
Loss on novation (1,066,165) (1,066,165)
Fair value of warrants issued (14,176) (14,176)
Loss on disposal of assets (2,600)
Interest expense (152,376) (110,328) (435,471) (290,628)
Interest income 9,740 21,019
Amortization of debt discount (233,948) (303,042) (874,193) (414,696)
Derivative liability movements 5,538,008 1,795,642 6,461,496 1,483,710
Loss before Income Taxes (1,728,064) (612,634) (2,856,602) (3,524,212)
Income Taxes
Net Loss after income taxes (1,728,064) (612,634) (2,856,602) (3,524,212)
Net loss from equity method investments (88) (402,509) (660) (403,890)
Net loss from continuing operations (1,728,152) (1,015,143) (2,857,262) (3,928,102)
Discontinued operations        
Operating loss from discontinued operations (40,821)
Loss on disposal of subsidiary and investment (495,424)
Net loss from discontinued operations, total (536,245)
Net loss (1,728,152) (1,015,143) (2,857,262) (4,464,347)
Net loss attributable to non-controlling interest 1,597
Deemed dividend (426,807) (426,807)  
Net loss attributable to Innovative Payment Solutions, Inc., stockholders $ (2,154,959) $ (1,015,143) $ (3,284,069) $ (4,462,750)
Basic and diluted loss per share*        
Continuing operations Basic (in Dollars per share) [1] $ (0.15) $ (0.08) $ (0.23) $ (0.31)
Continuing operations diluted (in Dollars per share) [1] (0.15) (0.08) (0.23) (0.31)
Discontinued operations Basic (in Dollars per share) [1] (0.04)
Discontinued operations diluted (in Dollars per share) [1] (0.04)
Earnings Per Share Basic (in Dollars per share) (0.15) (0.08) (0.23) (0.35)
Earnings Per Share diluted (in Dollars per share) $ (0.15) $ (0.08) $ (0.23) $ (0.35)
Weighted Average Number of Shares Outstanding – Basic (in Shares) 14,546,060 12,789,493 14,063,713 12,650,758
Weighted Average Number of Shares Outstanding – diluted (in Shares) 14,546,060 12,789,493 14,063,713 12,650,758
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
[1]
Accumulated Deficit
Non- controlling shareholders interest
Total
Balance at Dec. 31, 2022 $ 1,256 [1] $ 48,442,355 $ (52,399,858) $ 1,597 $ (3,954,650)
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Fair value of warrants issued to convertible debt holders [1] 251,856 251,856
Stock based compensation [1] 130,671 130,671
Net loss [1] (273,390) (1,597) (274,987)
Balance at Mar. 31, 2023 $ 1,256 [1] 48,824,882 (52,673,248) (3,847,110)
Balance (in Shares) at Mar. 31, 2023 12,563,426 [1]        
Balance at Dec. 31, 2022 $ 1,256 [1] 48,442,355 (52,399,858) 1,597 (3,954,650)
Balance (in Shares) at Dec. 31, 2022 12,563,426 [1]        
Net loss           (4,464,347)
Balance at Sep. 30, 2023 $ 1,303 [1] 50,013,798 (56,862,608) (6,847,507)
Balance (in Shares) at Sep. 30, 2023 [1]   13,030,034        
Balance at Mar. 31, 2023 $ 1,256 [1] 48,824,882 (52,673,248) (3,847,110)
Balance (in Shares) at Mar. 31, 2023 12,563,426 [1]        
Fair value of warrants issued to convertible debt holders [1] 130,025 130,025
Conversion of convertible debt $ 7 [1] 43,471 43,478
Conversion of convertible debt (in Shares) 72,464 [1]        
Fair value of warrants issued for equity method investments [1] 108,220 108,220
Stock based compensation [1] 130,671 130,671
Net loss     (3,174,217) (3,174,217)
Balance at Jun. 30, 2023 $ 1,263 [1] 49,237,269 (55,847,465) (6,608,933)
Balance (in Shares) at Jun. 30, 2023 12,635,890 [1]        
Fair value of warrants issued to convertible debt holders [1] 437,953 437,953
Conversion of convertible debt $ 40 [1] 193,729 193,769
Conversion of convertible debt (in Shares) [1]   391,306        
Additional shares issued on reverse stock split [1]
Additional shares issued on reverse stock split (in Shares) [1]   2,838        
Fair value of warrants issued for services [1] 14,176 14,176
Stock based compensation [1] 130,671 130,671
Net loss [1] (1,015,143) (1,015,143)
Balance at Sep. 30, 2023 $ 1,303 [1] 50,013,798 (56,862,608) (6,847,507)
Balance (in Shares) at Sep. 30, 2023 [1]   13,030,034        
Balance at Dec. 31, 2023 $ 1,382 [1] 50,656,225 (58,235,618) (7,578,011)
Balance (in Shares) at Dec. 31, 2023 13,819,889 [1]        
Fair value of warrants issued to convertible debt holders [1] 44,813 44,813
Fair value of warrants issued on debt extinguishment [1] 66,047 66,047
Fair value of warrants issued for services [1] 36,207 36,207
Stock based compensation [1] 94,464 94,464
Net loss [1] (331,465) (331,465)
Balance at Mar. 31, 2024 $ 1,382 [1] 50,897,756 (58,567,083) (7,667,945)
Balance (in Shares) at Mar. 31, 2024 13,819,889 [1]        
Balance at Dec. 31, 2023 $ 1,382 [1] 50,656,225 (58,235,618) (7,578,011)
Balance (in Shares) at Dec. 31, 2023 13,819,889 [1]        
Net loss           (2,857,262)
Balance at Sep. 30, 2024 $ 1,619 [1] 51,926,805 (61,519,687) (9,591,263)
Balance (in Shares) at Sep. 30, 2024   16,185,552        
Balance at Mar. 31, 2024 $ 1,382 [1] 50,897,756 (58,567,083) (7,667,945)
Balance (in Shares) at Mar. 31, 2024 13,819,889 [1]        
Fair value of warrants issued to convertible debt holders [1] 42,863 42,863
Fair value of warrants issued on debt extinguishment [1] 36,305 36,305
Fair value of warrants issued for services [1] 36,207 36,207
Stock based compensation [1] 94,464 94,464
Net loss [1] (797,645) (797,645)
Balance at Jun. 30, 2024 $ 1,382 [1] 51,107,595 (59,364,728) (8,255,751)
Balance (in Shares) at Jun. 30, 2024 13,819,889 [1]        
Conversion of convertible debt $ 237 [1] 357,972 358,209
Conversion of convertible debt (in Shares) [1]   2,365,663        
Deemed dividend on warrant anti-dilution [1] 426,807 (426,807)
Fair value of warrants issued for services [1] 2,943 2,943
Stock based compensation [1] 31,488 31,488
Net loss [1] (1,728,152) (1,728,152)
Balance at Sep. 30, 2024 $ 1,619 [1] $ 51,926,805 $ (61,519,687) $ (9,591,263)
Balance (in Shares) at Sep. 30, 2024   16,185,552        
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net loss $ (1,728,152) $ (2,857,262) $ (4,464,347)
Net loss from discontinued operations 536,245
Net loss from continuing operations (1,728,152) (2,857,262) (3,928,102)
Adjustments to reconcile net loss to net cash used in operating activities:      
Derivative liability movements (5,538,008) (6,461,496) (1,483,710)
Depreciation 543 1,627 380,092
Amortization of debt discount 233,948 874,193 414,696
Loss on convertible debt   4,636,843 77,247
Fair value adjustment to price protected warrants 2,051,405 2,051,405
Loss on novation 1,066,165
Penalty on convertible debt   6,611 9,306
Deemed interest income   (19,614)
Unrealized loss on equity method investments   660 403,890
Warrants issued for services   75,357 122,797
Stock based compensation   220,416 283,392
Changes in Assets and Liabilities      
Receivable from equity method investments   (800)
Other current assets   25,024 47,628
Accounts payable and accrued expenses   571,816 1,150,919
Related party payables   50,000
Interest accruals   394,374 281,383
Cash used in operating activities – continuing operations   (480,846) (1,124,297)
Cash provided by operating activities – discontinued operations   35,286
CASH USED IN OPERATING ACTIVITIES   (480,846) (1,089,011)
CASH FLOWS FROM INVESTING ACTIVITIES:      
Investment in notes receivable   (288,333)
Investment in intangibles   (44,405)
Deposits refunded   4,800
Investment in equity method investment   (500) (1,000,000)
Net cash used in investing activities – continuing operations   (288,833) (1,039,605)
Net cash used in investing activities – discontinued operations   (36,230)
CASH USED IN INVESTING ACTIVITIES   (288,833) (1,075,835)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Proceeds from notes payable   233,333
Proceeds from convertible notes   785,502 2,001,666
Repayment of convertible notes   (298,556) (189,326)
Repayment of federal relief loans   (2,864)
Net cash provided by financing activities – continuing operations   720,279 1,809,476
Net cash provided by financing activities – discontinued operations  
NET CASH PROVIDED BY FINANCING ACTIVITIES   720,279 1,809,476
NET DECREASE IN CASH   (49,400) (355,370)
Cash and cash included in assets held for sale at the beginning of the period   50,433 374,765
CASH AT END OF PERIOD 1,033 1,033 19,395
RECONCILIATION OF OPENING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS      
Cash   50,433 373,822
Cash included in assets held for sale   943
CASH AT THE BEGINNING OF THE PERIOD   50,433 374,765
RECONCILIATION OF CLOSING CASH WITHIN THE BALANCE SHEET TO THE STATEMENT OF CASH FLOWS      
Cash 1,033 1,033 19,395
Cash included in assets held for sale
CASH AT THE END OF THE PERIOD $ 1,033 1,033 19,395
CASH PAID FOR INTEREST AND TAXES:      
Cash paid for income taxes  
Cash paid for interest   41,096 9,245
NON-CASH INVESTING AND FINANCING ACTIVITIES      
Fair value of warrants issued with convertible notes   87,676 819,384
Conversion of convertible debt to equity   198,716 160,000
Fair value of warrants issued for equity method investments   $ 108,220
v3.24.3
Organization and Description of Business
9 Months Ended
Sep. 30, 2024
Organization and Description of Business [Abstract]  
ORGANIZATION AND DESCRIPTION OF BUSINESS
1 ORGANIZATION AND DESCRIPTION OF BUSINESS

 

  a) Organizational History

 

On May 12, 2016, Innovative Payment Solutions, Inc., a Nevada corporation (“IPSI” or the “Company”) (originally formed on September 23, 2013 under the name “Asiya Pearls, Inc.”), entered into an Agreement and Plan of Merger (the “Qpagos Merger Agreement”) with Qpagos Corporation, a Delaware corporation (“Qpagos Corporation”), and Qpagos Merge, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”). Pursuant to the Qpagos Merger Agreement, on May 12, 2016, the merger was consummated, and Qpagos Corporation and Merger Sub merged (the Qpagos “Merger”), with Qpagos Corporation continuing as the surviving corporation of the Merger. On May 27, 2016, the Company’s name was changed from “Asiya Pearls, Inc.” to “QPAGOS”.

 

Pursuant to the Qpagos Merger Agreement, upon consummation of the Qpagos Merger, each share of Qpagos Corporation’s capital stock issued and outstanding immediately prior to the Merger was converted into the right to receive two shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). Additionally, pursuant to the Qpagos Merger Agreement, upon consummation of the Merger, the Company assumed all of Qpagos Corporation’s warrants issued and outstanding immediately prior to the Merger, which were exercisable for an aggregate of approximately 621,920 shares of Common Stock as of the date of the Qpagos Merger. Prior to and as a condition to the closing of the Qpagos Merger, a then-current holder of 500,000 shares of Common Stock agreed to return 497,500 shares of Common Stock held by such holder to the Company and such holder retained an aggregate of 2,500 shares of Common Stock. The other stockholders of the Company retained 500,000 shares of Common Stock. Therefore, immediately following the Qpagos Merger, Qpagos Corporation’s former stockholders held 4,992,900 shares of Common Stock which represented approximately 91% of the outstanding Common Stock.

 

The Qpagos Merger was treated as a reverse acquisition of the Company, then a public shell company, for financial accounting and reporting purposes. As such, Qpagos Corporation was treated as the acquirer for accounting and financial reporting purposes while the Company was treated as the acquired entity for accounting and financial reporting purposes.

 

Qpagos Corporation was incorporated on May 1, 2015 under the laws of the state of Delaware to effectuate a reverse merger transaction with Qpagos, S.A.P.I. de C.V. (“Qpagos Mexico”) and Redpag Electrónicos S.A.P.I. de C.V. (“Redpag”). Each of the entities were incorporated in November 2013 in Mexico. Qpagos Mexico was formed to process payment transactions for service providers it contracts with, and Redpag was formed to deploy and operate kiosks as a distributor. 

 

On June 1, 2016, the board of directors of the Company (the “Board”) changed the Company’s fiscal year end from October 31 to December 31.

 

On November 1, 2019, the Company changed its corporate name from “QPAGOS” to “Innovative Payment Solutions, Inc.” Additionally, and immediately following the name change, the Company filed a Certificate of Change with the Secretary of State of the State of Nevada to effect a reverse split of the then outstanding Common Stock at a ratio of 1-for-10, effective on November 1, 2019 (the “Reverse Stock Split”). As a result of the Reverse Stock Split, each ten pre-split shares of Common Stock outstanding automatically combined into one new share of Common Stock without any further action on the part of the holders, and the number of outstanding shares of Common Stock was reduced from 320,477,867 shares to 32,047,817 after rounding for fractional shares.

 

On December 31, 2019, the Company consummated the disposal of Qpagos Corporation, Qpagos Mexico and Redpag in exchange for 2,250,000 shares (the “Vivi Shares”) of common stock of Vivi Holdings, Inc. (“Vivi. or “Vivi Holdings”) pursuant to a Stock Purchase Agreement dated August 5, 2019 (the “SPA”). Of the 2,250,000 shares of Vivi, nine percent (9%) was allocated as follows: Gaston Pereira (5%), Andrey Novikov (2.5%), and Joseph Abrams (1.5%). The transactions contemplated by the SPA closed on December 31, 2019 after the satisfaction of customary conditions, the receipt of a final fairness opinion and the approval of the Company’s shareholders. As a result, the Company no longer has any business operations in Mexico and has retained its U.S. operations, currently based in Carmel By The Sea, California.

  

On June 21, 2021, the Company acquired a 10% strategic interest in Frictionless Financial Technologies, Inc. (“Frictionless”). Frictionless delivered to the Company, a live fully compliant financial payment Software as a Service solution for use by the Company as a digital payment platform (which was subsequently branded as IPSIPay) that enabled payments within the United States and abroad, including Mexico, together with a service agreement providing a full suite of product services to facilitate the Company’s anticipated product offerings. The Company had an irrevocable right to acquire up to an additional 41% of the outstanding common stock of Frictionless at a purchase price of $300,000 for each 1% acquired.

 

On August 26, 2021, the Company formed a new subsidiary, Beyond Fintech, Inc. (“Beyond Fintech”), in which it owns a 51% stake, with Frictionless owning the remaining 49%. Beyond Fintech acquired an exclusive license to a product known as Beyond Wallet, to further its objective of providing virtual payment services allowing U.S. persons to transfer funds to Mexico and other countries.

 

On May 12, 2023, the Company entered into an Agreement with Frictionless (the “May 2023 Frictionless Agreement”) to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company; (ii) the warrant to purchase 1,000,000 shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless, were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless was a credit against potential future services to be provided by Frictionless to the Company in an amount up to $250,000. As a result of the novation agreement with Frictionless discussed below, the Company no longer utilizes, and does not expect to utilize, the services of Frictionless for the foreseeable future. The collectability of the remaining credit receivable of $231,431 was impaired.

 

On August 30, 2023, the Company implemented a 1 for 30 reverse stock split of its Common Stock. Unless the context expressly requires otherwise, as used in this Report, all share and per share numbers reflect such reverse stock split.

 

On September 5, 2023, the Company’s entered into a novation agreement whereby it assigned all its rights and interest in its e-wallet product, IPSIPay, and its receivables and payables due from and to Frictionless, related to IPSIPay, to a third party in order to concentrate all of its efforts on the IPSIPay Express LLC (“IPSIPay Express”) joint venture. See note 1(b) for further information.

 

  b) Description of current business

 

The Company is currently a fintech provider of digital payment solutions presently focused on, through its participation in IPSIPay Express, developing a new account-to-account payment application called Instant Direct Payments as well as traditional credit card processing services. The Company has in the past (under the name IPSIPay) and may in the future develop and operate “e-wallets” that enable consumers to deposit cash, convert it into a digital form and remit funds quickly and securely.

 

IPSIPay Express

 

On April 28, 2023, the Company formed a new company called IPSIPay Express. This entity was formed as a Delaware limited liability company joint venture with OpenPath, Inc. (“OpenPath”) and EfinityPay, LLC (“EfinityPay”, and the Company, collectively with OpenPath and EfinityPay, the “Members”) to develop and market a proprietary consumer to merchant real-time payment platform initially focused on the fast-growing online gaming and entertainment sectors.

 

On June 19, 2023, the Company entered into a Limited Liability Company Operating Agreement (the “Operating Agreement”) with OpenPath and EfinityPay to jointly provide for the governance of and rights of the Members with respect to IPSIPay Express. The effective date of the Operating Agreement is April 28, 2023.

 

IPSIPay Express was formed by the Members with the initial business purposes of providing credit card processing solutions and also a proprietary solution for real time bank-to-bank payment transactions in a manner that provides seamless and frictionless consumer and merchant experiences, with an initial focus on merchants operating in gaming and entertainment sectors. Such solutions are collectively referred to herein as “IPEX.”

 

Pursuant to the Operating Agreement, the Company agreed to contribute cash to or on behalf IPSIPay Express to be used for the IPEX business in the aggregate amount of up to $1,500,000 (the “IPSI Capital Contribution”). The Company was required to make the IPSIPay Capital Contribution in three tranches of $500,000 (each, a “Tranche”), or such lesser amounts as may be unanimously approved by the Board of Managers of IPSIPay Express. With the full funding of each Tranche, the Company will automatically receive an 11.11% membership interest in IPSIPay Express (or a pro rata portion thereof if less than a full Tranche is funded), and OpenPath and EfinityPay’s percentage interest in IPSIPay Express will be reduced pro rata accordingly. Should the Company contribute the full IPSI Capital Contribution, the Members will each own one-third (1/3) of the membership interests in IPSIPay Express. The IPSI Capital Contribution has been or will be made by the following dates and in the following amounts: (i) $200,000 of the initial Tranche was paid by the Company on June 21, 2023; (ii) the $300,000 balance of the initial Tranche was paid on August 4, 2023; (iii) the second $500,000 Tranche was paid in September 2023 and (iv) the third $500,000 Tranche was expected to be paid on or before November 30, 2023. In late 2023, the Company agreed with its joint venture partners that such investment was not required as IPEX is not operational. The need for any additional advances will be addressed with the joint venture partners once IPEX becomes operational and begins generating revenue, the Company’s current equity holding in IPSIPay Express remains at 22%.

 

Simultaneously with the funding of the initial Tranche, the Company issued to each of OpenPath and EfinityPay a five-year Common Stock purchase warrant (the “IPEX Warrant”) to purchase 133,334 shares of Common Stock with an exercise price of $0.45 per share. We are still obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 199,999 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the initial Tranche. Simultaneously with the funding of the second Tranche, we are obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Should we decide to fund a third Tranche, we will be obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock.

 

  c) Merger Agreement with Business Warrior

 

On July 28, 2024, the Company entered into an Agreement and Plan of Merger (the “BW Merger Agreement”), by and among the Company, IPSI Merger Sub, Inc., a Delaware corporation and a newly formed, wholly owned subsidiary of the Company (“Merger Sub”) and Business Warrior.

 

Pursuant to the BW Merger Agreement, subject to the terms and conditions set forth therein, at the closing of the transactions contemplated by the BW Merger Agreement (the “Closing”), Merger Sub will merge with and into Business Warrior (the “BW Merger” and, together with the other transactions contemplated by the BW Merger Agreement, the “BW Transactions”), with Business Warrior continuing as the surviving Wyoming corporation in the BW Merger and a wholly owned subsidiary of the Company.

 

Subject to the terms and conditions set forth in the BW Merger Agreement, at the effective time of the BW Merger (the “Effective Time”): (i) each outstanding share of common stock, par value $0.0001 per share, of Business Warrior (“Business Warrior Common Stock”), other than treasury shares and shares as to which appraisal rights have been exercised, will be automatically converted into the right to receive a number of shares of Common Stock equal to the Applicable Per Share Portion (as defined in the BW Merger Agreement) of the BW Merger Consideration (as defined below), (ii) each outstanding share of preferred stock of Business Warrior (“Business Warrior Preferred Stock”), other than treasury shares and shares as to which appraisal rights have been exercised, will be automatically converted into the right to receive a number of shares of Common Stock equal to the Applicable Per Share Portion (as defined in the BW Merger Agreement) of the BW Merger Consideration (as defined below) had such share of Business Warrior Preferred Stock been converted into shares of Business Warrior Common Stock immediately prior to the Effective Time and (iii) any other options, warrants or rights to subscribe for or purchase any capital stock of Business Warrior or securities convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire any capital stock of Business Warrior, if not exercised or converted prior to the Effective Time, shall be cancelled, retired and terminated.

 

Merger Consideration 

 

Pursuant to the terms of the BW Merger Agreement, the consideration to be delivered to the holders of Business Warrior Common Stock and Business Warrior Preferred Stock in connection with the BW Merger Consideration (the “BW Merger Consideration”) will be a number of newly issued shares of Common Stock representing forty-five percent (45%) of the Common Stock outstanding immediately following the Closing, and after giving effect to the conversion, exercise or cancellation of the Business Warrior Preferred Stock and other Business Warrior securities referred to above.

 

Representations and Warranties

 

The BW Merger Agreement contains representations and warranties of each of the Company, Merger Sub and Business Warrior that are customary for similar transactions and that include certain qualifications and customary exceptions, as applicable.

  

Covenants of the Parties

 

The BW Merger Agreement includes customary covenants of the parties with respect to, among others things, (i) operation of their respective businesses prior to consummation of the BW Merger and efforts to satisfy conditions to consummation of the BW Merger, (ii) access to information, (iii) cooperation in the preparation of the registration statement on Form S-4 (as may be amended or supplemented from time to time, the “Registration Statement”) which the Company is expected to file with the U.S. Securities and Exchange Commission (“SEC”) in connection with the BW Merger and the Transactions, (iv) use of reasonable best efforts to obtain regulatory approvals, (v) notification of the other party of certain breaches, (vi) Section 16 matters, (vii)  indemnification of directors and officers and tail insurance and (viii) obtaining all requisite approvals of each party’s respective stockholders. Additionally, Business Warrior has agreed not to solicit or enter into a competing alternative transaction (an “Alternative Transactions”), subject to the fiduciary duties of the board of directors Business Warrior, in accordance with customary terms and provisions set forth in the BW Merger Agreement.

 

The parties agreed to take all necessary actions to cause the Company’s board of directors immediately after Closing to consist of five directors, including: (i) two persons who are designated by the Company prior to Closing, (ii) two persons who are designated by Business Warrior prior to Closing and (iii) one person mutually agreed upon by the Company and Business Warrior.

 

Conditions to Consummation of the Merger; Convertible Note Exchange

 

Each party’s obligation to consummate the BW Merger is conditioned upon, among other things: (i) approval by the Company stockholders of the amendment to its certificate of incorporation (“the Company Stockholder Approval”), (ii) approval by Business Warrior stockholders of the BW Merger and related transactions and matters (“Business Warrior Stockholder Approval”), (iii) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and all other requisite regulatory approval, (iv) the absence of any applicable law or order that makes illegal, or prohibits or prevents, the Transactions and (v) the Registration Statement having become effective in accordance with the provisions of the Securities Act of 1933, as amended (“Securities Act”).

 

In addition, each party’s obligation to consummate the BW Merger is conditioned upon the following agreements being in full force and effect: (i) exchange agreements, to be entered into by and among the Company, Business Warrior and each holder of the outstanding convertible notes of the Company (the “Company Exchange Agreements”), pursuant to which each outstanding convertible note of the Company will be exchanged for shares of newly-issued shares of a newly designated Series A Convertible Preferred Stock of the Company (the “Company Series A Preferred”) and (ii) exchange agreements, to be entered into by and among the Company, Business Warrior and each holder of the outstanding convertible notes of Business Warrior (the “Business Warrior Exchange Agreements”), pursuant to which each outstanding convertible note of Business Warrior will be exchanged for shares of newly-issued shares of Company Series A Preferred. The designation of the Company Series A Preferred is subject to the Company Stockholder Approval. Further, as of the date of this Report, the terms of the Company Series A Preferred remain subject to negotiation between the Company, Business Warrior and the holders of such convertible notes. The Company and Business Warrior have certain convertible note holders in common.

 

In addition, the Company’s obligation to consummate the BW Merger is conditioned upon, among other things: (i) the representations and warranties of Business Warrior being true and correct on and as of the Closing Date (as defined in the Merger Agreement) as if made on the Closing Date (subject to certain exceptions and an overall “Material Adverse Effect” standard), (ii) Business Warrior having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the BW Merger Agreement to be performed or complied with by it on or prior to the Closing Date and (iii) receipt by the Company of each Lock-Up Agreement (as defined below) and Employment Agreement (as defined in the BW Merger Agreement).

 

Business Warrior’s obligation to consummate the BW Merger is further conditioned upon, among other things: (i) the representations and warranties of the Company being true and correct on and as of the Closing Date as if made on the Closing Date (subject to certain exceptions and an overall “Material Adverse Effect” standard) and (ii) the Company and Merger Sub having performed in all material respects all of its obligations and complied in all material respects with all of its agreements and covenants under the BW Merger Agreement to be performed or complied with by it on or prior to the Closing Date.

 

Termination

 

The BW Merger Agreement may be terminated at any time prior to the Effective Time by either the Company or Business Warrior if the BW Merger and related transactions are not consummated on or before the seven-month anniversary of the date of the Merger Agreement (the “Termination Date”), provided that the Termination Date shall be automatically extended to the nine-month anniversary of the BW Merger Agreement if the conditions to closing, other than receipt of the Company Stockholder Approval and Business Warrior Stockholder Approval, effectiveness of the Registration Statement and that the Company Exchange Agreements and Business Warrior Exchange Agreements are in full force and effect, have been satisfied.

   

The BW Merger Agreement may also be terminated under certain other customary and limited circumstances at any time prior the Closing, including, among other reasons (i) by mutual written consent of the Company and Business Warrior, (ii) by written notice by either the Company or Business Warrior if a governmental authority of competent jurisdiction shall have issued an order or taken any other action permanently restraining, enjoining or otherwise prohibiting the BW Merger, and such order or other action has become final and non-appealable, (iii) by written notice by Business Warrior of the Company’s or Merger Sub’s uncured breach of a representation, warranty, or covenant contained in the BW Merger Agreement that would cause the related condition to closing to not be satisfied, (iv) by written notice by the Company of Business Warrior’s uncured breach of a representation, warranty, or covenant contained in the BW Merger Agreement that would cause the related Closing condition to not be satisfied or a material breach of a Business Warrior Voting and Support Agreement (as defined below), (v) by either the Company or Business Warrior if Business Warrior holds its stockholder meeting to approve the BW Merger Agreement and the BW Merger, and Business Warrior Stockholder Approval is not obtained, (vi) by the Company if Business Warrior’s board of directors has failed to recommend or shall have withdrawn, amended or modified in any respect materially adverse to the Company its recommendation of the BW Merger Agreement or shall have recommended another proposal for an Alternative Transaction or accepted a Superior Proposal (as defined in the BW Merger Agreement) and (vii) by Business Warrior if, prior to receipt of Business Warrior Stockholder Approval, Business Warrior accepts a Superior Proposal, subject to the terms and conditions of the BW Merger Agreement.

 

Governing Law

 

The Merger Agreement is governed by the laws of the State of New York and the parties are subject to the jurisdiction of any New York state court or any federal court sitting in the State of New York in any action arising out of or relating to the Merger Agreement.

 

Certain Agreements Related to the Merger Agreement

 

Business Warrior Voting and Support Agreements

 

In connection with the execution of the Merger Agreement, on July 29, 2024, certain stockholders of Business Warrior, including Rhett Doolittle and Jonathan Brooks, the Chief Executive Officer and President, respectively, of Business Warrior (the “Business Warrior Holders”) entered into support agreements with the Company (the “Business Warrior Voting and Support Agreements”), pursuant to which such Business Warrior Holders agreed, among other things, to vote all shares of capital stock of Business Warrior beneficially owned by the Business Warrior Holders (the “Business Warrior Shares”) in favor of the BW Merger and related transactions. Such Business Warrior Holders also agreed to take certain other actions in support of the BW Merger Agreement and related transactions (and any actions required in furtherance thereof) and refrain from taking actions that would adversely affect such Business Warrior Holders’ ability to perform their obligations under the Business Warrior Voting and Support Agreement. Pursuant to the Business Warrior Voting and Support Agreements, the Business Warrior Holders also agreed not to transfer the Business Warrior Shares during the period from and including the date of the Business Warrior Voting and Support Agreement and the first to occur of the Effective Time or the date on which the Business Warrior Support Agreement is terminated, except for certain permitted transfers where the recipient also agrees to comply with the Business Warrior Voting and Support Agreement.

 

Lock-Up Agreements

 

Concurrently with and effective upon the Closing, officers, directors and certain stockholders of Business Warrior (each, a “Significant Stockholder”) shall each enter into a Lock-Up Agreement with the Company (each, a “Lock-Up Agreement”). Pursuant to the Lock-Up Agreements, with respect to the shares received as BW Merger Consideration, each Significant Stockholder may not, with limited exceptions, transfer shares, or publicly disclose the intention to transfer shares until the twelve-month anniversary of the Closing.

v3.24.3
Accounting Policies and Estimates
9 Months Ended
Sep. 30, 2024
Accounting Policies and Estimates [Abstract]  
ACCOUNTING POLICIES AND ESTIMATES
2 ACCOUNTING POLICIES AND ESTIMATES

 

  a) Basis of Presentation

 

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

  

  b) Principles of Consolidation

 

The unaudited condensed consolidated financial statements as of September 30, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, the Company currently has no subsidiaries.

 

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP.

 

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

 

  c) Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services, debt extinguishments or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

  d) Contingencies

 

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

 

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

 

  e) Fair Value of Financial Instruments

 

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

 

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

 

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

 

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

 

The carrying amounts reported in the balance sheets for cash, accounts receivable, notes receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

 

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

 

  f) Risks and Uncertainties

 

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. In particular, there is a risk that that IPSIPay Express business (the commercial launch of which has taken longer than originally expected) may never generate revenue for the Company. There are also significant risks and uncertainties associated with the Company’s proposed merger with Business Warrior (see notes 1(c) and 6 for further information). Further, the ongoing wars in Ukraine and between Israel, Hamas and more recently, Hezbollah and uncertainties regarding the global economic environment which has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

 

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

  g) Recent accounting pronouncements

 

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

 

  h) Reporting by Segment

 

No segmental information is required as the Company has only one operating segment.

 

  i) Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

 

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

 

  j) Accounts Receivable and Allowance for Doubtful Accounts

 

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2024 and 2023.

 

  k) Investments

 

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on the balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

  l) Plant and Equipment

 

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

 

Description  Estimated
Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

 

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

 

  m) Long-Term Assets

 

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

  n) Revenue Recognition

 

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

 

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

 

  i. identify the contract with a customer;

 

  ii. identify the performance obligations in the contract;

 

  iii. determine the transaction price;

 

  iv. allocate the transaction price to performance obligations in the contract; and

 

  v. recognize revenue as the performance obligation is satisfied.

 

The Company had minimal revenues of $0 and $410 for the nine months ended September 30, 2024 and 2023, respectively. 

 

  o) Share-Based Payment Arrangements

 

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

 

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value include, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

 

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

 

Where equity transactions with arms-length third parties included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

 

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

 

  p) Derivative Liabilities

 

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

 

  q) Income Taxes

 

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

 

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

  r) Comprehensive income

 

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

 

  s) Reclassification of prior year presentation

 

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

v3.24.3
Liquidity Matters and Going Concern
9 Months Ended
Sep. 30, 2024
Liquidity Matters and Going Concern [Abstract]  
LIQUIDITY MATTERS AND GOING CONCERN
3 LIQUIDITY MATTERS AND GOING CONCERN

 

The Company’s financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has incurred net losses since its inception and anticipates net losses and negative operating cash flows for the near future. For and as of the nine months ended September 30, 2024, the Company had a net loss of $2.86 million. In connection with preparing the unaudited condensed consolidated financial statements for the nine months ended September 30, 2024, management evaluated the risks described in Note 2(f) above on the Company’s business and its future liquidity for the next twelve months from the date of issuance of these financial statements.

 

The accompanying financial statements for the period ended September 30, 2024 have been prepared assuming the Company will continue as a going concern, but the ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it establishes a revenue stream and, ultimately, becomes profitable. Management’s plans to continue as a going concern include raising additional capital through sales of equity securities and borrowing. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. If the Company is not able to obtain the necessary additional financing on a timely basis, the Company will be required to delay and reduce the scope of the Company’s development and operations. Continuing as a going concern is dependent upon its ability to successfully secure other sources of financing and attain profitable operations. The accompanying unaudited condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Company has determined that there is substantial doubt about its ability to continue as a going concern.

v3.24.3
Disposal of Investment in Frictionless and Beyond Fintech
9 Months Ended
Sep. 30, 2024
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH
4 DISPOSAL OF INVESTMENT IN FRICTIONLESS AND BEYOND FINTECH

 

On May 12, 2023, the Company entered into the May 2023 Frictionless Agreement to unwind the equity ownership stakes that the Company and Frictionless have in each other and in Beyond Fintech. Pursuant to the May 2023 Frictionless Agreement: (i) the Company assigned to Frictionless all common stock of Frictionless owned by the Company (representing a 10% ownership interest in Frictionless); (ii) the warrant to purchase 1,000,000 (30,000,000 pre-split) shares of Common Stock previously issued by the Company to Frictionless as of December 30, 2022 was cancelled; (iii) the Company assigned to Frictionless all shares of common stock of Beyond Fintech owned by the Company (representing a 51% ownership interest in Beyond Fintech) (the “Beyond Fintech Shares”); and (iv) the rights previously granted to the Company to (a) acquire additional equity interests in Frictionless, (b) participate in future financings of Frictionless and (c) appoint a board member of Frictionless were terminated. The consideration to the Company for the assignment of the Beyond Fintech Shares to Frictionless is $250,000, which will be paid by Frictionless exclusively in the form of 20% credits against invoices for work done by Frictionless for the Company for the 18-month period following the closing under the existing software services between the Company and Frictionless. The May 2023 Frictionless Agreement has customary representations, indemnification and mutual release provisions. The closing of the transactions contemplated by the May 2023 Frictionless Agreement occurred on May 12, 2023.

 

The assets and liabilities disposed of were as follows:

 

   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
v3.24.3
Discontinued Operations
9 Months Ended
Sep. 30, 2024
Discontinued Operations [Abstract]  
DISCONTINUED OPERATIONS
5 DISCONTINUED OPERATIONS

 

In the prior year, effective May 12, 2023, the Company disposed of its investment in Beyond Fintech.

 

The statement of operations from discontinued operations is as follows:

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
                 
Net Revenue  $
               -
   $
               -
   $
               -
   $
               -
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    
-
    
-
    40,821 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    
-
    
-
    40,821 
                     
Loss from operations before income taxes   
-
    
-
    
-
    (40,821)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $
-
   $
-
   $(40,821)
v3.24.3
Loans Receivable
9 Months Ended
Sep. 30, 2024
Loans Receivable [Abstract]  
LOANS RECEIVABLE
6 LOANS RECEIVABLE

 

On February 22, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned funds to Business Warrior in the principal amount of $226,190, which includes an original issue discount equal to $67,857, for net proceeds to Business Warrior of $158,333. The loan is memorialized by a secured promissory note (the “Business Warrior Note”). The Business Warrior Note does not accrued interest, except in the case of an event of default, which case interest accrues at 15% per annum. The Business Warrior Note matures on the earlier to occur of December 31, 2025 and the date that Business Warrior securities are listed on a national securities exchange. The Business Warrior Note may be prepaid at any time for an amount equal to 110% of the then principal and accrued interest. The Company has the right to exchange the Business Warrior Note for securities issued by Business Warrior in any subsequent private placement by Business Warrior. The principal and accrued interest under Business Warrior Note is convertible into common stock of Business Warrior at a price equal to $0.0036 per share, subject to certain adjustments and potential resets. Business Warrior’s obligations under the Business Warrior Note are guaranteed by Business Warrior’s subsidiaries and secured by a lien on Business Warrior’s accounts receivable.

 

The debt discount on the Business Warrior’s note is amortized as income utilizing the effective interest rate method.

 

Between June 19, 2024 and September 10, 2024, the Company (utilizing a portion of the proceeds from the issuance of convertible notes) loaned additional funds to Business Warrior in the aggregate principal amount of $130,000 (the “2024 Business Warrior Note”). The 2024 Business Warrior Notes accrues interest at 8% per annum and matures between November 1, 2024 and February 1, 2025. The 2024 Business Warrior Notes plus any accrued interest may be prepaid at any time without penalty.

 

Loans receivable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
 
Business Warrior Corporation  0.0%  December 31, 2025  $226,190   $
-
   $(48,243)  $177,947 
   8.0%  November 1, 2024   30,000    677    
-
    30,677 
   8.0%  January 1, 2025   35,000    399         35,399 
   8.0%  February 1, 2025   50,000    263         50,263 
   8.0%  February 1, 2025   15,000    66         15,066 
Total convertible notes payable        $356,190   $1,405   $(48,243)  $309,352 
Disclosed as follows:                          
Current portion of notes receivable                       $131,405 
Long-term portion of notes receivable                        177,947 
                        $309,352 

  

Discount amortized to income as deemed interest during the three months and nine months ended September 30, 2024 was $8,407 and $19,614, respectively.

 

Interest earned for the three and nine months ended September 30, 2024 was $1,333 and $1,405, respectively.

v3.24.3
Intangibles
9 Months Ended
Sep. 30, 2024
Intangibles [Abstract]  
INTANGIBLES
7 INTANGIBLES

 

On August 26, 2021, the Company formed Beyond Fintech to acquire a product known as Beyond Wallet from a third party for gross proceeds of $250,000, together with the logo, use of name and implementation of the product into the Company’s technology. The Company owned 51% of Beyond Fintech with the other 49% owned by Frictionless. Prior to the disposal of Beyond Fintech to Frictionless the Company spent an additional 77,211 on the software to further enhance the Beyond Wallet product offering.  On May 12, 2023, Beyond Fintech was sold to Frictionless.

 

During the year ended December 31, 2021, the Company paid gross proceeds of $375,000 to Frictionless for the development of the IPSIPay wallet, prior to the novation of the rights and obligation to a third party, the Company spent an additional $1,171,805 to facilitate the functioning of the IPSIPay software in the cloud environment. On September 5, 2023, the Company novated all its rights and obligations to its IPSIPay wallet to a third party.

 

Amortization expense was $0 and $93,095 for the three months ended September 30, 2024 and 2023, respectively, and $0 and $347,298 for the nine months ended September 30, 2024 and 2023, respectively.

v3.24.3
Equity Method Investment
9 Months Ended
Sep. 30, 2024
Equity Method Investment [Abstract]  
EQUITY METHOD INVESTMENT
8 EQUITY METHOD INVESTMENT

 

On April 28, 2023, the Company formed IPSIPay Express with OpenPath and EFinityPay. As described in Note 1(b), the Company has agreed to make the IPSI Capital Contributions to IPSIPay Express. As of September 30, 2024, the initial Tranche of $500,000 and the second Tranche of $500,000 of capital contributions was paid by the Company to or on behalf of IPSIPay Express.

 

The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended September 30, 2024 and December 31, 2023 is as follows:

 

   September 30,
2024
   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (660)   
-
 
   $703,778   $703,938 
v3.24.3
Leases
9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
LEASES
9 LEASES

 

On March 22, 2021, the Company entered into a real property lease for an office located at 56B 5th Street, Lot 1, #AT, Carmel By The Sea, California. The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022. Following the expiry of the lease term, the landlord has agreed to continue the lease on a month-to-month basis at $4,800 per month. On January 1, 2023, the Company entered into a new month-to-month lease, with a 90-day termination clause, for a monthly rental of $5,088. The lease was terminated effective August 31, 2023.

 

The Company applied the practical expedient whereby operating leases with a duration of twelve months or less are expensed as incurred.

 

Total Lease Cost

 

Individual components of the total lease cost incurred by the Company is as follows:

 

   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Operating lease expense  $
                -
   $40,704 

 

Other lease information:

 

   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
                -
   $(40,704)
           
Remaining lease term – operating lease   -    Monthly 
v3.24.3
Federal Relief Loans
9 Months Ended
Sep. 30, 2024
Federal Relief Loans [Abstract]  
FEDERAL RELIEF LOANS
10 FEDERAL RELIEF LOANS

 

Small Business Administration Disaster Relief loan

 

On July 7, 2020, the Company received a Small Business Economic Injury Disaster loan amounting to $150,000, bearing interest at 3.75% per annum and repayable in monthly installments of $731 commencing twelve months after inception with the balance of interest and principal repayable on July 7, 2050. The loan is secured by all tangible and intangible assets of the Company. The proceeds are to be used for working capital purposes to alleviate economic injury caused by the COVID-19 pandemic.

 

The company has accrued interest of $7,670 and $9,369 on this loan as of September 30, 2024 and December 31, 2023, respectively.

v3.24.3
Notes Payable
9 Months Ended
Sep. 30, 2024
Notes Payable [Abstract]  
NOTES PAYABLE
11 NOTES PAYABLE

 

Notes payable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.00%  October 31, 2024  $482,000   $85,689   $
-
   $567,689   $531,004 
Mercer Street Global Opportunity Fund, LLC  10.00%  October 31, 2024   482,000    85,689    
-
    567,689    531,003 
2024 notes  8.5%  February 28, 2025 to May 5, 2025   311,111    4,609    (60,869)   254,851    
-
 
Total notes payable        $1,275,111   $175,987   $(60,869)  $1,390,229   $1,062,007 

  

Interest expense totaled $28,489 and $24,635 for the three months ended September 30, 2024 and 2023, respectively, and $77,980 and $73,371 for the nine months ended September 30, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $14,248 and $0 for the three months ended September 30, 2024 and 2023, respectively, and $16,908 and $0 for the nine months ended September 30, 2024 and 2023, respectively.

 

Cavalry Fund I LP and Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company entered into separate Securities Purchase Agreements (the “SPAs”), with each of Cavalry Fund I LP (“Cavalry”) and Mercer Street Global Opportunity Fund, LLC (“Mercer”), pursuant to which the Company received $500,500 and $500,500 from Cavalry and Mercer, respectively, in exchange for the issuance of: (i) Original Issue Discount 12.5% Convertible Notes (the “Notes” and each a “Note”) in the principal amount of $572,000 to each of Cavalry and Mercer; and (ii) five-year warrants (the “Original Warrants”) issued to each of Cavalry and Mercer to purchase 2,486,957 shares of Common Stock at an exercise price of $0.24 per share.

 

In terms of the December 30, 2022 Note Amendment Transaction, described in more detail in note 12 below, the Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”) to each of Cavalry and Mercer. This exchange caused the cancellation of the Original Warrants for all purposes. The Company accounted for the aggregate value of the notes issued of $964,000, less the fair value of the warrants exchanged for these notes of $43,608, totaling $920,392 as a component of the loss on convertible debt.

 

The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 51,901,711 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024 with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

2024 Notes

 

Between May 29, 2024 and September 9, 2024, the Company entered into five Securities Purchase Agreements with three accredited investors, pursuant to which the Company issued five non-convertible promissory notes (the “2024 Notes”) with an aggregate principal amount of $311,111 for gross proceeds of $233,333, after taking into account an aggregate original issuance discount of $77,778.

 

The 2024 Notes mature between February 28, 2025 and June 6, 2025 and bear interest at 8.5% per annum.

 

The 2024 Notes have restrictions relating to fundamental transactions which require the approval of the note holder, in addition the note holder has an optional redemption right on subsequent transactions that may require the Company to redeem all or part of the Note, at a premium of 120% of the cash amount of the Note, at the note holder’s discretion.

v3.24.3
Convertible Notes Payable
9 Months Ended
Sep. 30, 2024
Convertible Notes Payable [Abstract]  
CONVERTIBLE NOTES PAYABLE
12 CONVERTIBLE NOTES PAYABLE

 

December 2022 Note Amendment Transaction

 

The Company twice extended its indebtedness to each Cavalry and Mercer. On February 3, 2022, the Company agreed to extend the maturity date of the Cavalry/Mercer Notes to August 16, 2022. Additionally, on August 30, 2022, the Company entered agreements for an additional maturity date extension to November 16, 2022. In consideration for the second extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry and Mercer under the Cavalry/Mercer Notes by twenty percent (20%) and (ii) issue to each of Cavalry and Mercer a new five-year warrant (each, an “Extension Warrant”) to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. The Extension Warrant contains the same terms and provisions in all material respects as the Original Warrants, except for difference in exercise price.

 

On December 30, 2022, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to December 30, 2023. Each of Cavalry and Mercer entered into Note Amendment Letter Agreement with the Company (the “Note Amendment”) pursuant to which the parties agreed to the following:

 

  (1) The conversion price of the Cavalry/Mercer Notes was reduced from $4.50 to $0.345 per share (such reduced conversion price being the current conversion price of the Notes give the passage of the November 16, 2022 maturity date of the Cavalry/Mercer Notes). As a result of this change in conversion price, under the existing terms of the Cavalry/Mercer Notes, the 100,000 shares of Common Stock underlying the Extension Warrants was increased to 1,304,348 shares.

 

  (2) The Original Warrants issued on February 16, 2021 were irrevocably exchanged for 12-month non-convertible promissory notes in the amount of $482,000 (the “Exchange Notes”). This exchange caused the cancellation of the Original Warrants for all purposes. The Exchange Notes have a maturity date of December 30, 2023 and carry an interest rate of ten percent (10%). The Company shall have the right, but not the obligation, in lieu of a cash payment upon maturity of the Exchange Notes, to issue 1,730,057 shares of Common Stock, as adjusted for any stock splits, dividends or other similar corporate events, in full satisfaction of its obligations under each of the Exchange Notes (or any pro rata portion of such number of shares in partial satisfaction of such obligations). The Company is under no legal obligation to reserve such number of shares for future issuance;

 

  (3) Each of Cavalry and Mercer agreed (i) not to convert all or any portion of the Cavalry/Mercer Notes until after March 30, 2023 and (ii) waive any events of default under the Cavalry/Mercer Notes and the Cavalry/Mercer SPAs;

 

  (4) Certain other warrants held by Cavalry and Mercer which contain a mandatory exercise provision allowing us to force exercise of such warrants if the price of the Common Stock is $1.80 per share or above were amended effective December 30, 2022 to reduce such forced exercise price to $1.20 per share; and

 

  (5) The Company was obligated to register the shares of Common Stock underlying the Cavalry/Mercer Notes and the shares underlying all warrants held by Cavalry and Mercer for resale with the Securities and Exchange Commission and the Company filed the registration statement to satisfy such registration obligation.

 

The parties also acknowledged that the principal and accrued interest under the Cavalry/Mercer Notes as of December 28, 2022 is equal to an aggregate of $2,264,784, or $1,132,392 for each of Cavalry and Mercer. In addition, as a result of the reduction in the conversion price of the Cavalry/Mercer Notes, certain other warrants held by third parties have their exercise price of such warrants reduced to $0.345 per share. All of the shares of our Common Stock underlying the Cavalry/Mercer Notes as amended and all warrants held by Cavalry and Mercer as adjusted were registered for resale pursuant to a registration statement that was declared effective on February 6, 2023.

 

The amendments to the Cavalry/Mercer Notes were evaluated in terms of ASC 470, Debt, to determine if the amendments to the Cavalry/Mercer Notes were considered a modification of the debt or an extinguishment of the debt. Based on the penalty interest incurred on the convertible notes of $836,414, the reduction in the conversion price of the Cavalry/Mercer Notes from $4.50 to $0.345 per share, which was valued at $1,499,577 using a Black-Scholes valuation model, the issuance of additional warrants to the Cavalry and Mercer valued at $238,182 using a Black-Scholes valuation model and the conversion of certain warrants held by Cavalry and Mercer to notes payable, resulting in an additional charge of $920,392, consisting of a mark-to-market warrant cost of $43,608 and the value of the notes of $964,000 (see note 11 above) and the value of full ratchet provisions of certain of the warrants issued to the Cavalry and Mercer amounting to $841,003, the amendment of the Cavalry/Mercer Notes was determined to be a debt extinguishment.

 

Effective December 30, 2023, on February 27, 2024, the Company again extended the maturity dates of each of the Cavalry/Mercer Notes to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, other than the maturity date all other terms remained the same. The Company performed an analysis in terms of ASC 470 and it was determined that the extension was a debt modification, in addition, no additional consideration was paid for the maturity date extension.

 

Convertible notes payable consists of the following:

 

Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.0%  October 31, 2024  $868,951   $46,925   $
-
   $915,876   $909,218 
Mercer Street Global  Opportunity Fund, LLC  10.0%  October 31, 2024   901,334    222,687    
-
    1,124,021    1,139,764 
Red Road Holdings Corporation*  29.32%  -   
-
    
-
    
-
    
-
    41,771 
   27.77%  -   
-
    
-
    
-
    
-
    18,683 
   32.04%  September 30, 2024   7,900    181    
-
    8,081    3,109 
   24.98%  December 30, 2024   88,500    11,657    (29,608)   70,549    
-
 
   24.51%  March 30, 2025   125,080    8,481    (81,437)   52,124    
-
 
Quick Capital, LLC*  11.12%  -   
-
    
-
    
-
    
-
    
-
 
   11.03%  November 28, 2024   57,144    6,871    (2,406)   61,609    
-
 
2023 and 2024 convertible notes   8.0 to 12.0%  May 22, 2024 to May 9, 2025   2,523,890    231,847    (71,175)   2,684,562    1,591,735 
Total convertible notes payable        $4,572,799   $528,649   $(184,626)  $4,916,822   $3,704,280 

 

* The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.

 

Interest expense totaled $121,916 and $83,829 for the three months ended September 30, 2024 and 2023, respectively, and $351,764 and $212,886 for the nine months ended September 30, 2024 and 2023, respectively.

 

Amortization of debt discount totaled $219,700 and $303,042 for the three months ended September 30, 2024 and 2023, respectively, and $857,284 and $414,696 for the nine months ended September 30, 2024 and 2023, respectively.

 

The Cavalry, Mercer and Red Road Holdings convertible notes have variable conversion prices based on a discount to market price of trading activity over a specified period of time. The variable conversion features were valued using a Black Scholes valuation model. The difference between the fair market value of the Common Stock and the calculated conversion price on the issuance date was recorded as a debt discount with a corresponding credit to derivative financial liability.

 

Cavalry Fund LP

 

On February 16, 2021, the Company closed a transaction with Cavalry pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note was convertible into shares of Common Stock at an initial conversion price of $0.23 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Cavalry by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Cavalry agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Cavalry for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.  

 

Between August 24, 2023 and November 20, 2023, Cavalry converted $139,726 of interest and $192,774 of principal into 963,769 shares of Common Stock at a conversion price of $0.345 per share realizing a loss on conversion of $42,210.

 

On February 27, 2024, the maturity date of the notes was extended to April 30, 2024, with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

Between September 5, 2024 and September 10, 2024, Cavalry converted $30,029 of principal and $31,527 of interest into 732,815 shares of Common Stock at a conversion price of $0.084 per share realizing a loss on conversion of $32,253. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084 (see note 13).

 

The balance of the Cavalry Note plus accrued interest at September 30, 2024 was $915,876.

 

Mercer Street Global Opportunity Fund, LLC

 

On February 16, 2021, the Company closed a transaction with Mercer, pursuant to which the Company received net proceeds of $500,500, after an original issue discount of $71,500 in exchange for the issuance of a $572,000 Senior Secured Convertible Note, bearing interest at 10% per annum and maturing on February 16, 2022. The Note is convertible into shares of Common Stock at an initial conversion price of $6.90 per share, in addition, the Company issued a warrant exercisable for 82,899 shares of Common Stock at an initial exercise price of $7.20 per share.

 

As described more fully above, the maturity date of the note was extended to August 16, 2022, additionally to November 16, 2022 and again to December 30, 2023. In consideration for the November 16, 2022 extension, the Company agreed to (i) increase the principal amount outstanding and due to Mercer by twenty percent (20%) and (ii) issue a new five-year warrant to purchase an additional 100,000 shares of Common Stock at an exercise price of $4.50 per share. In consideration of the December 30, 2022 extension, the Company agreed to the following terms; (i) the conversion price of the Note was reduced from $4.50 to $0.345 per share; (ii) Mercer agreed (a) not to convert all or any portion of the Notes until after March 30, 2023 and (b) waive any events of default under the Note and the SPA; (iii) the Company agreed to and registered the shares of Common Stock underlying the Note and the shares underlying all warrants held by Mercer for resale with the Securities and Exchange Commission and filed the registration statement to satisfy the Company’s registration obligation.

 

Between May 19, 2023 and August 30, 2023, Mercer converted an aggregate of $100,000 into 289,856 shares of Common Stock at a conversion price of $0.345 per share, realizing a loss on conversion of $48,551.

 

On February 27, 2024, Mercer entered into a note amendment with the Company extending the maturity date of the convertible note to April 30, 2024. with an automatic one-month extension each month until such time as the note is declared to be in default, all other terms remain the same as the previous notes. Based on an analysis performed in terms of ASC 470, the amendment to the agreement was determined to be a debt modification, there were no expenses incurred on the amendment and interest will be accrued at the effective interest rate.

 

Between August 20, 2024 and September 5, 2023, Mercer converted an aggregate principal amount of $90,420 into 1,076,433 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $84,291. Such conversion caused a reduction in the $0.345 conversion price of the notes described above to $0.084 (see note 13).

 

The balance of the Mercer Note plus accrued interest at September 30, 2024 was $1,124,021.

 

Red Road Holdings Corporation

 

 

On September 9, 2023, the Company closed a transaction with Red Road Holdings Corporation (“RRH”) pursuant to which the Company received net proceeds of $125,000, after an original issue discount and fees of $21,900 in exchange for the issuance of a $146,900 Convertible Note (“RRH Note 1”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 29.3%, and maturing on June 15, 2024. The RRH Note 1 has mandatory monthly repayments of $18,444 which commenced on October 14, 2023. The RRH Note 1 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The RRH note 1 was repaid in full during the quarter ended June 30, 2024.

     
 

On October 19, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $60,000, after an original issue discount and fees of $13,450 in exchange for the issuance of a $73,450 Convertible Note (“RRH Note 2”), bearing interest at 13%, which interest is earned on issuance of the note, an effective interest rate of 27.8%, and maturing on July 30, 2024. The RRH Note 2 has mandatory monthly repayments of $9,222 which commenced on November 30, 2023. The RRH Note 2 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

On August 6, 2024, RRH converted an aggregate of $13,833, including a penalty of $4,611 into 164,679 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $28,984, thereby extinguishing the note.

     
 

On December 20, 2023, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $50,000, after an original issue discount and fees of $13,250 in exchange for the issuance of a $63,250 Convertible Note (“RRH Note 3”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 32.0%, and maturing on September 30, 2024. The RRH Note 3 has mandatory monthly repayments of $8,082. The RRH Note 3 is convertible into shares of Common Stock at a variable conversion rate of 60% of the lowest trading price twenty trading days before conversion.

 

The balance of the RRH Note 3 plus accrued interest at September 30, 2024 was $8,081.

     
 

On April 2, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $70,000, after an original issue discount and fees of $18,500 in exchange for the issuance of a $88,500 Convertible Note (“RRH Note 4”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 24.98%, and maturing on December 30, 2024. The RRH Note 4 has mandatory repayments of $61,065 on September 30, 2024 and $13,570 per month on October 30, 2024, November 30, 2024 and December 30, 2024. The RRH Note 4 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion.

 

The balance of the RRH Note 4 plus accrued interest at September 30, 2024 was $70,549, net of unamortized debt discount of $29,608.

     
 

On June 25, 2024, the Company closed a transaction with RRH pursuant to which the Company received net proceeds of $100,000, after an original issue discount and fees of $25,080 in exchange for the issuance of a $125,080 Convertible Note (“RRH Note 5”), bearing interest at 15%, which interest is earned on issuance of the note, an effective interest rate of 24.51%, and maturing on March 30, 2025. The RRH Note 5 has mandatory repayments of $93,498 on December 30, 2024 and $16,782 per month on January 30, 2025, February 28, 2025 and March 30, 2025. The RRH Note 5 is convertible into shares of Common Stock at a variable conversion rate of 65% of the lowest trading price ten trading days before conversion.

 

The balance of the RRH Note 5 plus accrued interest at September 30, 2024 was $52,124, net of unamortized debt discount of $81,437.

 

Quick Capital, LLC

 

 

On March 4, 2024, the Company closed a transaction with Quick Capital, LLC (“Quick Capital”) pursuant to which the Company received net proceeds of $94,000, after an original issue discount and fees of $20,286 in exchange for the issuance of a $114,286 Convertible Note (“Quick Cap Note 1”) , bearing interest at an effective interest rate of 11.12% per annum, which interest is earned on issuance of the note, and maturing on September 4, 2024. The Quick Cap Note 1 has monthly 30,875 commencing on May 4, 2024. The Note was convertible into shares of Common Stock at an adjusted conversion price of $0.084 per share, in addition, the Company issued a warrant exercisable for 357,764 shares of Common Stock at an initial exercise price of $0.345 per share. The warrant has full ratchet price protection which has resulted in the number of shares exercisable under the warrant increasing to 1,469,388 and the exercise price being amended to $0.084 per share.

 

The Company had repaid an aggregate of $92,523 of the principal and interest outstanding and between September 6, 2024 and September 17, 2024, Quick Capital converted an aggregate of $32,906, including a penalty of $2,000 into 391,736 shares of Common Stock at a conversion price of $0.084 per share, realizing a loss on conversion of $13,965, thereby extinguishing the note.

 

 

On May 28, 2024, the Company closed a transaction with Quick Capital pursuant to which the Company received net proceeds of $46,500, after an original issue discount and fees of $10,644 in exchange for the issuance of a $57,144 Convertible Note (“Quick Cap Note 2”), bearing interest at an effective interest rate of 11.03% per annum, which interest is earned on issuance of the note, and maturing on November 28, 2024. The Quick Cap Note 2 has monthly 15,429 commencing on July 28, 2024. The Note is convertible into shares of Common Stock at an adjusted conversion price of $0.084 per share, in addition, the Company issued a warrant exercisable for 178,882 shares of Common Stock at an initial exercise price of $0.345 per share. The warrant has full ratchet price protection which has resulted in the number of shares exercisable under the warrant increasing to 734,694 and the exercise price being amended to $0.084 per share.

 

No repayments have been made on the Quick Capital Note 2 which provides for a no notice default, whereupon the note accrues penalty interest at a rate of 24% per annum on the total balance outstanding. Penalty interest amounting to $2,597 has been accrued on the Quick Capital 2 note as at September 30, 2024.

 

The balance of the Quick Capital note plus accrued interest at September 30, 2024 was $61,610, net of unamortized debt discount of $2,406.

 

2023 and 2024 Convertible Notes

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors to purchase convertible notes (the “2023 Convertible Notes”). Between February 6, 2024 and August 9, 2024, the Company entered into Securities Purchase Agreements with 8 accredited investors to purchase convertible notes (the “2024 Convertible Notes”). The Company received an aggregate of $2,026,666 from the 2023 Convertible Notes and $475,002 from the 2024 Convertible Notes, in gross proceeds in private placements through the issuance of:

 

  the 2023 Convertible Notes and the 2024 Convertible Notes; and

 

  five-year warrants to purchase an aggregate 5,696,586 shares of Common Stock associated with the 2023 Convertible Notes (the “2023 Warrants”) and an aggregate of 289,856 shares of Common Stock associated with the 2024 Convertible Notes (the “2024 Warrants”), at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events).

 

The 2023 Convertible Notes and the 2024 Convertible Notes mature between 3.5 months and 12 months, bear interest at rates between 8% and 12% per annum and are convertible into shares of Common Stock at a conversion price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The 2023 Convertible Notes and 2024 Convertible Notes may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the 2023 Convertible Notes and the 2024 Convertible Notes or the 2023 Warrants and the 2024 Warrants, for public resale.

 

The 2023 Convertible Notes, the 2024 Convertible Notes and the 2023 Warrants and the 2024 Warrants contain conversion limitations providing that a holder thereof may not convert or exercise such securities to the extent that, if after giving effect to such conversion or exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

On December 14, 2023, two notes totaling $225,000 ($200,000 and $25,000, respectively) which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the extension, the Company issued the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to the note holders additional warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as consideration for the extension, the note holders were issued additional warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share. The modification was assessed in terms of ASC 470 and determined to be a debt extinguishment, resulting in the warrant value of $66,047 being expensed as a loss on convertible notes.

 

At September 30, 2024, notes with a principal amount of $1,676,666 and accrued interest thereon on $186,789 have matured. No further extensions on notes that have matured or are expected to mature prior to and subsequent to the date of this Report have been requested or granted. Pursuant to the Merger Agreement entered into with Business Warrior on July 28, 2024 and as a condition precedent to the consummation of the merger contemplated thereunder, the Company is negotiating with all of its convertible note holders to exchange such convertible notes for shares to be designated and issued as Series A Convertible Preferred Stock of the Company. The terms of the exchange and such Series A Convertible Preferred Stock are still to be determined and are subject to Company stockholder approval.

 

The balance of the 2023 Convertible Notes and the 2024 Convertible Notes plus accrued interest at September 30, 2024 was $2,684,562, net of unamortized debt discount of $71,175.

v3.24.3
Derivative Liability
9 Months Ended
Sep. 30, 2024
Derivative Liability [Abstract]  
DERIVATIVE LIABILITY
13DERIVATIVE LIABILITY

 

The convertible notes and warrants issued by the Company to Cavalry, Mercer and RRH as described in Note 12 have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time and certain notes and warrants have fundamental transaction clauses which might result in cash settlement, due to these factors, all convertible notes and any warrants attached thereto are valued and give rise to a derivative financial liability, which was initially valued at inception of the convertible notes using a Black-Scholes valuation model.

 

Between September 12, 2023 and December 20, 2023, and between April 2, 2024 and June 25, 2024, the Company entered into a convertible note agreement with RRH which have variable priced conversion rights with no fixed floor price and will re-price dependent on the share price performance over varying periods of time, which gave rise to a derivative financial liability, which was initially valued at inception of the convertible notes at $416,317 and $268,873, respectively, but limited to the cash value of the convertible notes of $235,000 and $170,000, respectively, using a Black-Scholes valuation model.

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12) pursuant to which $13,833 of the remaining principal, interest and late payment penalty under the RRH 2 Note was converted into 164,679 shares of Common Stock at a conversion price of $0.084 per share. As a result of the conversion of the RRH Note 2, all other outstanding promissory notes and warrants of the Company that contain price-based anti-dilution protection had the conversion prices of such notes and the exercise price of such warrants adjusted to $0.084 per share and certain warrants of the Company that contain “full ratchet” anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.084 per share (the “Triggering Event”).

 

Convertible notes with an aggregate principal and interest balance outstanding on August 6, 2024 of $2,165,578 have such price-based anti-dilution protection. Based on the conversion by the RRH Note 2 as described above, the conversion price of these notes will reset to $0.084. In addition, certain warrants exercisable for 3,145,342 shares of common stock at an exercise price of $0.345 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 9,773,028 to a total number of shares of Common Stock exercisable for such warrants of 12,918,370. In addition to this, certain warrants exercisable for 457,897 shares of common stock have exercise price protection which will reduce the exercise price of these warrants to $0.084 per share from $0.345 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $119,511.

 

The value of the derivative liability related to the anti-dilution price protected convertible notes and warrants was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability of $4,318,669 on the convertible notes and $2,051,405 on the warrants. In addition, a payment was not made on a convertible note with a no notice default clause, resulting in the triggering of a variable priced conversion feature, which gave rise to a derivative liability on the payment due date, this gave rise to an additional derivative liability of $56,329, both determined using a Black-Scholes valuation model.

 

The net mark-to-market movement of the derivative liability for the three months ended September 30, 2024 was a net mark-to-market credit of $5,538,008 and for the nine months ended September 30, 2024 was a net mark-to-market credit of $6,461,496, determined by using a Black-Scholes valuation model.

 

The following assumptions were used in the Black-Scholes valuation model:

 

   nine months
ended
September 30,
2024
   Year ended
December 31,
2023
 
Conversion price  $ 0.0491 to $0.345    $ 0.104 to $0.345 
Risk free interest rate   3.58 to 5.50 %    3.60 to 5.55% 
Expected life of derivative liability   1 to 35 months      3.5 to 47 months 
Expected volatility of underlying stock   24.3 to 262.09%      158.72 to 217.01% 
Expected dividend rate   0%    0% 

 

The movement in derivative liability is as follows:

 

   September 30,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   226,329    385,000 
Derivative liability arising on anti-dilutive convertible notes and warrants   6,370,074    
-
 
Fair value adjustment to derivative liability   (6,461,496)   (1,501,446)
   $1,569,103   $1,434,196 
v3.24.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2024
Stockholders’ Equity [Abstract]  
STOCKHOLDERS’ EQUITY
14STOCKHOLDERS’ EQUITY

 

  a. Common Stock

 

The Company has total authorized Common Stock of 750,000,000 shares with a par value of $0.0001 each. The Company had 16,185,552 and13,819,889 shares of Common Stock issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.

 

On May 19, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt.

 

On August 16, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 72,464 shares of Common Stock for the conversion of $25,000 of convertible debt.

 

On August 24, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 173,914 shares of Common Stock for the conversion of $60,000 of interest on convertible debt.

 

On August 30, 2023, the Company effectuated a 1 for 30 reverse stock split, resulting in the issuance of an additional 2,838 shares to existing stockholders due to rounding of existing shareholdings. All share amounts disclosed in the unaudited condensed consolidated financial statements have been adjusted to reflect the Company’s 1 for 30 reverse stock split effectuated on August 30, 2023.

 

On August 31, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 144,928 shares of Common Stock for the conversion of $50,000 of convertible debt.

 

On November 8, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 289,855 shares of Common Stock for the conversion of $100,000 of convertible debt.

 

On November 20, 2023, in terms of a conversion notice received from a convertible note holder, the Company issued 500,000 shares of Common Stock for the conversion of $172,500 of convertible debt.

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12) pursuant to which $13,833 of the remaining principal, interest and late payment penalty under the RRH 2 Note was converted into 164,679 shares of Common Stock at a conversion price of $0.084 per share. As a result of the conversion of the RRH Note 2, a warrant, with full ratchet anti-dilution price protection, exercise price was reduced from $0.345 per share to $0.084 per share and the number of shares exercisable was increased from 3,145,342 shares to 12,918,370 shares, resulting in a deemed dividend charge and a credit to additional paid in capital of $426,807.

 

Between August 6, 2024 and September 17, 2024, in terms of conversion notices received from 4 convertible note holders, including the RRH Note 2 described above, the Company issued 2,365,663 shares of common stock for the conversion of $198,716 of convertible debt at a conversion price of $0.084 per share, realizing an aggregate loss on conversion of $159,493.

 

  b. Restricted stock awards

 

A summary of restricted stock activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding September 30, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The restricted stock granted, issued and exercisable at September 30, 2024 is as follows:

 

    Restricted Stock
Granted and Vested
 
Grant date Price   Number Granted*   Weighted Average
Fair Value per Share*
 
$1.47              683,167   $     1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The Company has recorded an expense of $0 for the three and nine months ended September 30, 2024 and 2023. 

 

  c. Preferred Stock

 

The Company has authorized 25,000,000 shares of preferred stock with a par value of $0.0001 authorized. No preferred stock was issued and outstanding as of September 30, 2024 and December 31, 2023.

 

  d. Warrants

 

Between February 13, 2023 and November 27, 2023, the Company entered into Securities Purchase Agreements with 30 accredited investors. In terms of these Securities Purchase Agreements, the Company issued five-year warrants to purchase an aggregate 5,696,586 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the 2023 Notes or the 2023 Warrants for public resale.

 

On August 11, 2023, the Company issued an investor a five-year replacement warrant for a warrant that had expired on February 13, 2023 exercisable for 33,334 shares of Common Stock at an exercise price of $1.50 per share.

 

In connection with the formation of IPSIPay Express, the Company issued to each of the other venture partners, OpenPath and EfinityPay, IPEX Warrants to purchase an aggregate of 133,334 shares of Common Stock with an exercise of $0.45 per share. The Company is obligated to issue each of OpenPath and EfinityPay additional IPEX Warrants to purchase 199,999 shares of Common Stock at a price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the remaining initial Tranche. Simultaneously with the funding of the second Tranche in September 2023, the Company became obligated to issue to each of OpenPath and EfinityPay an additional IPEX Warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the second Tranche. Simultaneously with the funding of the third Tranche, the Company will issue to each of OpenPath and EfinityPay an additional IPEX warrant to purchase 166,667 shares of Common Stock with an exercise price equal to the average public closing price of the Common Stock for the three trading days immediately prior to the funding of the third Tranche. If the full IPSI Capital Contribution is funded, OpenPath and EfinityPay will receive IPEX Warrants to purchase an aggregate of 1,333,334 shares of Common Stock. See note 1(b) above. As of the date of this Report, it is not expected that the full IPSI Capital Contribution will be required to be funded.

 

On December 14, 2023, the maturity date of two notes totaling $225,000 ($200,000 and $25,000, respectively) which matured on December 31, 2023 were extended for an additional 3 months to March 30, 2024. In exchange for the maturity date extension, the Company issued the note holders five-year warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share. On May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

  

During 2023, warrants exercisable for 33,334 shares expired as unexercised and an additional warrant exercisable for 1,000,000 shares of Common Stock was forfeited on the disposal of Frictionless and Beyond Fintech.

 

On March 4, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, as disclosed in note 12 above. In terms of the Securities Purchase Agreement, the Company issued a five-year warrant to purchase an aggregate of 357,764 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes maturing between February 13, 2024 and February 23, 2024 by an additional six months and as compensation for the extension, the note holders were issued warrants exercisable for 387,673 shares of Common Stock at an exercise price of $0.345 per share.

 

Between May 3, 2024 and May 28, 2024, the Company entered into a Securities Purchase Agreements with four accredited investors, as disclosed in note 12 above. In terms of the Securities Purchase Agreement, the Company issued five-year warrants to purchase an aggregate of 468,738 shares of the Common Stock at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The Company is under no obligation to register the shares of Common Stock underlying the Note or the Warrant, for public resale.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock at an exercise price of $0.345 per share.

 

On August 6, 2024, the Company received a conversion notice from the holder of RRH Note 2 (see Note 12). As a result of the conversion of the RRH Note 2, all warrants of the Company that contain price-based anti-dilution protection had the exercise price of such warrants adjusted to $0.084 per share and certain warrants of the Company that contain “full ratchet” anti-dilution price protection had the number of shares exercisable for such warrants increased by the full ratchet provision and the conversion prices of such warrants adjusted to $0.084 per share. Certain warrants exercisable for 3,145,342 shares of common stock at an exercise price of $0.345 per share, have a full ratchet provision which results in an increase in the number of shares of Common Stock exercisable for such warrants by 9,773,028 to a total number of shares of Common Stock exercisable for such warrants of 12,918,370 and a reduction in the exercise price to $0.084 per share from $0.345 per share, In addition to this, certain warrants exercisable for 457,897 shares of common stock have exercise price protection which reduced the exercise price of these warrants to $0.084 per share from $0.345 per share, resulting in a decrease in potential proceeds receivable from the exercise price of such warrants by $119,511. This resulted in a fair value adjustment charge of $2,478,211 of which $2,051,405 was recorded as a charge to the statement of comprehensive loss as it related to warrants subject to derivative liability treatment and $426,807 was recorded as a deemed dividend expense, as it related to a down round adjustment to the price of a warrant issued during the current year, which is not subject to derivative liability treatment.

 

The 2023 and 2024 Warrants contain exercise limitations providing that a holder thereof may not exercise the Warrants to the extent that, if after giving effect to such exercise, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

  

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

   Nine months ended
September 30,
2024
 
Exercise price  $0.084 to 0.345 
Risk free interest rate   3.73 to 4.56% 
Expected life   1 to 5 years 
Expected volatility of underlying stock   

177.78 to 191.17%

 
Expected dividend rate   0% 

 

A summary of warrant activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   1,506,638    0.345    0.345 
Increase in warrants issued due to anti-dilution price protection   9,773,028    0.084    0.084 
Forfeited   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   21,721,759   $0.084 – 5.625   $0.3196 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding and exercisable at September 30, 2024 are as follows:

 

    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$             0.084    13,376,267    3.12                  13,376,267                     3.12 
$0.345    6,959,041    3.89         6,959,041         3.89 
$0.450    266,668    3.73         266,668         3.73 
$1.035    500,000    0.77         500,000         0.77 
$1.500    33,334    3.87         33,334         3.87 
$4.50    505,560    1.46         505,560         1.46 
$5.625    80,889    1.46         80,889         1.46 
      21,721,759    3.28   $0.3196    21,721,759   $0.3196    3.28 

 

*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The warrants outstanding have an intrinsic value of $13,376 and $0 as of September 30, 2024 and 2023.

 

  e. Stock options

 

On June 18, 2018, the Company established its 2018 Stock Incentive Plan (the “Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in June 2028.

 

The Plan is administered by the Board or a committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the Plan is 26,667 shares of Common Stock. The maximum number of shares of Common Stock awarded to any individual during any fiscal year may not exceed 100,000 shares of Common Stock.

 

On October 22, 2021, the Company established its 2021 Stock Incentive Plan (“2021 Plan”). The purpose of the Plan is to promote the interests of the Company and the stockholders of the Company by providing directors, officers, employees and consultants, advisors and service providers of the Company with appropriate incentives and rewards to encourage them to enter into and continue in the employ or service of the Company, to acquire a proprietary interest in the long-term success of the Company and to reward the performance of individuals in fulfilling long-term corporate objectives. The Plan terminates after a period of ten years in August 2031.

 

The 2021 Plan is administered by the Board or a Compensation Committee appointed by the Board, who have the authority to administer the Plan and to exercise all the powers and authorities specifically granted to it under the Plan.

 

The maximum number of securities available under the 2021 Plan is 1,766,667 shares of Common Stock.

 

Under the 2021 Plan the Company may award the following: (i) non-qualified stock options; (ii)) incentive stock options; (iii) stock appreciation rights; (iv) restricted stock; (v) restricted stock unit; and (vi) other stock-based awards.

  

During 2023, the Company cancelled options exercisable for 23,891 shares of Common Stock due to the previous resignation or termination of employees and officers whose stock options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

During 2024, the Company options exercisable for 6,667 shares of Common Stock expired due to the resignation of a director whose options were not exercised in accordance with the terms allowed under the plan and were therefore canceled.

 

A summary of option activity during the period January 1, 2023 to September 30, 2024 is as follows:

 

   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   1,543,891   $1.20 to 12.00   $       4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (6,667)   1.20    1.20 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   1,513,335   $1.20 to 12.00   $4.47 

 

* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

The options outstanding and exercisable at September 30, 2024 are as follows:

 

    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    13,334       7.96                13,334         7.96 
$4.50    1,500,001    7.19         1,500,001         7.19 
      1,513,335    7.20   $     4.47    1,513,335   $       4.47          7.20 

 

The options outstanding have an intrinsic value of $0 as of September 30, 2024 and 2023.

 

The option expense was $31,488 and $94,464 for the three months ended September 30, 2024 and 2023, respectively, and $220,416 and $283,392 for the nine months ended September 30, 2024 and 2023, respectively.

v3.24.3
Loss on Convertible Notes
9 Months Ended
Sep. 30, 2024
Loss on Convertible Notes [Abstract]  
LOSS ON CONVERTIBLE NOTES
15 LOSS ON CONVERTIBLE NOTES

 

The loss on convertible notes consists of the following:

 

   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
Expense on extension of maturity date of convertible notes   -    
-
    102,352    
-
 
Loss on conversion of convertible notes   159,493    58,769    159,493    77,247 
Loss on anti-dilution price protection adjustment   4,318,669    
-
    4,318,669    
-
 
Loss on no notice default convertible note   56,329    
-
    56,329    
-
 
    4,534,491    58,769    4,636,843    77,247 

 

On March 14, 2024, the Company extended the maturity date of 11 convertible notes which matured between February 13, 2024 and February 23, 2024 by six months and issued the note holders additional warrants exercisable for 387,673 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

 

On May 4, 2024, the maturity date of two notes totaling $225,000 which originally matured on December 31, 2023 and which maturity dates were extended to March 30, 2024, on May 4, 2024, the maturity date of the $200,000 note was further extended to June 14, 2024, and the maturity date of the $25,000 note was further extended to June 30, 2024. In exchange for the maturity date extension, on June 14, 2024, the Company issued to note holders warrants exercisable for 292,463 shares of Common Stock, the modification of the terms and the issue of the new warrants was assessed as a debt extinguishment.

 

The debt extinguishments resulted in a charge of $0 and $102,352 for the three and nine months ended September 30, 2024, respectively.

 

Between August 6, 2024 and September 17, 2024, in terms of conversion notices received from 4 convertible note holders, the Company issued 2,365,663 shares of common stock for the conversion of $198,716 of convertible debt at a conversion price of $0.084 per share, realizing an aggregate loss on conversion of $159,493.

 

As a result of the conversion of the RRH Note 2 ( see note 12 above), included in the paragraph above, all other outstanding convertible notes of the Company that contain price-based anti-dilution protection had the conversion prices of such notes adjusted to $0.084 per share (the “Triggering Event”).

 

The value of the derivative liability related to the anti-dilution price protected convertible notes was evaluated immediately prior to the Triggering Event and immediately after the Triggering Event, resulting in an additional derivative liability and loss on convertible notes of $4,318,669. In addition, a payment was not made on a convertible note with a no notice default clause, resulting in the triggering of a variable priced conversion feature, which gave rise to a derivative liability on the payment due date, this gave rise to an additional loss on convertible notes of $56,329.

v3.24.3
Net Loss Per Share
9 Months Ended
Sep. 30, 2024
Net Loss Per Share [Abstract]  
NET LOSS PER SHARE
16 NET LOSS PER SHARE

 

Basic loss per share is based on the weighted-average number of Common Stock outstanding during each period. Diluted loss per share is based on basic shares as determined above plus Common Stock equivalents. The computation of diluted net loss per share does not assume the issuance of Common Stock that have an anti-dilutive effect on net loss per share. For the three and nine months ended September 30, 2024 and 2023 all warrants options and convertible debt securities were excluded from the computation of diluted net loss per share.

 

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2024 and 2023 are as follows:

 

  

Three and
nine months
ended
September 30,
2024

(Shares)

   Three and
nine months
ended
September 30, 
2023
(Shares)
 
Convertible debt   38,680,397    13,046,469 
Stock options   1,513,335    1,543,893 
Warrants to purchase shares of Common Stock   21,721,759    9,135,137 
    61,915,491    23,725,499 
v3.24.3
Related Party Transactions
9 Months Ended
Sep. 30, 2024
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS
17 RELATED PARTY TRANSACTIONS

 

The following transactions were entered into with related parties during the nine months ended September 30, 2024:

 

William Corbett

 

An option expense for options still vesting for Mr. Corbett was $22,196 and $66,587 for the three months ended September 30, 2024 and 2023, respectively and $155,369 and $199,760 for the nine months ended September 30, 2024 and 2023, respectively.

 

Richard Rosenblum

 

An option expense for options still vesting for Mr. Rosenblum was $9,292 and $27,879 for the three months ended September 30, 2024 and 2023, respectively and $65,047 and $83,636 for the nine months ended September 30, 2024 and 2023, respectively.

v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies [Abstract]  
COMMITMENTS AND CONTINGENCIES
18 COMMITMENTS AND CONTINGENCIES

 

The Company has notes payable and convertible notes payable, disclosed under Notes 11 and 12 above, which had and have maturity dates between May 22, 2024 and May 9, 2025. The Company may settle certain of the notes payable, at its option by the issue of shares of its Common Stock and should the convertible notes not be converted to Common Stock prior to their maturity dates, the Company may need to repay the principal and interest outstanding on these notes.

v3.24.3
Subsequent Events
9 Months Ended
Sep. 30, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS
19 SUBSEQUENT EVENTS

 

October 2024 Senior Promissory Notes

 

On October 10, 2024, the Company entered into two Securities Purchase Agreements with accredited investors, pursuant to which the Company issued two senior promissory notes each with a principal amount totaling $66,667 (totaling $133,334), for gross proceeds of $50,000 each (totaling $100,000), including an aggregate original issuance discount of $16,667 (totaling $33,334), for each note. The notes mature on October 10, 2025 and bear interest at 8.5% per annum.

 

October 2024 Convertible Promissory Notes

 

On October 22, 2024, the Company entered into a Securities Purchase Agreement with an accredited investor, pursuant to which the Company received an aggregate of $100,000 through the issuance of a convertible promissory note and a five-year warrant to purchase an aggregate of 289,855 shares of common stock, at an exercise price of $0.345 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The note matures on October 22, 2025 and bears interest at 8% per annum and are convertible into shares of Common Stock at a conversion price of $0.084 per share (as adjusted for stock splits, stock combinations, dilutive issuances and similar events). The note may be prepaid at any time without penalty. The Company is under no obligation to register the shares of Common Stock underlying the notes or the warrants for public resale.

 

The note and warrant contain conversion limitations providing that a holder thereof may not convert the notes or exercise the warrants, to the extent that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the outstanding shares of the Common Stock immediately after giving effect to such conversion or exercise. The holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.

 

Note Conversions

 

On October 11, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $33,922 (totaling $67,844) of the interest outstanding on the notes, into an aggregate of 403,829 (totaling 807,658) shares of common stock, at a conversion price of $0.084 per share.

 

On October 25, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $35,614 (totaling $71,229) of the interest outstanding on the notes into an aggregate of 423,981 (totaling 847,962) shares of common stock, at a conversion price of $0.084 per share.

 

On November 11, 2024, the Company received two conversion notices from two convertible note holders, each converting an aggregate of $37,392 (totaling $74,783) of interest and principal outstanding on the notes into an aggregate of 445,137 (totaling 890,274) shares of common stock, at a conversion price of $0.084 per share.

 

Other than the above, the Company has evaluated subsequent events through the date the financial statements were issued and did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

v3.24.3
Pay vs Performance Disclosure - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ (2,154,959) $ (1,015,143) $ (3,284,069) $ (4,462,750)
v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
Accounting Policies, by Policy (Policies)
9 Months Ended
Sep. 30, 2024
Accounting Policies and Estimates [Abstract]  
Basis of Presentation
  a) Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X. Accordingly, these unaudited condensed financial statements do not include all of the information and disclosures required by U.S. GAAP for complete financial statements. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments (consisting only of normal recurring adjustments), which the Company considers necessary, for a fair presentation of those financial statements. The results of operations and cash flows for the three months and nine months ended September 30, 2024 may not necessarily be indicative of results that may be expected for any succeeding quarter or for the entire fiscal year. The information contained in this Report should be read in conjunction with the audited financial statements of IPSI for the year ended December 31, 2023, included in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 29, 2024 and amended on April 17, 2024.

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Principles of Consolidation
  b) Principles of Consolidation

The unaudited condensed consolidated financial statements as of September 30, 2024, include the financial statements of the Company. The unaudited condensed consolidated financial statements as of September 30, 2023, include the financial statements of the Company and its subsidiary in which it has a majority voting interest, until May 12, 2023, the date of disposal of its Beyond Fintech subsidiary. Pursuant to the May 2023 Frictionless Agreement, the Company disposed of its 51% interest in Beyond Fintech. Therefore, the Company currently has no subsidiaries.

All significant inter-company accounts and transactions have been eliminated in the unaudited condensed consolidated financial statements.

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP.

All amounts referred to in the notes to the unaudited condensed consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Use of Estimates
  c) Use of Estimates

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions, which are evaluated on an ongoing basis, that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and judgments. In particular, significant estimates and judgments include those related to, the estimated useful lives for plant and equipment, the fair value of long-lived investments, the fair value of warrants and stock options granted for services, debt extinguishments or compensation, convertible notes and amendments thereto, derivative liabilities, the valuation allowance for deferred tax assets due to continuing operating losses and the allowance for doubtful accounts.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from our estimates.

 

Contingencies
  d) Contingencies

Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur.

The Company’s management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment.

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s unaudited condensed consolidated financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.

Fair Value of Financial Instruments
  e) Fair Value of Financial Instruments

The Company adopted the guidance of Accounting Standards Codification (“ASC”) 820 for fair value measurements which clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:

Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date.

Level 2 - Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data.

Level 3 - Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information.

The carrying amounts reported in the balance sheets for cash, accounts receivable, notes receivable, other current assets, other assets, accounts payable, accrued liabilities, and notes payable, approximate fair value due to the relatively short period to maturity for these instruments. The Company has identified the short-term convertible notes and certain warrants attached to certain of the notes that are required to be presented on the balance sheets at fair value in accordance with the accounting guidance.

ASC 825-10 “Financial Instruments” allows entities to voluntarily choose to measure certain financial assets and liabilities at fair value (fair value option). The fair value option may be elected on an instrument-by-instrument basis and is irrevocable unless a new election date occurs. If the fair value option is elected for an instrument, unrealized gains and losses for that instrument should be reported in earnings at each subsequent reporting date. We evaluate the fair value of variably priced derivative liabilities on a quarterly basis and report any movements thereon in earnings.

Risks and Uncertainties
  f) Risks and Uncertainties

The Company’s operations and prospects are and will be subject to significant risks and uncertainties including financial, operational, regulatory, and other risks, including the potential risk of business failure. In particular, there is a risk that that IPSIPay Express business (the commercial launch of which has taken longer than originally expected) may never generate revenue for the Company. There are also significant risks and uncertainties associated with the Company’s proposed merger with Business Warrior (see notes 1(c) and 6 for further information). Further, the ongoing wars in Ukraine and between Israel, Hamas and more recently, Hezbollah and uncertainties regarding the global economic environment which has resulted in a general tightening in the credit markets, lower levels of liquidity, increases in the rates of default and bankruptcy, and extreme volatility in credit, equity and fixed income markets. These conditions may not only limit the Company’s access to capital, but also make it difficult for its customers, vendors and the Company to accurately forecast and plan future business activities, which may have an adverse impact on its business and financial condition and may hamper the Company’s ability to generate revenue and access usual sources of liquidity on reasonable terms.

The Company’s results may be adversely affected by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, and rates and methods of taxation, among other things.

 

Recent accounting pronouncements
  g) Recent accounting pronouncements

The Financial Accounting Standards Board (“FASB”) issued additional updates during the quarter ended September 30, 2024. None of these standards are either applicable to the Company or require adoption at a future date and none are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements upon adoption.

Reporting by Segment
  h) Reporting by Segment

No segmental information is required as the Company has only one operating segment.

Cash and Cash Equivalents
  i) Cash and Cash Equivalents

The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. At September 30, 2024 and December 31, 2023, respectively, the Company had no cash equivalents.

The Company minimizes credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution in the United States. The balance at times may exceed federally insured limits. At September 30, 2024 and December 31, 2023, the balance did not exceed federally insured limits.

Accounts Receivable and Allowance for Doubtful Accounts
  j) Accounts Receivable and Allowance for Doubtful Accounts

Accounts receivable are reported at realizable value, net of allowances for doubtful accounts, which is estimated and recorded in the period the related revenue is recorded. The Company has a standardized approach to estimate and review the collectability of its receivables based on a number of factors, including the period they have been outstanding. Historical collection and payer reimbursement experience is an integral part of the estimation process related to allowances for doubtful accounts. In addition, the Company regularly assesses the state of its billing operations in order to identify issues, which may impact the collectability of these receivables or reserve estimates. Revisions to the allowance for doubtful accounts estimates are recorded as an adjustment to bad debt expense. Receivables deemed uncollectible are charged against the allowance for doubtful accounts at the time such receivables are written-off. Recoveries of receivables previously written-off are recorded as credits to the allowance for doubtful accounts. There were no recoveries during the period ended September 30, 2024 and 2023.

Investments
  k) Investments

The Company’s non-marketable equity securities are investments in privately held companies without readily determinable market values. The carrying value of our non-marketable equity securities is adjusted to fair value for observable transactions for identical or similar investments of the same issuer or impairment (referred to as the measurement alternative). All gains and losses on non-marketable equity securities, realized and unrealized, are recognized in other income (expense), net. Non-marketable equity securities that have been remeasured during the period are classified within Level 3 in the fair value hierarchy because the Company estimates the value based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the securities the Company holds. The cost method is used when the Company has a passive, long-term investment that doesn’t result in influence over the Company. The cost method is used when the investment results in an ownership stake of less than 20%, and there is no substantial influence. Under the cost method, the stock purchased is recorded on the balance sheet as a non-current asset at the historical acquisition/purchase price, and is not modified unless shares are sold, additional shares are purchased or there is evidence of the fair market value of the investment declining below carrying value. Any dividends received are recorded as income.

 

Plant and Equipment
  l) Plant and Equipment

Plant and equipment is stated at cost, less accumulated depreciation. Plant and equipment with costs greater than $1,000 are capitalized and depreciated. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are as follows:

Description  Estimated
Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years

The cost of repairs and maintenance is expensed as incurred. When assets are retired or disposed of, the cost and accumulated depreciation are removed from the accounts, and any resulting gains or losses are included in income in the year of disposition.

Long-Term Assets
  m) Long-Term Assets

Assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

Revenue Recognition
  n) Revenue Recognition

The Company’s revenue recognition policy is consistent with the requirements of FASB ASC 606, Revenue.

The Company’s revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those services. The Company derives its revenues from the sale of its services, as defined below. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its revenue transactions:

  i. identify the contract with a customer;
  ii. identify the performance obligations in the contract;
  iii. determine the transaction price;
  iv. allocate the transaction price to performance obligations in the contract; and
  v. recognize revenue as the performance obligation is satisfied.

The Company had minimal revenues of $0 and $410 for the nine months ended September 30, 2024 and 2023, respectively. 

 

Share-Based Payment Arrangements
  o) Share-Based Payment Arrangements

Generally, all forms of share-based payments, including stock option grants, restricted stock grants and stock appreciation rights are measured at their fair value on the awards’ grant date, based on the estimated number of awards that are ultimately expected to vest. Share-based compensation awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable. The expense resulting from share-based payments is recorded in operating expenses in the consolidated statement of operations.

Prior to the Company’s reverse merger which took place on May 12, 2016, all share-based payments were based on management’s estimate of market value of the Company’s equity. The factors considered in determining management’s estimate of market value include, assumptions of future revenues, expected cash flows, market acceptability of our technology and the current market conditions. These assumptions are complex and highly subjective, compounded by the business being in its early stage of development in a new market with limited data available.

Where equity transactions with arms-length third parties, who had applied their own assumptions and estimates in determining the market value of our equity, had taken place prior to and within a reasonable time frame of any share-based payments, the value of those share transactions have been used as the fair value for any share-based equity payments.

Where equity transactions with arms-length third parties included both shares and warrants, the value of the warrants have been eliminated from the unit price of the securities using a Black-Scholes valuation model to determine the value of the warrants. The assumptions used in the Black Scholes valuation model includes market related interest rates for risk-free government issued treasury securities with similar maturities; the expected volatility of the Common Stock based on companies operating in similar industries and markets; the estimated stock price of the Company; the expected dividend yield of the Company and; the expected life of the warrants being valued.

Subsequent to the Company’s reverse merger which took place on May 12, 2016, the Company has utilized the market value of its Common Stock as quoted on the OTCQB, as an indicator of the fair value of its Common Stock in determining share- based payment arrangements.

Derivative Liabilities
  p) Derivative Liabilities

ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re- measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.

Income Taxes
  q) Income Taxes

The Company is based in the U.S. and currently enacted U.S. tax laws are used in the calculation of income taxes.

Income taxes are computed using the asset and liability method. Under the asset and liability method, deferred income tax assets and liabilities are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the currently enacted tax rates and laws. A full valuation allowance is provided for the amount of deferred tax assets that, based on available evidence, are not expected to be realized. It is the Company’s policy to classify interest and penalties on income taxes as interest expense or penalties expense. As of September 30, 2024 and December 31, 2023, there have been no interest or penalties incurred on income taxes.

 

Comprehensive income
  r) Comprehensive income

Comprehensive income is defined as the change in equity of a company during a period from transactions and other events and circumstances excluding transactions resulting from investments from owners and distributions to owners. The Company does not have any comprehensive income (loss) for the periods presented.

Reclassification of prior year presentation
  s) Reclassification of prior year presentation

Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.

v3.24.3
Accounting Policies and Estimates (Tables)
9 Months Ended
Sep. 30, 2024
Accounting Policies and Estimates [Abstract]  
Schedule of Estimated Useful Lives of the Assets The estimated useful lives of the assets are as follows:
Description  Estimated
Useful Life
    
Computer equipment  3 years
    
Office equipment  10 years
v3.24.3
Disposal of Investment in Frictionless and Beyond Fintech (Tables)
9 Months Ended
Sep. 30, 2024
Disposal of Investment in Frictionless and Beyond Fintech [Abstract]  
Schedule of Assets and Liabilities Disposed The assets and liabilities disposed of were as follows:
   Amount 
Assets    
     
Current Assets    
Cash  $339 
      
Non-current assets     
Intangible assets   327,211 
Security deposit   15,000 
Investment   500,000 
    842,211 
Total assets   842,550 
      
Liabilities     
      
Current Liabilities     
Accounts payable   97,126 
      
Net assets sold   745,424 
Proceeds due on disposal   (250,000)
Net loss on disposal  $495,424 
v3.24.3
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2024
Discontinued Operations [Abstract]  
Schedule of Statement of Operations from Discontinued Operations The statement of operations from discontinued operations is as follows:
   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
                 
Net Revenue  $
               -
   $
               -
   $
               -
   $
               -
 
                     
Cost of Goods Sold   
-
    
-
    
-
    
-
 
                     
Gross loss   
-
    
-
    
-
    
-
 
                     
General and administrative   
-
    
-
    
-
    40,821 
Depreciation and amortization   
-
    
-
    
-
    
-
 
Total Expense   
-
    
-
    
-
    40,821 
                     
Loss from operations before income taxes   
-
    
-
    
-
    (40,821)
                     
Income Taxes   
-
    
-
    
-
    
-
 
Loss from discontinued operations, net of taxation  $
-
   $
-
   $
-
   $(40,821)
v3.24.3
Loans Receivable (Tables)
9 Months Ended
Sep. 30, 2024
Loans Receivable [Abstract]  
Schedule of Loans Receivable Loans receivable consists of the following:
Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
 
Business Warrior Corporation  0.0%  December 31, 2025  $226,190   $
-
   $(48,243)  $177,947 
   8.0%  November 1, 2024   30,000    677    
-
    30,677 
   8.0%  January 1, 2025   35,000    399         35,399 
   8.0%  February 1, 2025   50,000    263         50,263 
   8.0%  February 1, 2025   15,000    66         15,066 
Total convertible notes payable        $356,190   $1,405   $(48,243)  $309,352 
Disclosed as follows:                          
Current portion of notes receivable                       $131,405 
Long-term portion of notes receivable                        177,947 
                        $309,352 
v3.24.3
Equity Method Investment (Tables)
9 Months Ended
Sep. 30, 2024
Equity Method Investment [Abstract]  
Schedule of Equity Method Investments The Company accounts for its investment in IPSIPay Express in accordance with ASC 323, Investments – Equity Method and Joint Ventures, the movement in equity method investments related to IPSIPay Express for the period ended September 30, 2024 and December 31, 2023 is as follows:
   September 30,
2024
   December 31,
2023
 
Cash contribution to IPSIPay Express  $999,500   $999,000 
Fair value of warrants issued to third party joint venture partners   108,220    108,220 
    1,107,720    1,107,220 
Prior period equity loss from joint venture   (403,282)   (403,282)
Current period equity income (loss) from joint venture   (660)   
-
 
   $703,778   $703,938 
v3.24.3
Leases (Tables)
9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
Schedule of Total Lease Cost Incurred Individual components of the total lease cost incurred by the Company is as follows:
   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Operating lease expense  $
                -
   $40,704 
Other lease information:
   Nine months
ended
September 30,
2024
   Nine months
ended
September 30,
2023
 
Cash paid for amounts included in the measurement of lease liabilities        
Operating cash flows from operating leases  $
                -
   $(40,704)
           
Remaining lease term – operating lease   -    Monthly 
v3.24.3
Notes Payable (Tables)
9 Months Ended
Sep. 30, 2024
Notes Payable [Abstract]  
Schedule of Notes Payable Notes payable consists of the following:
Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.00%  October 31, 2024  $482,000   $85,689   $
-
   $567,689   $531,004 
Mercer Street Global Opportunity Fund, LLC  10.00%  October 31, 2024   482,000    85,689    
-
    567,689    531,003 
2024 notes  8.5%  February 28, 2025 to May 5, 2025   311,111    4,609    (60,869)   254,851    
-
 
Total notes payable        $1,275,111   $175,987   $(60,869)  $1,390,229   $1,062,007 
v3.24.3
Convertible Notes Payable (Tables)
9 Months Ended
Sep. 30, 2024
Convertible Notes Payable [Abstract]  
Schedule of Convertible Notes Payable Convertible notes payable consists of the following:
Description  Interest
Rate
  Maturity
date
  Principal   Accrued
Interest
   Unamortized
debt
discount
   September 30,
2024
Amount, net
   December 31,
2023
Amount, net
 
Cavalry Fund I LP  10.0%  October 31, 2024  $868,951   $46,925   $
-
   $915,876   $909,218 
Mercer Street Global  Opportunity Fund, LLC  10.0%  October 31, 2024   901,334    222,687    
-
    1,124,021    1,139,764 
Red Road Holdings Corporation*  29.32%  -   
-
    
-
    
-
    
-
    41,771 
   27.77%  -   
-
    
-
    
-
    
-
    18,683 
   32.04%  September 30, 2024   7,900    181    
-
    8,081    3,109 
   24.98%  December 30, 2024   88,500    11,657    (29,608)   70,549    
-
 
   24.51%  March 30, 2025   125,080    8,481    (81,437)   52,124    
-
 
Quick Capital, LLC*  11.12%  -   
-
    
-
    
-
    
-
    
-
 
   11.03%  November 28, 2024   57,144    6,871    (2,406)   61,609    
-
 
2023 and 2024 convertible notes   8.0 to 12.0%  May 22, 2024 to May 9, 2025   2,523,890    231,847    (71,175)   2,684,562    1,591,735 
Total convertible notes payable        $4,572,799   $528,649   $(184,626)  $4,916,822   $3,704,280 
* The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
v3.24.3
Derivative Liability (Tables)
9 Months Ended
Sep. 30, 2024
Derivative Liability [Abstract]  
Schedule of Assumptions were used in the Black-Scholes Valuation Model The following assumptions were used in the Black-Scholes valuation model:
   nine months
ended
September 30,
2024
   Year ended
December 31,
2023
 
Conversion price  $ 0.0491 to $0.345    $ 0.104 to $0.345 
Risk free interest rate   3.58 to 5.50 %    3.60 to 5.55% 
Expected life of derivative liability   1 to 35 months      3.5 to 47 months 
Expected volatility of underlying stock   24.3 to 262.09%      158.72 to 217.01% 
Expected dividend rate   0%    0% 
Schedule of Movement in Derivative Liability The movement in derivative liability is as follows:
   September 30,
2024
   December 31,
2023
 
Opening balance  $1,434,196   $2,550,642 
Derivative financial liability arising from convertible note and warrants   226,329    385,000 
Derivative liability arising on anti-dilutive convertible notes and warrants   6,370,074    
-
 
Fair value adjustment to derivative liability   (6,461,496)   (1,501,446)
   $1,569,103   $1,434,196 
v3.24.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2024
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Activity A summary of restricted stock activity during the period January 1, 2023 to September 30, 2024 is as follows:
   Total
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total
unvested
restricted
shares*
   Weighted
average
fair market
value per
share*
   Total vested
restricted
shares*
   Weighted
average
fair market
value per share*
 
Outstanding January 1, 2023   783,167   $1.50    170,792   $1.47    612,375   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    (170,792)   (1.47)   170,792    1.47 
Outstanding December 31, 2023   783,167   $1.50    
-
   $
-
    783,167   $1.50 
Granted and issued   
-
    
-
    
-
    
-
    
-
    
-
 
Forfeited/Cancelled   
-
    
-
    
-
    
-
    
-
    
-
 
Vested   
-
    
-
    
-
    
-
    
-
    
-
 
Outstanding September 30, 2024   783,167   $1.50    
-
   $
-
    783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Restricted Stock Granted Issued and Exercisable The restricted stock granted, issued and exercisable at September 30, 2024 is as follows:
    Restricted Stock
Granted and Vested
 
Grant date Price   Number Granted*   Weighted Average
Fair Value per Share*
 
$1.47              683,167   $     1.47 
$1.50    33,333    1.50 
$1.65    66,667    1.65 
      783,167   $1.50 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Fair Value of the Warrants Granted and Issued The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:
   Nine months ended
September 30,
2024
 
Exercise price  $0.084 to 0.345 
Risk free interest rate   3.73 to 4.56% 
Expected life   1 to 5 years 
Expected volatility of underlying stock   

177.78 to 191.17%

 
Expected dividend rate   0% 
Schedule of Warrant Activity A summary of warrant activity during the period January 1, 2023 to September 30, 2024 is as follows:
   Shares
Underlying
Warrants*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   5,186,376   $0.345 – 5.625   $0.9000 
Granted   6,289,051     0.345 – 1.50    0.3556 
Forfeited   (33,334)   1.50    1.5000 
Cancelled on disposal of investment in Frictionless and Beyond Fintech   (1,000,000)   0.345    0.3450 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   10,442,093   $0.345 – 5.625   $0.6265 
Granted   1,506,638    0.345    0.345 
Increase in warrants issued due to anti-dilution price protection   9,773,028    0.084    0.084 
Forfeited   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   21,721,759   $0.084 – 5.625   $0.3196 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.

 

Schedule of Warrants Outstanding and Exercisable The warrants outstanding and exercisable at September 30, 2024 are as follows:
    Warrants Outstanding*   Warrants Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$             0.084    13,376,267    3.12                  13,376,267                     3.12 
$0.345    6,959,041    3.89         6,959,041         3.89 
$0.450    266,668    3.73         266,668         3.73 
$1.035    500,000    0.77         500,000         0.77 
$1.500    33,334    3.87         33,334         3.87 
$4.50    505,560    1.46         505,560         1.46 
$5.625    80,889    1.46         80,889         1.46 
      21,721,759    3.28   $0.3196    21,721,759   $0.3196    3.28 
*After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Option Activity A summary of option activity during the period January 1, 2023 to September 30, 2024 is as follows:
   Shares
Underlying
options*
   Exercise
price per
share*
   Weighted
average
exercise
price*
 
Outstanding January 1, 2023   1,543,891   $1.20 to 12.00   $       4.47 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (23,889)  $1.20 to 12.00    5.41 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2023   1,520,002   $1.20 to 12.00   $4.46 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (6,667)   1.20    1.20 
Exercised   
-
    
-
    
-
 
Outstanding September 30, 2024   1,513,335   $1.20 to 12.00   $4.47 
* After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
Schedule of Options Outstanding and Exercisable The options outstanding and exercisable at September 30, 2024 are as follows:
    Options Outstanding*   Options Exercisable* 
Exercise Price*   Number
Outstanding*
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price*
   Number
Exercisable*
   Weighted
Average
Exercise
Price*
   Weighted
Average
Remaining
Contractual
life in years
 
$1.20    13,334       7.96                13,334         7.96 
$4.50    1,500,001    7.19         1,500,001         7.19 
      1,513,335    7.20   $     4.47    1,513,335   $       4.47          7.20 
v3.24.3
Loss on Convertible Notes (Tables)
9 Months Ended
Sep. 30, 2024
Loss on Convertible Notes [Abstract]  
Schedule of the Loss on Convertible Notes The loss on convertible notes consists of the following:
   Three months
ended
   Three months
ended
   Nine months
ended
   Nine months
ended
 
   September 30,   September 30,   September 30,   September 30, 
   2024   2023   2024   2023 
Expense on extension of maturity date of convertible notes   -    
-
    102,352    
-
 
Loss on conversion of convertible notes   159,493    58,769    159,493    77,247 
Loss on anti-dilution price protection adjustment   4,318,669    
-
    4,318,669    
-
 
Loss on no notice default convertible note   56,329    
-
    56,329    
-
 
    4,534,491    58,769    4,636,843    77,247 
v3.24.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Net Loss Per Share [Abstract]  
Schedule of Anti-dilutive Shares Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive for the three and nine months ended September 30, 2024 and 2023 are as follows:
  

Three and
nine months
ended
September 30,
2024

(Shares)

   Three and
nine months
ended
September 30, 
2023
(Shares)
 
Convertible debt   38,680,397    13,046,469 
Stock options   1,513,335    1,543,893 
Warrants to purchase shares of Common Stock   21,721,759    9,135,137 
    61,915,491    23,725,499 
v3.24.3
Organization and Description of Business (Details) - USD ($)
1 Months Ended 9 Months Ended
Nov. 30, 2023
Sep. 30, 2023
Sep. 05, 2023
Aug. 11, 2023
Aug. 04, 2023
Jun. 21, 2023
May 12, 2023
Dec. 30, 2022
Aug. 26, 2021
Jun. 21, 2021
Dec. 31, 2019
May 28, 2024
Sep. 30, 2024
Dec. 31, 2023
Nov. 01, 2019
Organization and Description of Business [Line Items]                              
Date of incorporation                         May 12, 2016    
Common stock, par value (in Dollars per share)                         $ 0.0001 $ 0.0001  
Aggregate shares of common stock                         621,920    
Retained shares of common stock                         500,000    
Reverse stock split                         1 for 30 reverse stock split    
Shares percentage                     9.00%        
Percentage of remaining shares owned                 49.00%            
Number of warrant purchase             1,000,000                
Credit consideration amount (in Dollars)             $ 250,000                
Credit receivables (in Dollars)             $ 231,431                
Capital contribution (in Dollars)                         $ 1,500,000    
Percentage of membership interest                         11.11%    
Joint venture percentage                         22.00%    
Shares of common stock                       468,738 1,333,334    
Exercise price per share (in Dollars per share)     $ 0.084         $ 1.2              
IPEX Warrant [Member]                              
Organization and Description of Business [Line Items]                              
Shares of common stock                         133,334    
Exercise price per share (in Dollars per share)                         $ 0.45    
Beyond Fintech Inc [Member]                              
Organization and Description of Business [Line Items]                              
Ownership percentage                 51.00%       51.00%    
Share-Based Payment Arrangement, Tranche One [Member]                              
Organization and Description of Business [Line Items]                              
Payments (in Dollars)         $ 300,000                    
Share-Based Payment Arrangement, Tranche Two [Member]                              
Organization and Description of Business [Line Items]                              
Payments (in Dollars)   $ 500,000                          
Share-Based Payment Arrangement, Tranche Three [Member]                              
Organization and Description of Business [Line Items]                              
Payments (in Dollars) $ 500,000                            
Maximum [Member]                              
Organization and Description of Business [Line Items]                              
Fractional shares                             320,477,867
Minimum [Member]                              
Organization and Description of Business [Line Items]                              
Fractional shares                             32,047,817
QPAGOS [Member]                              
Organization and Description of Business [Line Items]                              
Reverse stock split                         1-for-10    
Stock Purchase Agreement [Member]                              
Organization and Description of Business [Line Items]                              
Stock purchase agreement                     2,250,000        
Common Stock [Member]                              
Organization and Description of Business [Line Items]                              
Common stock outstanding, percentage                         91.00%    
Reverse stock split                         1 for 30    
Frictionless [Member]                              
Organization and Description of Business [Line Items]                              
Acquired interest                   1.00%          
Series of Individually Immaterial Business Acquisitions [Member]                              
Organization and Description of Business [Line Items]                              
Acquired interest                         45.00%    
Qpagos Corporation’s Capital Stock [Member]                              
Organization and Description of Business [Line Items]                              
Aggregate shares of common stock                         4,992,900    
Aggregate of shares                         2,500    
Vivi Holdings, Inc [Member]                              
Organization and Description of Business [Line Items]                              
Exchange shares                     2,250,000        
Gaston Pereira [Member]                              
Organization and Description of Business [Line Items]                              
Shares percentage                     5.00%        
Andrey Novikov [Member]                              
Organization and Description of Business [Line Items]                              
Shares percentage                     2.50%        
Joseph Abrams [Member]                              
Organization and Description of Business [Line Items]                              
Shares percentage                     1.50%        
Frictionless Financial Technologies, Inc.[Member]                              
Organization and Description of Business [Line Items]                              
Variable interest entity ownership percentage                   10.00%          
Common stock outstanding percentage                   41.00%          
Purchase price (in Dollars)                   $ 300,000          
Three Tranches [Member]                              
Organization and Description of Business [Line Items]                              
Capital contribution (in Dollars)                         $ 500,000    
Tranche [Member]                              
Organization and Description of Business [Line Items]                              
Payments (in Dollars)           $ 200,000                  
Shares of common stock                         199,999    
Second Tranche [Member]                              
Organization and Description of Business [Line Items]                              
Shares of common stock                         166,667    
Third Tranche [Member]                              
Organization and Description of Business [Line Items]                              
Shares of common stock                         166,667    
Common Stock [Member]                              
Organization and Description of Business [Line Items]                              
Common stock, par value (in Dollars per share)                         $ 0.0001    
Common stock shares holder current                         500,000    
Exercise price per share (in Dollars per share)       $ 1.5                      
Common Stock [Member] | Qpagos Corporation’s Capital Stock [Member]                              
Organization and Description of Business [Line Items]                              
Aggregate shares of common stock                         497,500    
v3.24.3
Accounting Policies and Estimates (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Aug. 26, 2021
Accounting Policies and Estimates [Line Items]          
Operating segment     1    
Plant and equipment costs $ 1,000   $ 1,000    
Revenues $ (28) $ 410  
Beyond Fintech Inc. [Member]          
Accounting Policies and Estimates [Line Items]          
Ownership percentage 51.00%   51.00%   51.00%
Long Term Investment [Member]          
Accounting Policies and Estimates [Line Items]          
Ownership percentage 20.00%   20.00%    
v3.24.3
Accounting Policies and Estimates (Details) - Schedule of Estimated Useful Lives of the Assets
Sep. 30, 2024
Computer equipment [Member]  
Schedule of Estimated Useful Lives of the Assets [Line Items]  
Estimated Useful Life 3 years
Office equipment [Member]  
Schedule of Estimated Useful Lives of the Assets [Line Items]  
Estimated Useful Life 10 years
v3.24.3
Liquidity Matters and Going Concern (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Liquidity Matters and Going Concern [Line Items]                
Net loss $ (1,728,152) $ (797,645) $ (331,465) $ (1,015,143) $ (3,174,217) $ (274,987) $ (2,857,262) $ (4,464,347)
v3.24.3
Disposal of Investment in Frictionless and Beyond Fintech (Details) - USD ($)
May 12, 2023
Sep. 30, 2024
Dec. 31, 2023
Aug. 26, 2021
Disposal of Investment in Frictionless and Beyond Fintech [Line Items]        
Class of Warrant or Right, Outstanding (in Shares) 1,000,000      
Common stock previously issued (in Shares)   16,185,552 13,819,889  
Credits against invoices percent 20.00%      
Frictionless Financial Technologies, Inc.[Member]        
Disposal of Investment in Frictionless and Beyond Fintech [Line Items]        
Common stock previously issued (in Shares) 30,000,000      
Frictionless Financial Technologies, Inc.[Member]        
Disposal of Investment in Frictionless and Beyond Fintech [Line Items]        
Ownership interest 10.00%     49.00%
Shares coverted amount (in Dollars) $ 250,000      
Beyond Fintech [Member]        
Disposal of Investment in Frictionless and Beyond Fintech [Line Items]        
Ownership interest 51.00%     51.00%
v3.24.3
Disposal of Investment in Frictionless and Beyond Fintech (Details) - Schedule of Assets and Liabilities Disposed - Assets and Liabilities Disposed [Member]
9 Months Ended
Sep. 30, 2024
USD ($)
Current Assets  
Cash $ 339
Non-current assets  
Intangible assets 327,211
Security deposit 15,000
Investment 500,000
Total Non-Current Assets 842,211
Total Assets 842,550
Current Liabilities  
Accounts payable 97,126
Net assets sold 745,424
Proceeds due on disposal (250,000)
Net loss on disposal $ 495,424
v3.24.3
Discontinued Operations (Details) - Schedule of Statement of Operations from Discontinued Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Schedule of Statement of Operations From Discontinued Operations [Abstract]        
Net Revenue
Cost of Goods Sold
Gross loss
General and administrative 40,821
Depreciation and amortization
Total Expense 40,821
Loss from operations before income taxes (40,821)
Income Taxes
Loss from discontinued operations, net of taxation $ (40,821)
v3.24.3
Loans Receivable (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 22, 2024
Sep. 30, 2024
Sep. 30, 2024
May 04, 2024
Dec. 14, 2023
Loans Receivable [Line Items]          
Principal amount       $ 25,000 $ 225,000
Original issue discount equal $ 67,857        
Net proceeds from issuance of convertible notes $ 158,333        
Percentage of amount equals prepayment of note 110.00%        
Aggregate principal amount.     $ 130,000    
Discount amortized to income as deemed interest   $ 8,407 19,614    
Interest earned   $ 1,333 $ 1,405    
BZWR Note [Member]          
Loans Receivable [Line Items]          
Principal amount $ 226,190        
Interest accrues percentage 15.00%        
Business Warrior Corporation [Member]          
Loans Receivable [Line Items]          
Interest accrues percentage     8.00%    
Common Stock [Member] | BZWR Note [Member]          
Loans Receivable [Line Items]          
Conversion price per share (in Dollars per share) $ 0.0036        
v3.24.3
Loans Receivable (Details) - Schedule of Loans Receivable - USD ($)
9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Schedule of Loans Receivable [Line Items]    
Amount, net $ 177,947
Disclosed as follows:    
Current portion of notes receivable 131,405
Long-term portion of notes receivable 177,947
Total convertible notes payable, Amount, net $ 309,352  
Business Warrior Corporation [Member]    
Schedule of Loans Receivable [Line Items]    
Interest Rate 0.00%  
Maturity date Dec. 31, 2025  
Principal $ 226,190  
Accrued Interest  
Unamortized debt discount (48,243)  
Amount, net 177,947  
Disclosed as follows:    
Long-term portion of notes receivable $ 177,947  
Business Warrior Corporation One [Member]    
Schedule of Loans Receivable [Line Items]    
Interest Rate 8.00%  
Maturity date Nov. 01, 2024  
Principal $ 30,000  
Accrued Interest 677  
Unamortized debt discount  
Amount, net 30,677  
Disclosed as follows:    
Long-term portion of notes receivable $ 30,677  
Business Warrior Corporation Two [Member]    
Schedule of Loans Receivable [Line Items]    
Interest Rate 8.00%  
Maturity date Jan. 01, 2025  
Principal $ 35,000  
Accrued Interest 399  
Amount, net 35,399  
Disclosed as follows:    
Long-term portion of notes receivable $ 35,399  
Business Warrior Corporation Three [Member]    
Schedule of Loans Receivable [Line Items]    
Interest Rate 8.00%  
Maturity date Feb. 01, 2025  
Principal $ 50,000  
Accrued Interest 263  
Amount, net 50,263  
Disclosed as follows:    
Long-term portion of notes receivable $ 50,263  
Business Warrior Corporation Four [Member]    
Schedule of Loans Receivable [Line Items]    
Interest Rate 8.00%  
Maturity date Feb. 01, 2025  
Principal $ 15,000  
Accrued Interest 66  
Amount, net 15,066  
Disclosed as follows:    
Long-term portion of notes receivable 15,066  
Convertible Notes Payable [Member] | Loans Receivables [Member]    
Schedule of Loans Receivable [Line Items]    
Principal 356,190  
Accrued Interest 1,405  
Unamortized debt discount (48,243)  
Amount, net 309,352  
Disclosed as follows:    
Long-term portion of notes receivable $ 309,352  
v3.24.3
Intangibles (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Aug. 26, 2021
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2021
May 12, 2023
Intangibles [Line Items]              
Gross proceeds $ 250,000         $ 375,000  
Additional amount for acquisition $ 77,211         $ 1,171,805  
Amortization expense   $ 0 $ 93,095 $ 0 $ 347,298    
Beyond Fintech [Member]              
Intangibles [Line Items]              
Ownership percentage 51.00%           51.00%
Frictionless [Member]              
Intangibles [Line Items]              
Ownership percentage 49.00%           10.00%
v3.24.3
Equity Method Investment (Details)
Sep. 30, 2024
USD ($)
Equity Method Investment [Abstract]  
Capital contribution initial tranche amount $ 500,000
Capital contribution second tranche amount $ 500,000
v3.24.3
Equity Method Investment (Details) - Schedule of Equity Method Investments - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Schedule of Equity Method Investments [Abstract]    
Cash contribution to IPSIPay Express $ 999,500 $ 999,000
Fair value of warrants issued to third party joint venture partners 108,220 108,220
Equity total 1,107,720 1,107,220
Prior period equity loss from joint venture (403,282) (403,282)
Current period equity income (loss) from joint venture (660)
Joint venture total $ 703,778 $ 703,938
v3.24.3
Leases (Details) - USD ($)
9 Months Ended
Jan. 01, 2023
Sep. 30, 2024
Leases [Abstract]    
Lease terminate   The lease commenced on April 1, 2021 and is for a twelve-month period, terminating on April 1, 2022
Rent payments $ 5,088 $ 4,800
v3.24.3
Leases (Details) - Schedule of Total Lease Cost Incurred - USD ($)
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Schedule Of Total Lease Cost Incurred Abstract    
Operating lease expense $ 40,704
Cash paid for amounts included in the measurement of lease liabilities    
Operating cash flows from operating leases $ (40,704)
Remaining lease term – operating lease Monthly
v3.24.3
Federal Relief Loans (Details) - USD ($)
Jul. 07, 2020
Sep. 30, 2024
Dec. 31, 2023
Federal Relief Loans [Line Items]      
Federal relief loans   $ 7,670 $ 9,369
Small Business Economic Injury Disaster Loan [Member]      
Federal Relief Loans [Line Items]      
Loan amount $ 150,000    
Interest rate 3.75%    
Loan monthly payment $ 731    
v3.24.3
Notes Payable (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 16, 2021
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Aug. 06, 2024
May 28, 2024
May 04, 2024
Mar. 04, 2024
Dec. 14, 2023
Nov. 27, 2023
Dec. 31, 2022
Notes Payable [Line Items]                        
Interest expense   $ 28,489 $ 24,635 $ 77,980 $ 73,371              
Amortization of debt discount   $ 14,248 $ 0 16,908 $ 0              
Exercise price (in Dollars per share)           $ 0.084 $ 0.084       $ 0.345  
Non-convertible promissory notes $ 482,000                      
Aggregate original issue discount       77,778                
Warrant [Member]                        
Notes Payable [Line Items]                        
Class of warrant or right number of securities called by warrants $ 2,486,957                      
Exercise price (in Dollars per share)           $ 0.345   $ 0.345 $ 0.084 $ 0.345    
Warrants       $ 43,608                
Cavalry and Mercer [Member]                        
Notes Payable [Line Items]                        
Interest rate 12.50%                      
Debt principal amount $ 572,000                      
Amendment Transaction [Member]                        
Notes Payable [Line Items]                        
Interest rate       10.00%                
Maturity date       Dec. 30, 2023                
Conversion shares issued (in Shares)       51,901,711                
2024 Notes [Member]                        
Notes Payable [Line Items]                        
Issued amount       $ 5                
Gross proceeds       $ 233,333                
Bear interest, percentage   8.50%   8.50%                
Premium cash amount       120.00%                
Amendment Transaction [Member]                        
Notes Payable [Line Items]                        
Non-convertible promissory notes                       $ 482,000
Notes issued       $ 964,000                
Purchase Agreements [Member] | 2024 Notes [Member]                        
Notes Payable [Line Items]                        
Gross proceeds       3,111,111                
Cavalry Fund I LP [Member]                        
Notes Payable [Line Items]                        
Company received 500,500                      
Debt principal amount   $ 868,951   868,951                
Mercer Street Global Opportunity Fund, LLC [Member]                        
Notes Payable [Line Items]                        
Company received $ 500,500                      
Debt principal amount   901,334   901,334                
Convertible Debt [Member]                        
Notes Payable [Line Items]                        
Convertible debt   $ 920,392   $ 920,392                
Common Stock [Member]                        
Notes Payable [Line Items]                        
Exercise price (in Dollars per share)               $ 0.345        
Common Stock [Member] | Warrant [Member]                        
Notes Payable [Line Items]                        
Exercise price (in Dollars per share) $ 0.24                      
v3.24.3
Notes Payable (Details) - Schedule of Notes Payable - Note Payable [Member] - USD ($)
9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Schedule of Notes Payable [Line Items]    
Principal $ 1,275,111  
Accrued Interest 175,987  
Unamortized debt discount (60,869)  
Amount, net $ 1,390,229 $ 1,062,007
Cavalry Fund I LP [Member]    
Schedule of Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date Oct. 31, 2024  
Principal $ 482,000  
Accrued Interest 85,689  
Unamortized debt discount  
Amount, net $ 567,689 531,004
Mercer Street Global Opportunity Fund, LLC [Member]    
Schedule of Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date Oct. 31, 2024  
Principal $ 482,000  
Accrued Interest 85,689  
Unamortized debt discount  
Amount, net $ 567,689 531,003
2023 and 2024 notes [Member]    
Schedule of Notes Payable [Line Items]    
Interest Rate 8.50%  
Principal $ 311,111  
Accrued Interest 4,609  
Unamortized debt discount (60,869)  
Amount, net $ 254,851
Maturity date February 28, 2025 to May 5, 2025  
v3.24.3
Convertible Notes Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 30, 2025
Feb. 28, 2025
Jan. 30, 2025
Dec. 31, 2024
Dec. 30, 2024
Nov. 30, 2024
Oct. 30, 2024
Sep. 30, 2024
Sep. 17, 2024
Sep. 10, 2024
Sep. 06, 2024
Sep. 05, 2024
Aug. 20, 2024
Aug. 06, 2024
Jun. 25, 2024
May 28, 2024
Apr. 02, 2024
Mar. 14, 2024
Mar. 04, 2024
Nov. 30, 2023
Nov. 20, 2023
Oct. 19, 2023
Oct. 14, 2023
Sep. 09, 2023
Sep. 05, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 11, 2023
Jul. 28, 2023
May 19, 2023
Mar. 14, 2023
Dec. 30, 2022
Dec. 28, 2022
Feb. 03, 2022
Feb. 16, 2021
Sep. 17, 2024
Dec. 20, 2023
Jun. 20, 2023
Nov. 16, 2022
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
May 04, 2024
Dec. 14, 2023
Nov. 27, 2023
Convertible Notes Payable [Line Items]                                                                                            
Warrant exercisable (in Shares)               1,304,348                                                               1,304,348   1,304,348       5,696,586
Non-convertible promissory notes                                                                     $ 482,000                      
Purchase an additional shares (in Shares)                                                                                   426,807        
Common stock price per share (in Dollars per share)                                                               $ 1.8                            
Exercise price per share (in Dollars per share)                                                 $ 0.084             1.2                            
Aggregate amount                                                                 $ 2,264,784                          
Convertible notes                           $ 28,984                                           $ 159,493           $ 836,414        
Black-scholes valuation model                                                                                   1,499,577        
Convertible note holders                           $ 2,165,578                                                                
Market warrant cost                                                                                   43,608        
Value of notes               $ 964,000                                                               $ 964,000   964,000        
Holders amount                                                                                   841,003        
Interest expense                                                                               28,489 $ 24,635 77,980 $ 73,371      
Amortization of debt discount total                                                                                   $ 77,778        
Common stock conversion price (in Shares)                           164,679       387,673     963,769           963,769                                      
Conversion price per share (in Dollars per share)                           $ 0.084                                                                
Loss on conversion                   $ 32,253   $ 32,253                             $ 42,210                                      
Penalty amount                     $ 2,000     $ 4,611                                                                
Conversion of common stock (in Shares)                           164,679                                                                
Commencing shares (in Shares)                                     30,875                   15,429                                  
Exercise warrant shares (in Shares)                               734,694                                                            
Warrants exercise price (in Dollars per share)                           $ 0.084   $ 0.084                                                           $ 0.345
Accrues penalty interest                                                                                   24.00%        
Beneficially own of percentage                                                                                   4.99%        
Limitation exceeds of percentage                                                                                   9.99%        
Principal amount                                                                                       $ 25,000 $ 225,000  
Warrant [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Additional shares of common stock (in Shares)                                                                                   100,000        
Exercise price per share (in Dollars per share)                                                                                   $ 4.5        
Warrant exercisable (in Shares)                           457,897                                                                
Purchase an additional shares (in Shares)                                                                     1,730,057                      
Exercise price per share (in Dollars per share)                                                                 $ 0.345                          
Convertible note holders               $ 2,051,405                                                               $ 2,051,405   $ 2,051,405        
Exercise warrant shares (in Shares)                           457,897         1,469,388                                                      
Warrants exercise price (in Dollars per share)                           $ 0.345         $ 0.084                                                 $ 0.345 $ 0.345  
Warrants exercise price per share (in Dollars per share)                           0.084                                                                
Principal amount                                                                                       $ 225,000    
Cavalry and Mercer [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Maturity date                                                                   Aug. 16, 2022                        
Interest rate percentage               20.00%                                                               20.00%   20.00%        
Shares of underlying common stock (in Shares)               100,000                                                               100,000   100,000        
Aggregate amount                                                                 $ 1,132,392                          
Convertible note holders               $ 238,182                                                               $ 238,182   $ 238,182        
Exchange Notes [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Maturity date                                                                     Dec. 30, 2023                      
Interest rate percentage                                                                     10.00%                      
Cavalry/Mercer Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Additional Charge                                                                                   $ 920,392        
Mercer Street Global Opportunity Fund, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)                         $ 0.084                       0.084                                          
Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)               $ 0.345                                                               $ 0.345   $ 0.345        
Original issue discount                                                                                   $ 2,684,562        
Accrued interest               $ 1,676,666                                                               $ 1,676,666   $ 1,676,666        
Variable conversion rate percentage               8.00%                                                               8.00%   8.00%        
Purchase of aggregate shares (in Shares)                                                                                   5,696,586        
Aggregate of shares (in Shares)               289,856                                                               289,856   289,856        
Warrants exercise price per share (in Dollars per share)                                                                                   $ 0.345        
Exercise price per share (in Dollars per share)                                                                                       $ 0.345 $ 0.345  
Warrant Exercise Price (in Shares)                                                             387,673                              
Common stock exercise price (in Dollars per share)                                                             $ 0.345                              
Warrant value                                                             $ 66,047                              
Issuance of convertible note                                                                                   $ 71,175        
RRH [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)                 $ 0.084         $ 0.084                                           $ 0.084                    
Debt instrument, periodic payment                           $ 13,833                                                                
Accrued Interest [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Principal amount               $ 186,789                                                               $ 186,789   186,789        
Quick Capital, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)                     $ 0.084                                                                      
Convertible notes                     $ 13,965                                                                      
Converted interest                     32,906                                                                      
Repaid amount                 $ 92,523   $ 92,523                                                                      
2023 and 2024 Convertible Notes [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Aggregate amount                                                                                 2,026,666   2,026,666      
Convertible notes                                                                                   475,002        
Red Road Holdings Corporation and Quick Capital LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest expense                                                                               121,916 83,829 351,764 212,886      
Amortization of debt discount total                                                                               219,700 $ 303,042 857,284 $ 414,696      
Cavalry Fund LP [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage                                                                     10.00%       20.00%              
Conversion price, per share (in Dollars per share)                       $ 0.345                                                                    
Warrant exercisable (in Shares)                                                                     82,899                      
Purchase an additional shares (in Shares)                                                                             100,000              
Exercise price per share (in Dollars per share)                       $ 0.084                                             $ 7.2       $ 4.5              
Net proceeds                                                                     $ 500,500                      
Original issue discount                                                                     71,500                      
Senior secured convertible note                                                                     $ 572,000                      
Initial conversion price per share (in Dollars per share)                                                                     $ 0.23                      
Converted interest                   $ 31,527   $ 30,029                             $ 139,726                                      
Common stock conversion price (in Shares)                                         192,774                                                  
Conversion price per share (in Dollars per share)                                         $ 0.345           $ 0.345                                      
Accrued interest               915,876                                                               915,876   915,876        
Mercer Street Global Opportunity Fund, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage                                                                             20.00%              
Conversion price, per share (in Dollars per share)                                                 $ 0.345                                          
Warrant exercisable (in Shares)                                                                     82,899                      
Purchase an additional shares (in Shares)                                                                             100,000              
Exercise price per share (in Dollars per share)                                                                     $ 7.2       $ 4.5              
Net proceeds                                                                     $ 500,500                      
Original issue discount                                                                     572,000                      
Senior secured convertible note                                                                     $ 71,500                      
Accrued interest               1,124,021                                                               1,124,021   1,124,021        
Original issue discount rate                                                                     10.00%                      
Conversion price (in Dollars per share)                                                                     $ 6.9                      
Mercer Converted [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Converted interest                         $ 90,420                         $ 100,000       $ 100,000                                
Common stock conversion price (in Shares)                         1,076,433                       1,076,433 289,856       289,856                                
Conversion price per share (in Dollars per share)                                                   $ 0.345       $ 0.345                                
Loss on conversion                         $ 84,291                       $ 84,291         $ 48,551                                
Diagonal Street Lending LLC [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Accrued interest                                               $ 125,000                                            
Net of unamortized debt discount                                               $ 21,900                                            
Diagonal Street Lending LLC [Member] | Accrued Interest [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Accrued interest               70,549                                                               70,549   70,549        
Net of unamortized debt discount               29,608                                                               29,608   29,608        
Red Road Holdings Corporation [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Repayment debt                                       $ 9,222     $ 18,444                           $ 8,082                  
Red Road Holdings Corporation [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage                                 15.00%         13.00%   13.00%                         15.00%                  
Original issue discount                                 $ 88,500         $ 73,450   $ 146,900                         $ 63,250                  
Accrued interest               52,124                 70,000         60,000                             50,000     52,124   52,124        
Net of unamortized debt discount               81,437                 $ 18,500         $ 13,450                             $ 13,250     $ 81,437   $ 81,437        
Effective interest rate                                 24.98%         27.80%   29.30%                         32.00%                  
Repayment debt               $ 61,065                                                                            
Variable conversion rate percentage               65.00%                       60.00%       60.00%                         60.00%     65.00%   65.00%        
Red Road Holdings Corporation [Member] | Note 4 Plus Accrued Interest [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Accrued interest               $ 8,081                                                               $ 8,081   $ 8,081        
Red Road Holdings Corporation [Member] | Accrued Interest [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage                             15.00%                                                              
Original issue discount                             $ 125,080                                                              
Accrued interest                             100,000                                                              
Net of unamortized debt discount                             $ 25,080                                                              
Effective interest rate                             24.51%                                                              
Variable conversion rate percentage                             65.00%                                                              
Converted [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Converted interest                           $ 13,833                                                                
Quick Capital, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Warrant exercisable (in Shares)                               178,882     357,764                                                      
Exercise price per share (in Dollars per share)                               $ 0.084                                           $ 0.084                
Net proceeds                                     $ 94,000                                                      
Original issue discount                               $ 57,144                                                            
Senior secured convertible note                               10,644     $ 20,286                                                      
Accrued interest               61,610               $ 46,500                                               61,610   61,610        
Original issue discount rate                               11.03%     11.12%                                                      
Conversion price (in Dollars per share)                               $ 0.345                                                            
Net of unamortized debt discount               2,406                                                               2,406   2,406        
Quick Capital, LLC [Member] | Warrant [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Accrued interest               $ 2,597                                                               $ 2,597   $ 2,597        
Quick Capital, LLC [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Original issue discount                                     $ 114,286                                                      
Conversion price (in Dollars per share)                                     $ 0.345                                                      
Maximum [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)               $ 4.5                                                               $ 4.5   $ 4.5        
Warrant exercisable (in Shares)                           12,918,370                                                                
Warrants exercise price (in Dollars per share)                           $ 0.084                                                                
Principal amount                                                                                         $ 200,000  
Maximum [Member] | Warrant [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Warrants exercise price per share (in Dollars per share)                           $ 0.345                                                                
Principal amount                                                                                         200,000  
Maximum [Member] | Cavalry and Mercer [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)               $ 4.5                                                               $ 4.5   $ 4.5        
Maximum [Member] | Cavalry Fund LP [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price per share (in Dollars per share)                                                                             4.5              
Maximum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)                                                               4.5                            
Maximum [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage               12.00%                                                               12.00%   12.00%        
Minimum [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)               $ 0.345                                                               $ 0.345   $ 0.345        
Warrant exercisable (in Shares)                           9,773,028                                                                
Warrants exercise price (in Dollars per share)                           $ 0.345                                                                
Principal amount                                                                                         25,000  
Minimum [Member] | Warrant [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Principal amount                                                                                         $ 25,000  
Minimum [Member] | Cavalry and Mercer [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)               $ 0.345                                                               $ 0.345   $ 0.345        
Minimum [Member] | Cavalry Fund LP [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price per share (in Dollars per share)                                                                             $ 0.345              
Minimum [Member] | Mercer Street Global Opportunity Fund, LLC [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Conversion price, per share (in Dollars per share)                                                               $ 0.345                            
Minimum [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Interest rate percentage               8.00%                                                               8.00%   8.00%        
Note Two [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Warrant exercisable (in Shares)                                                                                       292,463 292,463  
Principal amount                                                                                       $ 25,000 $ 225,000  
Common Stock [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Exercise price per share (in Dollars per share)                                                       $ 1.5                                    
Common stock conversion price (in Shares)                   732,815   732,815                                                                    
Conversion price per share (in Dollars per share)                   $ 0.084   $ 0.084                                                                    
Conversion of common stock (in Shares)                     391,736                                                                      
Warrants exercise price (in Dollars per share)                                                                                       $ 0.345    
Common Stock [Member] | Warrant [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Warrants exercise price (in Dollars per share)                                                                     $ 0.24                      
Forecast [Member] | Red Road Holdings Corporation [Member] | Convertible Note [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Debt instrument, periodic payment         $ 13,570 $ 13,570 $ 13,570                                                                              
Forecast [Member] | Red Road Holdings Corporation [Member] | Accrued Interest [Member]                                                                                            
Convertible Notes Payable [Line Items]                                                                                            
Repayment debt $ 16,782 $ 16,782 $ 16,782 $ 93,498                                                                                    
v3.24.3
Convertible Notes Payable (Details) - Schedule of Convertible Notes Payable - USD ($)
9 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Schedule of Convertible Notes Payable [Line Items]    
Amount, net $ 4,916,822 $ 3,704,280
Cavalry Fund I LP [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date October 31, 2024  
Principal $ 868,951  
Accrued Interest 46,925  
Unamortized debt discount  
Amount, net $ 915,876 909,218
Mercer Street Global Opportunity Fund, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 10.00%  
Maturity date October 31, 2024  
Principal $ 901,334  
Accrued Interest 222,687  
Unamortized debt discount  
Amount, net $ 1,124,021 1,139,764
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 29.32%  
Maturity date [1] -  
Principal [1]  
Accrued Interest [1]  
Unamortized debt discount [1]  
Amount, net [1] 41,771
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 27.77%  
Maturity date [1] -  
Principal [1]  
Accrued Interest [1]  
Unamortized debt discount [1]  
Amount, net [1] 18,683
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 32.04%  
Maturity date [1] September 30, 2024  
Principal [1] $ 7,900  
Accrued Interest [1] 181  
Unamortized debt discount [1]  
Amount, net [1] $ 8,081 3,109
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 24.98%  
Maturity date [1] December 30, 2024  
Principal [1] $ 88,500  
Accrued Interest [1] 11,657  
Unamortized debt discount [1] (29,608)  
Amount, net [1] $ 70,549
Red Road Holdings Corporation [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 24.51%  
Maturity date [1] March 30, 2025  
Principal [1] $ 125,080  
Accrued Interest [1] 8,481  
Unamortized debt discount [1] (81,437)  
Amount, net [1] $ 52,124
Quick Capital, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 11.12%  
Maturity date [1] -  
Principal [1]  
Accrued Interest [1]  
Unamortized debt discount [1]  
Amount, net [1]
Quick Capital, LLC [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate [1] 11.03%  
Maturity date [1] November 28, 2024  
Principal [1] $ 57,144  
Accrued Interest [1] 6,871  
Unamortized debt discount [1] (2,406)  
Amount, net [1] $ 61,609
2023 and 2024 Convertible Notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Maturity date May 22, 2024 to May 9, 2025  
Principal $ 2,523,890  
Accrued Interest 231,847  
Unamortized debt discount (71,175)  
Amount, net 2,684,562 1,591,735
Total Convertible Notes Payable [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Principal 4,572,799  
Accrued Interest 528,649  
Unamortized debt discount (184,626)  
Amount, net $ 4,916,822 $ 3,704,280
Minimum [Member] | 2023 and 2024 Convertible Notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 8.00%  
Maximum [Member] | 2023 and 2024 Convertible Notes [Member]    
Schedule of Convertible Notes Payable [Line Items]    
Interest Rate 12.00%  
[1] The Red Road Holdings Corporation and Quick Capital LLC, interest rates are an effective interest rate as these convertible notes have a fixed interest charge which is earned on the issuance date, regardless of when payments are made.
v3.24.3
Derivative Liability (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 06, 2024
Mar. 14, 2024
Nov. 20, 2023
Aug. 24, 2023
May 28, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 17, 2024
Jun. 25, 2024
May 04, 2024
Apr. 02, 2024
Mar. 04, 2024
Dec. 31, 2023
Dec. 20, 2023
Dec. 14, 2023
Nov. 27, 2023
Sep. 12, 2023
Derivative Liability [Abstract]                                      
Convertible notes                     $ 170,000   $ 235,000     $ 268,873     $ 416,317
Converted shares (in Shares) 164,679 387,673 963,769 963,769                              
Warrants per share (in Dollars per share) $ 0.084       $ 0.084                         $ 0.345  
Convertible notes $ 2,165,578                                    
Warrants exercisable (in Shares) 3,145,342 387,673       6,667   6,667             33,334        
Exercise price per share (in Dollars per share) $ 0.345       $ 0.345                            
Exercisable warrants (in Shares)         734,694                            
Proceeds from warrants $ 119,511                                    
Derivative liability           $ 4,318,669   $ 4,318,669                      
Derivative liability movements           5,538,008 $ 1,795,642 6,461,496 $ 1,483,710                    
Black Scholes Valuation Model [Member]                                      
Derivative Liability [Abstract]                                      
Derivative liability           56,329   56,329                      
Derivative liability movements           5,538,008   6,461,496                      
Warrant [Member]                                      
Derivative Liability [Abstract]                                      
Warrants per share (in Dollars per share) $ 0.345                     $ 0.345   $ 0.084     $ 0.345    
Convertible notes           $ 2,051,405   $ 2,051,405                      
Warrants exercisable (in Shares) 3,145,342                                    
Exercisable warrants (in Shares) 457,897                         1,469,388          
RRH [Member]                                      
Derivative Liability [Abstract]                                      
Remaining principal $ 13,833                                    
Conversion price (in Dollars per share) $ 0.084                 $ 0.084                  
Convertible Notes [Member]                                      
Derivative Liability [Abstract]                                      
Conversion price (in Dollars per share) 0.084                 $ 0.084                  
Convertible Notes [Member] | Warrant [Member]                                      
Derivative Liability [Abstract]                                      
Conversion price (in Dollars per share) 0.084                                    
Triggering Event [Member]                                      
Derivative Liability [Abstract]                                      
Warrants per share (in Dollars per share) $ 0.084                                    
Common Stock [Member]                                      
Derivative Liability [Abstract]                                      
Warrants exercisable (in Shares) 9,773,028                                    
Common Stock [Member] | Warrant [Member]                                      
Derivative Liability [Abstract]                                      
Warrants per share (in Dollars per share) $ 0.084                                    
Exercisable warrants (in Shares) 12,918,370                                    
v3.24.3
Derivative Liability (Details) - Schedule of Assumptions were used in the Black-Scholes Valuation Model
Sep. 30, 2024
Dec. 31, 2023
Conversion price [Member] | Minimum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 0.0491 0.104
Conversion price [Member] | Maximum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 0.345 0.345
Risk free interest rate [Member] | Minimum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 3.58 3.6
Risk free interest rate [Member] | Maximum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 5.5 5.55
Expected life of derivative liability [Member] | Minimum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 1 3.5
Expected life of derivative liability [Member] | Maximum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 35 47
Expected volatility of underlying stock [Member] | Minimum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 24.3 158.72
Expected volatility of underlying stock [Member] | Maximum [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 262.09 217.01
Expected dividend rate [Member]    
Schedule of Assumptions were used in the Black-Scholes Valuation Model [Line Items]    
Derivative measurement inputs 0 0
v3.24.3
Derivative Liability (Details) - Schedule of Movement in Derivative Liability - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Schedule of Movement in Derivative Liability [Abstract]    
Opening balance $ 1,434,196 $ 2,550,642
Derivative financial liability arising from convertible note and warrants 226,329 385,000
Derivative liability arising on anti-dilutive convertible notes and warrants 6,370,074
Fair value adjustment to derivative liability (6,461,496) (1,501,446)
Ending balance $ 1,569,103 $ 1,434,196
v3.24.3
Stockholders’ Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 10, 2024
Sep. 05, 2024
Aug. 06, 2024
May 04, 2024
Mar. 14, 2024
Mar. 04, 2024
Nov. 20, 2023
Nov. 08, 2023
Sep. 05, 2023
Aug. 31, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
Aug. 11, 2023
May 19, 2023
Dec. 30, 2022
Oct. 22, 2021
Feb. 16, 2021
Sep. 17, 2024
May 28, 2024
Sep. 30, 2024
Sep. 30, 2023
Jun. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 14, 2023
Nov. 27, 2023
Dec. 31, 2022
Stockholders’ Equity [Line Items]                                                          
Common stock authorized                                         750,000,000     750,000,000   750,000,000      
Common stock par value (in Dollars per share)                                         $ 0.0001     $ 0.0001   $ 0.0001      
Common stock issued                                         16,185,552     16,185,552   13,819,889      
Common stock outstanding                                         16,185,552     16,185,552   13,819,889      
Common stock conversion shares             500,000 289,855   144,928 2,838 173,914 72,464   72,464       2,365,663                    
Convertible debt (in Dollars)             $ 172,500 $ 100,000   $ 50,000   $ 60,000 $ 25,000   $ 25,000       $ 198,716   $ 358,209 $ 193,769 $ 43,478            
Shares converted     164,679   387,673   963,769         963,769                                  
Common stock conversion price (in Dollars per share)     $ 0.084                                                    
Exercise price increase (in Dollars per share)     $ 0.345                                 $ 0.345                  
Exercisable shares     3,145,342   387,673                               6,667     6,667   33,334      
Additional paid in capital                                               426,807          
Aggregate loss on conversion (in Dollars)     $ 28,984                               $ 159,493         $ 836,414          
Description of reverse stock split                                               1 for 30 reverse stock split          
Preferred stock, authorized                                         25,000,000     25,000,000   25,000,000      
Preferred stock, par value (in Dollars per share)                                         $ 0.0001     $ 0.0001   $ 0.0001      
Preferred stock, issued                                         0     0   0      
Preferred stock, outstanding                                         0     0   0      
Warrant purchase                                         1,304,348     1,304,348       5,696,586  
Exercise price (in Dollars per share)     $ 0.084                                 $ 0.084               $ 0.345  
Exercise price per share (in Dollars per share)                 $ 0.084             $ 1.2                          
Principal amount (in Dollars)       $ 25,000                                             $ 225,000    
Warrants exercisable       292,463                                             292,463    
Extension of maturity date       Jun. 30, 2024                                                  
Exercisable shares                                                   1,000,000      
Agreement fee (in Dollars)           $ 357,764                                              
Exercise price per share (in Dollars per share)         $ 0.345 $ 0.345                                              
Purchase shares of common stock                                       468,738       1,333,334          
Expense (in Dollars)       $ 200,000                                                  
Warrants exercise price (in Dollars)     $ 119,511                                                    
fair value adjustment (in Dollars)     2,478,211                                                    
Comprehensive loss (in Dollars)     2,051,405                                                    
Derivative liability (in Dollars)     $ 426,807                                   $ 1,569,103     $ 1,569,103   $ 1,434,196     $ 2,550,642
Limitation exceeds percentage                                               9.99%          
Options outstanding intrinsic value (in Dollars)                                         0 13,376   $ 0 $ 13,376        
Option expense (in Dollars)                                         $ 94,464 31,488   $ 220,416 $ 283,392        
Warrant [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Exercisable shares     3,145,342                                                    
Number of shares exercisable [1]                                         21,721,759     21,721,759          
Additional paid in capital                                   1,730,057                      
Warrant purchase     457,897                                                    
Exercise price (in Dollars per share)     $ 0.345 $ 0.345   $ 0.084                                         $ 0.345    
Purchase an aggregate shares                           33,334                              
Principal amount (in Dollars)       $ 225,000                                                  
Warrants exercisable       292,463                                                  
Option expense (in Dollars)       $ 25,000                                                  
Exercise per share (in Dollars per share)     0.084                                                    
Warrant exercise price (in Dollars per share)     $ 0.084                                                    
RRH [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Remaining principal (in Dollars)     $ 13,833                                                    
Conversion price (in Dollars per share)     $ 0.084                               $ 0.084                    
Maximum [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Number of shares exercisable     12,918,370                                                    
Conversion price (in Dollars per share)                                         $ 4.5     $ 4.5          
Warrant purchase     12,918,370                                                    
Exercise price (in Dollars per share)     $ 0.084                                                    
Principal amount (in Dollars)                                                     $ 200,000    
Warrants beneficially percentage                                               4.99%          
Shares of common stock                                         26,667     26,667          
Maximum [Member] | Warrant [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Exercise price decrease (in Dollars per share)     0.345                                                    
Principal amount (in Dollars)                                                     200,000    
Exercise per share (in Dollars per share)     $ 0.345                                                    
Minimum [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Exercisable shares     3,145,342                                                    
Conversion price (in Dollars per share)                                         $ 0.345     $ 0.345          
Warrant purchase     9,773,028                                                    
Exercise price (in Dollars per share)     $ 0.345                                                    
Principal amount (in Dollars)                                                     25,000    
Minimum [Member] | Warrant [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Exercise price increase (in Dollars per share)     $ 0.084                                                    
Principal amount (in Dollars)                                                     $ 25,000    
Preferred Stock [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Common stock conversion shares                                                        
Convertible debt (in Dollars)                                                    
Preferred stock, authorized                                         25,000,000     25,000,000          
Preferred stock, par value (in Dollars per share)                                         $ 0.0001     $ 0.0001          
Preferred stock, issued                                         0     0          
Preferred stock, outstanding                                                   0      
2021 Stock Incentive Plan [Member] | Maximum [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Shares of common stock                                         1,766,667     1,766,667          
OpenPath and EfinityPay [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Warrant purchase                                         133,334 166,667   133,334 166,667        
Exercise price (in Dollars per share)                                         $ 0.45     $ 0.45          
OpenPath and EfinityPay [Member] | Additional Warrants [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Warrant purchase                                         199,999 166,667   199,999 166,667        
IPSI Common Stock [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Warrant purchase                                           1,333,334     1,333,334        
Restricted stock awards [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Expense (in Dollars)                                         $ 0 $ 0   $ 0 $ 0        
2018 Stock Incentive Plan [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Terminates period                                               10 years          
2021 Stock Incentive Plan [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Terminates period                                 10 years                        
Common Stock [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Common stock authorized                                         750,000,000     750,000,000          
Common stock par value (in Dollars per share)                                         $ 0.0001     $ 0.0001          
Common stock issued                                         16,185,552     16,185,552          
Common stock outstanding                                                   819,889      
Shares converted 732,815 732,815                                                      
Common stock conversion price (in Dollars per share) $ 0.084 $ 0.084                                                      
Exercise price (in Dollars per share)       $ 0.345                                                  
Exercise price per share (in Dollars per share)                           $ 1.5                              
Options exercisable shares                                                   23,891      
Common Stock [Member] | Warrant [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Exercise price (in Dollars per share)                                   $ 0.24                      
Common Stock [Member] | Maximum [Member]                                                          
Stockholders’ Equity [Line Items]                                                          
Shares of common stock                                         100,000     100,000          
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Restricted Stock Activity - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Total restricted shares [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total restricted shares, Outstanding at beginning [1] 783,167 783,167
Total restricted shares, Granted and issued [1]
Total restricted shares, Forfeited/Cancelled [1]
Total restricted shares, Vested [1]
Total restricted shares, Outstanding at ending [1] 783,167 783,167
Weighted average fair market value per share [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.5
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1]
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
Total unvested restricted shares [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 170,792
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] (170,792)
Total unvested restricted shares, Outstanding at ending [1]
Unvested restricted Weighted average fair market value per share [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.47
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] (1.47)
Weighted average fair market value per share, Outstanding at ending [1]
Total vested restricted shares [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Total unvested restricted shares, Outstanding at beginning [1] 783,167 612,375
Total unvested restricted shares, Granted and issued [1]
Total unvested restricted shares, Forfeited/Cancelled [1]
Total unvested restricted shares, Vested [1] 170,792
Total unvested restricted shares, Outstanding at ending [1] 783,167 783,167
Vested restricted Weighted average fair market value per share [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average fair market value per share, Outstanding at beginning [1] $ 1.5 $ 1.5
Weighted average fair market value per share, Granted and issued [1]
Weighted average fair market value per share, Forfeited/Cancelled [1]
Weighted average fair market value per share, Vested [1] 1.47
Weighted average fair market value per share, Outstanding at ending [1] $ 1.5 $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Restricted Stock Granted, Issued and Exercisable
9 Months Ended
Sep. 30, 2024
$ / shares
shares
[1]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Granted and Vested, Number Granted | shares 783,167
Restricted Stock Granted and Vested, Weighted Average Fair Value per Share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.47 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Granted and Vested, Number Granted | shares 683,167
Restricted Stock Granted and Vested, Weighted Average Fair Value per Share (in Dollars per share) | $ / shares $ 1.47
Grant Date Price 1.50 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Granted and Vested, Number Granted | shares 33,333
Restricted Stock Granted and Vested, Weighted Average Fair Value per Share (in Dollars per share) | $ / shares $ 1.5
Grant Date Price 1.65 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Restricted Stock Granted and Vested, Number Granted | shares 66,667
Restricted Stock Granted and Vested, Weighted Average Fair Value per Share (in Dollars per share) | $ / shares $ 1.65
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Fair Value of the Warrants Granted and Issued - Warrants [Member]
Sep. 30, 2024
Exercise Price [Member] | Minimum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 0.084
Exercise Price [Member] | Maximum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 0.345
Risk free Interest Rate [Member] | Minimum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 3.73
Risk free Interest Rate [Member] | Maximum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 4.56
Expected Life [Member] | Minimum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 1
Expected Life [Member] | Maximum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 5
Expected Volatility of Underlying Stock [Member] | Minimum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 177.78
Expected Volatility of Underlying Stock [Member] | Maximum [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 191.17
Expected Dividend Rate [Member]  
Schedule of Fair Value of the Warrants Granted and Issued [Line Items]  
Fair value of the warrants granted and issued 0
v3.24.3
Stockholders’ Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Schedule of Warrant Activity [Line Items]    
Shares Underlying, Outstanding (in Shares) [1] 10,442,093 5,186,376
Exercise price per share, Outstanding [1]  
Weighted average exercise price, Outstanding [1] $ 0.6265 $ 0.9
Shares Underlying, Outstanding (in Shares) [1] 21,721,759 10,442,093
Exercise price per share, Outstanding [1]  
Weighted average exercise price, Outstanding [1] $ 0.3196 $ 0.6265
Shares Underlying, Granted (in Shares) [1] 1,506,638 6,289,051
Exercise price per share, Granted $ 0.345  
Weighted average exercise price, Granted [1] $ 0.345 $ 0.3556
Shares Underlying, Increase in warrants issued due to anti-dilution price protection (in Shares) 9,773,028  
Exercise price per share, Increase in warrants issued due to anti-dilution price protection $ 0.084  
Weighted average exercise price, Increase in warrants issued due to anti-dilution price protection $ 0.084  
Shares Underlying, Forfeited (in Shares) [1] (33,334)
Exercise price per share, Forfeited [1] $ 1.5
Weighted average exercise price, Forfeited [1] $ 1.5
Shares Underlying, Cancelled on disposal of investment in Frictionless and Beyond Fintech (in Shares) [1]   (1,000,000)
Exercise price per share, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]   $ 0.345
Weighted average exercise price, Cancelled on disposal of investment in Frictionless and Beyond Fintech [1]   $ 0.345
Shares Underlying, Exercised (in Shares) [1]
Exercise price per share, Exercised [1]
Weighted average exercise price, Exercised [1]
Minimum [Member]    
Schedule of Warrant Activity [Line Items]    
Exercise price per share, Outstanding [1] 0.345 0.345
Exercise price per share, Outstanding [1] 0.084 0.345
Exercise price per share, Granted [1]   0.345
Maximum [Member]    
Schedule of Warrant Activity [Line Items]    
Exercise price per share, Outstanding [1] 5.625 5.625
Exercise price per share, Outstanding [1] $ 5.625 5.625
Exercise price per share, Granted [1]   $ 1.5
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Warrants Outstanding and Exercisable - Warrant [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 21,721,759 [1]
Weighted Average Remaining Contractual life in years 3 years 3 months 10 days [1]
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.3196 [1]
Number Exercisable 21,721,759 [1]
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 0.3196 [1]
Weighted Average Remaining Contractual life in years 3 years 3 months 10 days
Exercise Price 0.084 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 13,376,267 [1]
Weighted Average Remaining Contractual life in years 3 years 1 month 13 days [1]
Number Exercisable 13,376,267 [1]
Weighted Average Remaining Contractual life in years 3 years 1 month 13 days
Exercise Price 0.345 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 6,959,041 [1]
Weighted Average Remaining Contractual life in years 3 years 10 months 20 days [1]
Number Exercisable 6,959,041 [1]
Weighted Average Remaining Contractual life in years 3 years 10 months 20 days
Exercise Price 0.450 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 266,668 [1]
Weighted Average Remaining Contractual life in years 3 years 8 months 23 days [1]
Number Exercisable 266,668 [1]
Weighted Average Remaining Contractual life in years 3 years 8 months 23 days
Exercise Price 1.035 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 500,000 [1]
Weighted Average Remaining Contractual life in years 9 months 7 days [1]
Number Exercisable 500,000 [1]
Weighted Average Remaining Contractual life in years 9 months 7 days
Exercise Price 1.500 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 33,334 [1]
Weighted Average Remaining Contractual life in years 3 years 10 months 13 days [1]
Number Exercisable 33,334 [1]
Weighted Average Remaining Contractual life in years 3 years 10 months 13 days
Exercise Price 4.50 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 505,560 [1]
Weighted Average Remaining Contractual life in years 1 year 5 months 15 days [1]
Number Exercisable 505,560 [1]
Weighted Average Remaining Contractual life in years 1 year 5 months 15 days
Exercise Price 5.625 [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Outstanding 80,889 [1]
Weighted Average Remaining Contractual life in years 1 year 5 months 15 days [1]
Number Exercisable 80,889 [1]
Weighted Average Remaining Contractual life in years 1 year 5 months 15 days
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Option Activity - Stock Option [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Shares Underlying, Outstanding (in Shares) [1] 1,520,002 1,543,891
Weighted average exercise price, Outstanding [1] $ 4.46 $ 4.47
Shares Underlying, Outstanding (in Shares) [1] 1,513,335 1,520,002
Weighted average exercise price, Outstanding [1] $ 4.47 $ 4.46
Shares Underlying, Granted (in Shares) [1]
Exercise price per share, Granted [1]
Weighted average exercise price, Granted [1]
Shares Underlying, Forfeited/Cancelled (in Shares) [1] (6,667) (23,889)
Exercise price per share, Forfeited/Cancelled [1] $ 1.2
Weighted average exercise price, Forfeited/Cancelled [1] $ 1.2 $ 5.41
Shares Underlying, Exercised (in Shares) [1]
Exercise price per share, Exercised [1]
Weighted average exercise price, Exercised [1]
Minimum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price per share, Outstanding [1] 1.2 1.2
Exercise price per share, Outstanding [1] 1.2 1.2
Exercise price per share, Forfeited/Cancelled [1]   1.2
Maximum [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Exercise price per share, Outstanding [1] 12 12
Exercise price per share, Outstanding [1] $ 12 12
Exercise price per share, Forfeited/Cancelled [1]   $ 12
[1] After giving effect to a 1 for 30 reverse stock split on August 30, 2023.
v3.24.3
Stockholders’ Equity (Details) - Schedule of Options Outstanding and Exercisable - Option [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,513,335
Weighted Average Remaining Contractual life in years 7 years 2 months 12 days
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.47
Number Exercisable 1,513,335
Weighted Average Exercise Price (in Dollars per share) | $ / shares $ 4.47
Weighted Average Remaining Contractual life in years 7 years 2 months 12 days
Exercise Price 1.20 [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 13,334
Weighted Average Remaining Contractual life in years 7 years 11 months 15 days
Number Exercisable 13,334
Weighted Average Remaining Contractual life in years 7 years 11 months 15 days
Exercise Price 4.50 [Member]  
Schedule of Options Outstanding and Exercisable [Line Items]  
Number Outstanding 1,500,001
Weighted Average Remaining Contractual life in years 7 years 2 months 8 days
Number Exercisable 1,500,001
Weighted Average Remaining Contractual life in years 7 years 2 months 8 days
v3.24.3
Loss on Convertible Notes (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Aug. 06, 2024
May 04, 2024
Mar. 14, 2024
Nov. 20, 2023
Nov. 08, 2023
Aug. 31, 2023
Aug. 30, 2023
Aug. 24, 2023
Aug. 16, 2023
May 19, 2023
Sep. 17, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Jun. 14, 2024
Loss on Convertible Notes [Line Items]                                
Additional warrants exercisable for shares of common stock (in Shares) 164,679   387,673 963,769       963,769                
Debt extinguishments                       $ 0   $ 102,352    
Shares of common stock (in Shares)       500,000 289,855 144,928 2,838 173,914 72,464 72,464 2,365,663          
Conversion of convertible debt to equity                     $ 198,716     198,716 $ 160,000  
Loss on conversion of convertible notes                     $ 159,493 159,493 $ 58,769 159,493 77,247  
Derivative liability                       4,318,669 4,318,669  
Loss on no notice default convertible note                       $ 56,329 $ 56,329  
Warrant [Member]                                
Loss on Convertible Notes [Line Items]                                
Warrant exercisable share (in Shares)                               292,463
Two Notes [Member]                                
Loss on Convertible Notes [Line Items]                                
Debt original amount   $ 225,000                            
Original due date   Dec. 31, 2023                            
Debt Instrument, Maturity Date   Mar. 30, 2024                            
Note One [Member]                                
Loss on Convertible Notes [Line Items]                                
Debt Instrument, Maturity Date   Jun. 14, 2024                            
Principle amount   $ 200,000                            
Notes two [Member]                                
Loss on Convertible Notes [Line Items]                                
Debt Instrument, Maturity Date   Jun. 30, 2024                            
Principle amount   $ 25,000                            
Convertible Notes [Member]                                
Loss on Convertible Notes [Line Items]                                
Conversion price (in Dollars per share) $ 0.084                   $ 0.084          
Convertible Notes [Member] | Warrant [Member]                                
Loss on Convertible Notes [Line Items]                                
Conversion price (in Dollars per share) $ 0.084                              
Triggering Event [Member]                                
Loss on Convertible Notes [Line Items]                                
Conversion price (in Dollars per share)                       $ 0.084   $ 0.084    
v3.24.3
Loss on Convertible Notes (Details) - Schedule of the Loss on Convertible Notes - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 17, 2024
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Schedule of the Loss on Convertible Notes [Abstract]          
Expense on extension of maturity date of convertible notes     $ 102,352
Loss on conversion of convertible notes $ 159,493 $ 159,493 58,769 159,493 77,247
Loss on anti-dilution price protection adjustment   4,318,669 4,318,669
Loss on no notice default convertible note   56,329 56,329
Total loss on convertible notes   $ 4,534,491 $ 58,769 $ 4,636,843 $ 77,247
v3.24.3
Net Loss Per Share (Details) - Schedule of Anti-dilutive Shares - shares
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 61,915,491 23,725,499
Convertible debt [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 38,680,397 13,046,469
Stock Options [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 1,513,335 1,543,893
Warrants to purchase shares of Common Stock [Member]    
Schedule of Anti-dilutive Shares [Line Items]    
Anti-dilutive shares 21,721,759 9,135,137
v3.24.3
Related Party Transactions (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
William Corbett [Member]        
Related Party Transaction [Line Items]        
Option vesting $ 22,196 $ 66,587 $ 155,369 $ 199,760
Richard Rosenblum [Member]        
Related Party Transaction [Line Items]        
Option vesting $ 9,292 $ 27,879 $ 65,047 $ 83,636
v3.24.3
Commitments and Contingencies (Details) - Note Payable [Member]
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies [Line Items]  
Maturity date May 09, 2025
Convertible Notes Payable [Member]  
Commitments and Contingencies [Line Items]  
Maturity date May 22, 2024
v3.24.3
Subsequent Events (Details) - USD ($)
1 Months Ended 9 Months Ended
Nov. 11, 2024
Oct. 25, 2024
Oct. 22, 2024
Oct. 11, 2024
Oct. 10, 2024
Aug. 06, 2024
Sep. 17, 2024
Sep. 30, 2024
Oct. 25, 2025
May 28, 2024
May 04, 2024
Mar. 04, 2024
Dec. 14, 2023
Nov. 27, 2023
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)           $ 0.084       $ 0.084       $ 0.345
Conversion principal interest           $ 28,984 $ 159,493 $ 836,414            
Conversion of stock issue (in Shares)           164,679                
Conversion price per share (in Dollars per share)           $ 0.084                
Convertible Promissory Notes [Member]                            
Subsequent Event [Line Items]                            
Percentage of limitation               9.99%            
Warrant [Member]                            
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)           0.084                
Exercise price per share (in Dollars per share)           0.345         $ 0.345 $ 0.084 $ 0.345  
Securities Purchase Agreement [Member]                            
Subsequent Event [Line Items]                            
Conversion percentage               4.99%            
Convertible Note [Member]                            
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)               $ 0.345            
Conversion price per share (in Dollars per share)               $ 0.345            
Convertible percentage               8.00%            
Convertible Promissory Notes [Member]                            
Subsequent Event [Line Items]                            
Debt instrument mature date               Oct. 22, 2025            
Minimum [Member]                            
Subsequent Event [Line Items]                            
Conversion price per share (in Dollars per share)               $ 0.345            
Exercise price per share (in Dollars per share)           0.345                
Maximum [Member]                            
Subsequent Event [Line Items]                            
Conversion price per share (in Dollars per share)               $ 4.5            
Exercise price per share (in Dollars per share)           0.084                
Maximum [Member] | Warrant [Member]                            
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)           $ 0.345                
Subsequent Event [Member]                            
Subsequent Event [Line Items]                            
Gross proceeds         $ 50,000                  
Principal         33,334                  
Convertible Warrant Promissory Note     5 years                      
Conversion price per share (in Dollars per share) $ 0.084 $ 0.084   $ 0.084                    
Subsequent Event [Member] | Warrant [Member]                            
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)     $ 0.345                      
Subsequent Event [Member] | Securities Purchase Agreement [Member]                            
Subsequent Event [Line Items]                            
Principal amount         66,667                  
Issued of promissory notes         133,334                  
Gross proceeds         100,000                  
Principal         $ 16,667                  
Subsequent Event [Member] | Convertible Note [Member]                            
Subsequent Event [Line Items]                            
Exercise price per share (in Dollars per share)     100,000                      
Conversion price per share (in Dollars per share)     0.084                      
Subsequent Event [Member] | Convertible Note [Member] | Warrant [Member]                            
Subsequent Event [Line Items]                            
Conversion price per share (in Dollars per share)     $ 289,855                      
Subsequent Event [Member] | Minimum [Member]                            
Subsequent Event [Line Items]                            
Conversion principal interest $ 37,392 $ 35,614   $ 33,922                    
Conversion of stock issue (in Shares) 445,137 423,981   403,829                    
Subsequent Event [Member] | Maximum [Member]                            
Subsequent Event [Line Items]                            
Conversion principal interest $ 74,783 $ 71,229   $ 67,844                    
Conversion of stock issue (in Shares) 890,274 847,962   807,658                    
Forecast [Member] | Securities Purchase Agreement [Member]                            
Subsequent Event [Line Items]                            
Percentage of Bears interest rate                 8.50%          

Innovative Payment Solut... (QB) (USOTC:IPSI)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Innovative Payment Solut... (QB) Charts.
Innovative Payment Solut... (QB) (USOTC:IPSI)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Innovative Payment Solut... (QB) Charts.